AFLATOXIN A M EDICAL D ICTIONARY , B IBLIOGRAPHY , AND A NNOTATED R ESEARCH G UIDE TO I NTERNET R E FERENCES
J AMES N. P ARKER , M.D. AND P HILIP M. P ARKER , P H .D., E DITORS
ii
ICON Health Publications ICON Group International, Inc. 4370 La Jolla Village Drive, 4th Floor San Diego, CA 92122 USA Copyright 2004 by ICON Group International, Inc. Copyright 2004 by ICON Group International, Inc. All rights reserved. This book is protected by copyright. No part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without written permission from the publisher. Printed in the United States of America. Last digit indicates print number: 10 9 8 7 6 4 5 3 2 1
Publisher, Health Care: Philip Parker, Ph.D. Editor(s): James Parker, M.D., Philip Parker, Ph.D. Publisher's note: The ideas, procedures, and suggestions contained in this book are not intended for the diagnosis or treatment of a health problem. As new medical or scientific information becomes available from academic and clinical research, recommended treatments and drug therapies may undergo changes. The authors, editors, and publisher have attempted to make the information in this book up to date and accurate in accord with accepted standards at the time of publication. The authors, editors, and publisher are not responsible for errors or omissions or for consequences from application of the book, and make no warranty, expressed or implied, in regard to the contents of this book. Any practice described in this book should be applied by the reader in accordance with professional standards of care used in regard to the unique circumstances that may apply in each situation. The reader is advised to always check product information (package inserts) for changes and new information regarding dosage and contraindications before prescribing any drug or pharmacological product. Caution is especially urged when using new or infrequently ordered drugs, herbal remedies, vitamins and supplements, alternative therapies, complementary therapies and medicines, and integrative medical treatments. Cataloging-in-Publication Data Parker, James N., 1961Parker, Philip M., 1960Aflatoxin: A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References / James N. Parker and Philip M. Parker, editors p. cm. Includes bibliographical references, glossary, and index. ISBN: 0-497-00034-2 1. Aflatoxin-Popular works. I. Title.
iii
Disclaimer This publication is not intended to be used for the diagnosis or treatment of a health problem. It is sold with the understanding that the publisher, editors, and authors are not engaging in the rendering of medical, psychological, financial, legal, or other professional services. References to any entity, product, service, or source of information that may be contained in this publication should not be considered an endorsement, either direct or implied, by the publisher, editors, or authors. ICON Group International, Inc., the editors, and the authors are not responsible for the content of any Web pages or publications referenced in this publication.
Copyright Notice If a physician wishes to copy limited passages from this book for patient use, this right is automatically granted without written permission from ICON Group International, Inc. (ICON Group). However, all of ICON Group publications have copyrights. With exception to the above, copying our publications in whole or in part, for whatever reason, is a violation of copyright laws and can lead to penalties and fines. Should you want to copy tables, graphs, or other materials, please contact us to request permission (E-mail:
[email protected]). ICON Group often grants permission for very limited reproduction of our publications for internal use, press releases, and academic research. Such reproduction requires confirmed permission from ICON Group International, Inc. The disclaimer above must accompany all reproductions, in whole or in part, of this book.
iv
Acknowledgements The collective knowledge generated from academic and applied research summarized in various references has been critical in the creation of this book which is best viewed as a comprehensive compilation and collection of information prepared by various official agencies which produce publications on aflatoxin. Books in this series draw from various agencies and institutions associated with the United States Department of Health and Human Services, and in particular, the Office of the Secretary of Health and Human Services (OS), the Administration for Children and Families (ACF), the Administration on Aging (AOA), the Agency for Healthcare Research and Quality (AHRQ), the Agency for Toxic Substances and Disease Registry (ATSDR), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), the Healthcare Financing Administration (HCFA), the Health Resources and Services Administration (HRSA), the Indian Health Service (IHS), the institutions of the National Institutes of Health (NIH), the Program Support Center (PSC), and the Substance Abuse and Mental Health Services Administration (SAMHSA). In addition to these sources, information gathered from the National Library of Medicine, the United States Patent Office, the European Union, and their related organizations has been invaluable in the creation of this book. Some of the work represented was financially supported by the Research and Development Committee at INSEAD. This support is gratefully acknowledged. Finally, special thanks are owed to Tiffany Freeman for her excellent editorial support.
v
About the Editors James N. Parker, M.D. Dr. James N. Parker received his Bachelor of Science degree in Psychobiology from the University of California, Riverside and his M.D. from the University of California, San Diego. In addition to authoring numerous research publications, he has lectured at various academic institutions. Dr. Parker is the medical editor for health books by ICON Health Publications. Philip M. Parker, Ph.D. Philip M. Parker is the Eli Lilly Chair Professor of Innovation, Business and Society at INSEAD (Fontainebleau, France and Singapore). Dr. Parker has also been Professor at the University of California, San Diego and has taught courses at Harvard University, the Hong Kong University of Science and Technology, the Massachusetts Institute of Technology, Stanford University, and UCLA. Dr. Parker is the associate editor for ICON Health Publications.
vi
About ICON Health Publications To discover more about ICON Health Publications, simply check with your preferred online booksellers, including Barnes&Noble.com and Amazon.com which currently carry all of our titles. Or, feel free to contact us directly for bulk purchases or institutional discounts: ICON Group International, Inc. 4370 La Jolla Village Drive, Fourth Floor San Diego, CA 92122 USA Fax: 858-546-4341 Web site: www.icongrouponline.com/health
vii
Table of Contents FORWARD .......................................................................................................................................... 1 CHAPTER 1. STUDIES ON AFLATOXIN ............................................................................................... 3 Overview........................................................................................................................................ 3 Federally Funded Research on Aflatoxin ....................................................................................... 3 E-Journals: PubMed Central ....................................................................................................... 23 The National Library of Medicine: PubMed ................................................................................ 44 CHAPTER 2. NUTRITION AND AFLATOXIN ..................................................................................... 91 Overview...................................................................................................................................... 91 Finding Nutrition Studies on Aflatoxin ...................................................................................... 91 Federal Resources on Nutrition ................................................................................................... 99 Additional Web Resources ......................................................................................................... 100 CHAPTER 3. ALTERNATIVE MEDICINE AND AFLATOXIN ............................................................. 101 Overview.................................................................................................................................... 101 National Center for Complementary and Alternative Medicine................................................ 101 Additional Web Resources ......................................................................................................... 121 General References ..................................................................................................................... 123 CHAPTER 4. DISSERTATIONS ON AFLATOXIN ............................................................................... 125 Overview.................................................................................................................................... 125 Dissertations on Aflatoxin ......................................................................................................... 125 Keeping Current ........................................................................................................................ 126 CHAPTER 5. PATENTS ON AFLATOXIN .......................................................................................... 127 Overview.................................................................................................................................... 127 Patents on Aflatoxin .................................................................................................................. 127 Patent Applications on Aflatoxin .............................................................................................. 149 Keeping Current ........................................................................................................................ 151 CHAPTER 6. BOOKS ON AFLATOXIN ............................................................................................. 153 Overview.................................................................................................................................... 153 Book Summaries: Online Booksellers......................................................................................... 153 Chapters on Aflatoxin ................................................................................................................ 154 APPENDIX A. PHYSICIAN RESOURCES .......................................................................................... 159 Overview.................................................................................................................................... 159 NIH Guidelines.......................................................................................................................... 159 NIH Databases........................................................................................................................... 161 Other Commercial Databases..................................................................................................... 163 APPENDIX B. PATIENT RESOURCES ............................................................................................... 165 Overview.................................................................................................................................... 165 Patient Guideline Sources.......................................................................................................... 165 Finding Associations.................................................................................................................. 167 APPENDIX C. FINDING MEDICAL LIBRARIES ................................................................................ 169 Overview.................................................................................................................................... 169 Preparation................................................................................................................................. 169 Finding a Local Medical Library................................................................................................ 169 Medical Libraries in the U.S. and Canada ................................................................................. 169 ONLINE GLOSSARIES................................................................................................................ 175 Online Dictionary Directories ................................................................................................... 175 AFLATOXIN DICTIONARY ....................................................................................................... 177 INDEX .............................................................................................................................................. 229
1
FORWARD In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading."1 Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and printing. Since only the smallest fraction of information dealing with aflatoxin is indexed in search engines, such as www.google.com or others, a non-systematic approach to Internet research can be not only time consuming, but also incomplete. This book was created for medical professionals, students, and members of the general public who want to know as much as possible about aflatoxin, using the most advanced research tools available and spending the least amount of time doing so. In addition to offering a structured and comprehensive bibliography, the pages that follow will tell you where and how to find reliable information covering virtually all topics related to aflatoxin, from the essentials to the most advanced areas of research. Public, academic, government, and peer-reviewed research studies are emphasized. Various abstracts are reproduced to give you some of the latest official information available to date on aflatoxin. Abundant guidance is given on how to obtain free-of-charge primary research results via the Internet. While this book focuses on the field of medicine, when some sources provide access to non-medical information relating to aflatoxin, these are noted in the text. E-book and electronic versions of this book are fully interactive with each of the Internet sites mentioned (clicking on a hyperlink automatically opens your browser to the site indicated). If you are using the hard copy version of this book, you can access a cited Web site by typing the provided Web address directly into your Internet browser. You may find it useful to refer to synonyms or related terms when accessing these Internet databases. NOTE: At the time of publication, the Web addresses were functional. However, some links may fail due to URL address changes, which is a common occurrence on the Internet. For readers unfamiliar with the Internet, detailed instructions are offered on how to access electronic resources. For readers unfamiliar with medical terminology, a comprehensive glossary is provided. For readers without access to Internet resources, a directory of medical libraries, that have or can locate references cited here, is given. We hope these resources will prove useful to the widest possible audience seeking information on aflatoxin. The Editors
1
From the NIH, National Cancer Institute (NCI): http://www.cancer.gov/cancerinfo/ten-things-to-know.
3
CHAPTER 1. STUDIES ON AFLATOXIN Overview In this chapter, we will show you how to locate peer-reviewed references and studies on aflatoxin.
Federally Funded Research on Aflatoxin The U.S. Government supports a variety of research studies relating to aflatoxin. These studies are tracked by the Office of Extramural Research at the National Institutes of Health.2 CRISP (Computerized Retrieval of Information on Scientific Projects) is a searchable database of federally funded biomedical research projects conducted at universities, hospitals, and other institutions. Search the CRISP Web site at http://crisp.cit.nih.gov/crisp/crisp_query.generate_screen. You will have the option to perform targeted searches by various criteria, including geography, date, and topics related to aflatoxin. For most of the studies, the agencies reporting into CRISP provide summaries or abstracts. As opposed to clinical trial research using patients, many federally funded studies use animals or simulated models to explore aflatoxin. The following is typical of the type of information found when searching the CRISP database for aflatoxin: •
Project Title: ADDUCT INDUCED FRAMESHIFT MUTAGENESIS Principal Investigator & Institution: Stone, Michael P.; Professor; Chemistry; Vanderbilt University 3319 West End Ave. Nashville, Tn 372036917 Timing: Fiscal Year 2002; Project Start 15-FEB-1992; Project End 31-DEC-2003 Summary: The goal is to understand relationships between conformational perturbations of DNA which has been adducted by endogenous and exogenous
2 Healthcare projects are funded by the National Institutes of Health (NIH), Substance Abuse and Mental Health Services (SAMHSA), Health Resources and Services Administration (HRSA), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDCP), Agency for Healthcare Research and Quality (AHRQ), and Office of Assistant Secretary of Health (OASH).
4
Aflatoxin
chemical mutagens, and the subsequent biological processing of adducted DNA, e.g., during error-prone replication. We seek to understand what features of adduct structure promote frameshifts vs. substitutions. Using a frameshift-prone sequence from the Salmonella typhimurium hisD3052 gene, we will examine whether the primary adduct of malondialdehyde, M1G, induces frameshift mutations as a consequence of the ability of duplex DNA to spontaneously ring-open this adduct to its derivative N2-(3-oxo-lpropenyl)-dG. We propose that N2-(3-oxo-l- propenyl)-dG induces/promotes strand slippage structures subsequent to incorporation of dCTP, possibly as a consequence of the positioning of the propenyl moiety in the minor groove of the duplex, fostering dissociation/reassociation of the polymerase due to potential disruption of protein DNA interactions involving the thumb region of the polymerase. We will examine the potential formation of DNA crosslinks by the N2-(3-oxo-l-propenyl)-dG derivative. We will examine why the planar intercalated trans-8,9-dihydro-8-(N7-guanyl)-9hydroxyaflatoxin B1 adduct is not a strong inducer of frameshifts, using the codon 249 sequence of the p53 tumor suppressor gene, which has been linked to human cancer via aflatoxin-induced G yields T mutations. This adduct stabilizes DNA, and perhaps discourages strand slippage intermediates, which we propose reduces the propensity for frameshifts. The adduct may not disrupt minor groove interactions between DNA polymerase and the duplex. We will compare this adduct with its imidazole ringopened derivative, the FAPY adduct, which induces greater stabilization of the DNA duplex. We will examine structural hypotheses to explain the G yields T and G yields A transitions induced by the trans-8,9-dihydro-8- (N7-guanyl)-9-hydroxyaflatoxin B1. A proposed mechanism for the "signature" 5'-neighbor mutation C yields T will be examined. Our working hypothesis posits that the adduct alters or inhibits extension following the correct incorporation of cytosine, possibly by misaligning the primer terminous for further extension. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: AFLATOXIN B1 BIOSYNTHESIS IN ASPERGILLUS PARASITICUS Principal Investigator & Institution: Linz, John E.; Food Science & Human Nutrition; Michigan State University 301 Administration Bldg East Lansing, Mi 48824 Timing: Fiscal Year 2003; Project Start 01-JAN-1991; Project End 31-MAR-2007 Summary: This abstract is not available. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: SYNTHESIS
AFLATOXIN
BIOSYNTHESIS
AND
TYPE
I
POLYKETIDE
Principal Investigator & Institution: Townsend, Craig A.; Professor; Chemistry; Johns Hopkins University 3400 N Charles St Baltimore, Md 21218 Timing: Fiscal Year 2003; Project Start 01-FEB-1978; Project End 31-MAR-2008 Summary: (provided by applicant): Studies of the potent environmental carcinogen aflatoxin B1 will be continued. This mycotoxin enters the food supply through contamination of grains by the molds Aspergitlus fiavus, A. parasiticus and A. nomius, which produce this compound as a normal metabolite. Chronic ingestion leads to liver tumors that are a major cause of premature death in Asia, Africa and Central America. A direct link has been forged between the interaction of the metabolically activated form of the toxin and DNA, particularly at a "hot spot" in the p53 gene leading to mutation of the encoded protein. Alterations in p53 are associated with ca. 50% of human cancers. An understanding of its biosynthesis presents problems of fundamental interest in
Studies
5
bioorganic chemistry and may afford means to control the occurrence of this environmental hazard. The investigation has two major goals. The first seeks understanding of fungal Type t polyketide synthases (PKSs)-how iterative function is accomplished, how "programming" is achieved to control polyketide chain length, cyclization geometry and oxidation state. A particularly interesting example of this class lies at the heart of aflatoxin biosynthesis in a complex of the PKS with two specialized yeast-like fatty acid synthase (FAS) subunits in a catalytic complex, NorS. The function of NorS will be examined both in "dissection" experiments using expressed domains of the PKS and FASs, and with the intact recombinant subunits themselves. A newly developed algorithm (UMA) to identify linker regions in multidomainal proteins will guide the experiments to examine function, physical association and structure of domains individually and in groups. The second goal focuses on the three principal oxidative skeletal rearrangement steps that characterize the progression of the biosynthetic pathway from the initially formed anthraquinone to the final substituted coumarin of aflatoxin B1. These are the rearrangement of averufin to l'hydroxyversicolorone, versicolorin A to demethylsterigmatocystin, and Omethylsterigmatocystin to aflatoxin. Gene disruption experiments have identified as many as 3 proteins mediating a single transformation, but in each case a particular cytochrome P450 has been identified. The mechanisms of these reactions are of interest in themselves, and in the broader context of acetogenin biosynthesis. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: ALDO-KETO REDUCTASES AS PART OF CHEMICAL STRESS RESPONSE Principal Investigator & Institution: Barski, Oleg A.; Pediatrics; Baylor College of Medicine 1 Baylor Plaza Houston, Tx 77030 Timing: Fiscal Year 2002; Project Start 17-AUG-2000; Project End 31-JUL-2004 Summary: Aldo-keto reductases provide protection against environmental and nutritional toxins and carcinogens by detoxification of reactive aldehydes capable of modifying cellular macromolecules. Chemical stress induces the expression of a number of detoxification enzymes. Thus, aflatoxin reductase is induced by ethoxyquin and other antioxidants. Recently it was shown that ethoxyquin and antiobiotic tunicamycin also induce aldehyde reductase, another member of the aldo-keto reductase family. A crucial element of the human aldehyde reductase gene promoter binds transcription factor CHOP, which is induced in cells exposed to chemical stress. Preliminary results suggest that CHOP mediates the induction of aldehyde reductase expression and that both aflatoxin and aldehyde reductases are part of the cellular chemical stress response system, hence their expression is induced in response to toxic insult. The application proposes to: a) evaluate the ability of physiologically relevant compounds to induce aldehyde reductase expression and to find out whether induction of both reductases goes through the CHOP-dependent pathway. B) test the compounds of the two major groups: toxic substrates and chemoprotectors that are known to induce aflatoxin reductase and other drug metabolizing enzymes (e.g. glutathione-S-transferase). C) test the Selected stimuli for their ability to induce CHOP. D) determine whether CHOP plays a role in inducing aflatoxin and aldehyde reductase by testing the effect of CHOP overexpression and deficiency, and known CHOP-inducing agents on the of the reductases expression. e) clone and sequence aflatoxin reductase promoter and examine it for a CHOP-binding element and response elements described to direct antioxidant induction in other detoxification genes. Understanding the nature and mechanism of regulation of aldehyde and aflatoxin reductase expression will potentially assist in the
6
Aflatoxin
prevention of harmful and carcinogenic effects of toxic aldehydes as well as provide a basis for identifying populations with increased susceptibility to certain environmental agents. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: ANALYTICAL CHEMISTRY CORE Principal Investigator & Institution: Wishnok, John S.; Senior Research Scientist; Johns Hopkins University 3400 N Charles St Baltimore, Md 21218 Timing: Fiscal Year 2002; Project Start 07-APR-1993; Project End 31-MAY-2007 Summary: (provided by applicant): This Core operates as a service, a developmental laboratory, and a resource for the Program Project. Both the overall objectives and the specific aims of the Core laboratories follow primarily from those of the individual projects; e.g., development of methods for identification or quantitation of carcinogennucleic acid adducts, carcinogen-protein adducts, and carcinogen metabolites and/or their conjugates. This includes continued evaluation of capillary HPLC-LIF for quantitation of protein or DNA damage and continued development of capillary HPLC and nanoelectrospray/microelectrospray tandem MS techniques to characterize and quantitate modified proteins or DNA. Development or adaptation of methods to quantitate DNA or protein adducts or urinary levels of PhIP or 2-amino-3,8dimethylimidazo-[4,5-f]quinoxaline (MeIQx) or their metabolites during previous funding periods, for example, was in direct response to the needs of epidemiological studies that evolved into Project 1 in this proposal. Many of the methods listed below were adapted or developed by the Core in this context and some methods, such as quantitation of aromatic amine-hemoglobin adducts by NICI GC-MS have in some cases become the methods of choice for other laboratories that carry out related investigations. The specific aims of the various research projects involve quantitation in urine, physiological fluids or tissue, of DNA and protein adducts of several carcinogens including aflatoxin and aromatic amines and related compounds (e.g., alkylated anilines) and quantitation of urinary excretion of the food-related carcinogen, PhIP, and its metabolites or conjugates. Literature methods are often based on pure or in vitro samples, so methods are developed for the isolation or concentration of low levels of these compounds in complex biological mixtures using, for example, solid-phase extractions or affinity chromatography. Where necessary, for example with tandem MS methods for analyses of modified oligonucleotides, the developmental work is done in the Core laboratories. Specific objectives for additional analyses or techniques include: (1) development and applications of ultrasensitive MS methods for nucleobase and deoxyribonucleoside adducts; (2) development and applications of HPLC-LIF methods for quantitation of derivatized adducts; and (3) transfer of HPLC-LIF technology to the Johns Hopkins University (Project 1 and Core). Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: BIOLOGICAL MARKERS OF AFLATOXIN EXPOSURE Principal Investigator & Institution: Santella, Regina M.; Professor; Environmental Health Sciences; Columbia University Health Sciences Po Box 49 New York, Ny 10032 Timing: Fiscal Year 2002; Project Start 01-JAN-1990; Project End 30-JUN-2005 Summary: (provided by applicant): This project will continue to focus on the identification of environmental and genetic risk factors for development of hepatocellular carcinoma (HCC) in Taiwan. We have demonstrated that, in conjunction with hepatitis B or C virus (HBV and HCV) infection, aflatoxin B1 (AFB1), 4-
Studies
7
aminobiphenyl, and polycyclic aromatic hydrocarbons (PAH), increase HCC risk. Synergistic interactions between virus and chemical were also observed. Deletion o glutathione S-transferase M1(GSTM1) further increased risk in exposed subjects. The current proposal will focus on a case-control study nested in a cohort established by our collaborator Dr. Chien Jen Chen in which 25,611 subjects were recruited and a total of approximately 350 HCC cases will be identified by the end of the next four years. We will analyze blood samples from cases and controls for urinary aflatoxin metabolites and AFB1- and PAH-albumin adducts as markers of exposure. We will also begin to investigate the role of oxidative stress in risk for HCC by analyzing for variants in genes that encode enzymes with pro-oxidant and anti-oxidant activities. damage from ROS and carcinogenic metabolites that are not detoxified may be prevented from contributing to carcinogenesis by DNA repair; thus, we will extend our investigation of genetic susceptibility to DNA repair genes in the base excision and nucleotide excision repair pathways. We hypothesize that cases will more frequently be carriers of "higher risk" alleles than controls and that there will also be an interaction between environmental exposures and genotype. Finally, we will carry out a small exploratory study to determine whether tumor DNA can be detected in plasma of HCC cases. Other studies have demonstrated that tumor DNA circulating in blood contains the same genetic alterations as are found in the tumor. We will begin to investigate this phenomena in our HCC cases specifically looking at p.53 mutations and methylation of p16. These pilot studies will allow us to determine whether tumor DNA can be found at a high enough frequency to be useful in diagnosis and studies of etiology, when in the cancer process they are detectable. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: BIOSTATISTICS/EPIDEMIOLOGY CORE Principal Investigator & Institution: Munoz, Alvaro; Associate Professor; Johns Hopkins University 3400 N Charles St Baltimore, Md 21218 Timing: Fiscal Year 2002; Project Start 07-APR-1993; Project End 31-MAY-2007 Summary: (provided by applicant): During the previous 2 cycles of this Program Project on "Molecular Biomarkers for Environmental Carcinogens," the investigators have established close links with the Projects which have led to several publications. As part of the renewal of the Program Project, they will continue to collaborate with investigators of Projects in the Program Project for the design of studies using specimens collected as part of previous studies, for the analysis of data, and for the development of methods relevant to the issues of the research Projects. The design and analysis of the experiments and studies to be conducted under the auspices of the Program Project will benefit by the inclusion of expertise in biostatistics and epidemiology. The specific aims of the Biostatistics/Epidemiology Core are: (1) To establish methods that promote adherence to standard protocols with particular attention to data collection and management. The Biostatistics/Epidemiology Core will assist with the selection of appropriate samples for testing; monitor data entry; implement data editing procedures design a data base to expedite analysis and linkage of the different projects; and establish systems for data security and backup. (2) To collaborate with investigators in the Projects of the Program Project for the purpose of data analysis. Data from the projects will require the implementation of multivariate (e.g., exposure to aflatoxin, HBV status and p53 mutation on codon 249) regression methods for analyses of longitudinal data and for binary and continuous outcomes. Furthermore, they will use methods for the evaluation of treatments administered in clinical trials using changes of biomarkers as the primary outcome measure. (3) To develop new statistical methods
8
Aflatoxin
appropriate for the data generated by the Projects which will allow for testing and estimating parameters relevant to the specific aims of the Program Project. First, they will investigate the use of sequential designs to minimize sample testing. Second, a salient feature of the data from the proposed Projects is that most biomarkers will be a mixture of discrete (% undetectable) and continuous (level among those detectable) components. Methods that treat the data as left censored, as opposed to assigning all undetectable observations a given value, are preferred and will be developed and implemented as part of this application. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: CATALYTIC AND STEREOSELECTIVE C-C BOND FORMING REACTION Principal Investigator & Institution: Hoveyda, Amir H.; J. T. & P. Vanderslice Millennium Profes; Chemistry; Boston College 140 Commonwealth Ave Newton, Ma 02467 Timing: Fiscal Year 2002; Project Start 01-MAY-1992; Project End 30-APR-2005 Summary: (Applicant's Description) Efficient and selective preparation of organic molecules is critical to the synthesis of therapeutics. Thus development of catalytic and stereoselective addition of alkylmetals to olefins stands as an important objective. Catalytic olefin alkylation offers a practical and inexpensive route for synthesis of C-C bonds; these reactions require readily available substrates and alkylmetals. A catalytic enatioselective version would be most useful especially if it were to afford molecules that are readily amenable to further functionalization. Similar to carbomagnesation, the reactions proposed herein are Zr-catalyzed, but they proceed by an entirely different mechanism and will be significantly more general. In catalytic carbometalations reported to-date, the alkyl group of the alkyl metal is typically incorporated within the final product; here it is the alkyl moiety of an electrophilic reagent that is transferred to the product. Thus, the new Zr-catalyzed reactions are unusual: there is efficient reaction between the alkene substrate and the electrophile, but there is little or no reaction between the alkylmetal and the electrophile. The following specific objectives will be pursued: I. Development of regio- and stereoselective Zr-catalyzed alkylation and carbometalation of olefins with alkyl electrophiles. Mechanistic evidence from our previous studies will be used to develop unique methods for catalytic regio- and diastereoselective synthesis of C-C bonds. These transformations offer a new approach to C-C bond formation, where readily available olefinic substrates, alkylmetals and electrophiles can be used. II. Development of diastereoselective intramolecular Zrcatalyzed electrophilic alkylations and carbometalations. The intramolecular version of the Zr-catalyzed alkylation should allow for an unprecedented and efficient synthesis of various carbo- and heterocycles with high regio- and diastereoselectivity. III.Development of Zr-catalyzed enantioselective electrophilic alkylations and carbometalations. We will develop a catalytic and asymmetric alkylation and carbometalation of olefins with various electrophiles. These transformations offer unique and selective routes to the enantioselective synthesis of easily functionalizable molecules. The utility of the new methods will be demonstrated by synthesis of anticancer LY300502, antispastic baclofen, anti-fungal aflatoxin B2, antidepressant gemfexine and anti-leukemic helianane. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies
•
9
Project Title: CHEMOPREVENTION OF GREEN TEA POLYPHENOL ON LIVER CANCER Principal Investigator & Institution: Wang, Jia-Sheng; None; Texas Tech University Box 42013 Lubbock, Tx 79409 Timing: Fiscal Year 2003; Project Start 16-JUN-2003; Project End 31-MAY-2008 Summary: (provided by applicant): The long-term goal of this revised application is to design effective prevention strategies for reducing the incidence of liver cancer in highrisk populations. Primary liver cancer, mainly hepatocellular carcinoma (HCC), is one of the most common cancers in Asia and Africa. The poor prognosis of this malignancy results in it being the third most common cause of cancer deaths in the world. Chronic infection with hepatitis B viruses (HBV) and dietary aflatoxin exposure are two major etiologic risk factors for HCC in high-risk areas. The great challenge in cancer prevention and control is how to manage those who have already been exposed to carcinogens, such as individuals who are HBsAg carriers and have long-term aflatoxin exposure. Chemoprevention has been proposed as the good tool to target these high-risk populations. Among various identified chemopreventive agents, green tea polyphenols (GTP) have been shown to be safe and high effective in inhibition of carcinogen-induced mutagenesis and tumorigenesis in bioassays and animal models for different target organ sites, including aflatoxin-induced liver tumors. The specific aims for this study are (1) to incorporate molecular biomarkers analysis for aflatoxin exposure, HBV infection, and oxidative DNA damage into an on-going randomized, double blinded, and placebocontrolled intervention trial of GTP in 1,800 residents who are double seropositive of HBsAg and aflatoxin-albumin adduct in Fusui County, Guangxi Zhuang Autonomous Region, People's Republic of China; efficacy of the chemopreventive trial will be determined by monitoring changes of levels of risk-factor specific molecular biomarkers and the actual incidence of HCC in the studied population. (2) to examine and assess the efficacy of GTP in reducing aflatoxin biomarkers by measuring aflatoxin-albumin adducts in serum and various aflatoxin biomarkers in urine collected from 300 participants in different time of the study. Difference in metabolic phenotypes/genotypes as they related to aflatoxin biomarker levels will be determined. (3) to evaluate the inhibitory effect of GTP on HBV-associated markers including HBVDNA replication and HBV-induced immunologic changes in serum samples. (4) to determine antioxidative role of GTP in inhibition of the level of 8-hydroxy-2'deoxyguanosine in urine samples collected from the study participants and (5) to determine and assess long-term bioavailability and biotransformation of GTP and the long-term toxicological effect of GTP on study participants. The results of this study would help to evaluate the chemoprotective effect of GTP against human HCC and to understand the molecular mechanisms of GTP in chemoprevention of human HCC caused by well-defined major risk factors. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: CHLOROPHYLLS AS TRANS-SPECIES BLOCKING AGENTS Principal Investigator & Institution: Bailey, George S.; Distinguished Professor & Center Directo; Oregon State University Corvallis, or 973391086 Timing: Fiscal Year 2003; Project Start 17-MAR-2003; Project End 28-FEB-2008 Summary: This Project aims to compare in depth the mechanisms and dose-response characteristics for two plant-based blocking agents, native chlorophyll (Chla) and its derivative Cu-chlorophyllin (CHL). Our working hypothesis is that these agents act in vivo primarily via strong non-covalent complexation with carcinogens having
10
Aflatoxin
complementary planar aromatic structure, thereby reducing carcinogen uptake and systemic bioavailability. Though CHL studies have progressed to an initial clinical intervention trial against aflatoxin B1 (AFB1), its mechanisms against this and other carcinogens are not fully defined. We recently showed native Chla to also strongly reduce dibenzo(alpha,1)pyrene (DBP)-DNA adduction in trout, but beyond this promising result, almost nothing is known of Chla chemoprevention in vivo. Finally, since few if any blocking agents are 100% effective, additional strategies are needed to fully abrogate the effects of genotoxins such as AFB1 and DBP. To address these issues we use 5 models: AFB1 hepatic tumors in rats; AFB1 hepatic tumors in trout; the trout multi-organ DBP model; DBP rat mammary tumors; and human 14C-AFB2 exposures. AIMS 1A-C compare CHL and Chla efficacy in four tumor models, including a 10,000 trout dose-dose matrix design to test the molecular dose hypothesis that Chla-mediated reduction in DNA adduct biomarkers quantitatively predicts tumor outcome over all DBP doses. AIM 1D investigates CHL and Chla effects on AFB2 uptake in humans. AIM 2 compares CHL and Chla protective mechanisms, both systemic (complex stoichiometry and stability; degree and specificity of effects on carcinogen pharmacokinetics; predictivity of complex Kd on CHL efficacy) and cellular (P450 inhibition; electrophile destabilization). AIM 3 investigates combined chemoprevention as a strategy to supplement the incomplete blocking effects of chlorophylls. It examines initiator-specificity and basic mechanisms of tumor suppression in trout, and establishes quantitative interactions between CHL as a blocking agent and ellagie acid (EA) or tea catechins as suppressing agents in the trout stomach tumor model. It provides the first dose-dose matrix quantification of tumor suppression ever conducted, and provides a model to establish rigorously if CHL blocking and EA/tea suppression are synergistic in combined chemoprevention. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: CHROMOSOMAL CARCINOGENS
PROBES
FOR
MUTAGENESIS
BY
Principal Investigator & Institution: Essigmann, John M.; Professor of Chemistry & Toxicology; Division of Toxicology; Massachusetts Institute of Technology Room E19750 Cambridge, Ma 02139 Timing: Fiscal Year 2002; Project Start 01-JUL-1998; Project End 30-JUN-2003 Summary: The stated goal of the work is to investigate the mechanisms by which sample alkylating agents and the potent human live carcinogen aflatoxin induce mutations. Natural bases in the genome of viruses of plasmids will be replaced by DNA adduct known to be formed by alkylating agents and by aflatoxin. The genomes containing adducts at specific sites will be constructed by using a combination of chemical synthesis and recombinant DNA techniques. Following their construction, the modified genomes will be introduced into bacterial or mammalian cells, where the adducts will be exposed to and processed by the natural repair and replicative systems of the host. Progeny will be isolated and characterized for the type and frequency of mutation induced at or near the original site of the adduct. The genetic requirements for mutagenesis will be characterized, as will the ability of the adduct to affect survival. This study can help to rank the genetic threats posed by the various DNA adducts formed by DNA-damaging agents. With aflatoxin, the hypothesis being tested is that some feature of the mutational spectrum of aflatoxin will correlate with the type of mutations induced by one or more of the DNA adducts. With alkylating agents, previous work has defined the types of mutations induced by the most mutagenic adducts. The field has now progressed to a deeper level of biochemical detail, in which
Studies
11
probing the extent to which the context (the neighboring sequence of nucleotides) of a lesion determines the likelihood that the lesion will be repaired or mutate. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: COLON ACETAMINOPHEN
AND
LIVER
ANTICARCINOGENICITY
BY
Principal Investigator & Institution: Williams, Gary M.; Professor; Pathology; New York Medical College Valhalla, Ny 10595 Timing: Fiscal Year 2002; Project Start 30-SEP-2002; Project End 31-AUG-2005 Summary: (provided by applicant): The overall objective of the proposed research is to examine the hypothesis that phenolic compounds can act as anticarcinogens at low levels by blocking the cellular effects of carcinogens that operate as reactive electrophiles. In testing this hypothesis, we will conduct a series of in vivo studies in rats with the widely used analgesic acetaminophen (APAP), which has demonstrated anticarcinogenic properties in colon. As model carcinogens in the rat, 3,2'-dimethyl-4aminobiphenyl (DMAB) and 2-amino-3-methyl-3H-imidazo [4,5-f]quinoline (IQ) will be used to produce a moderate level of initiation in rat colon as well as liver. We will establish the ability of low levels of APAP to inhibit the early carcinogen-induced effects that underlie initiation of colon and liver carcinogenesis, such as enhanced cell proliferation, decreased apoptosis and induction of preneoplastic lesions, and will study the mechanism(s) of this inhibition, focusing on blocking of intracellular reactivity of the carcinogens (i.e., adduct formation). These experiments will be pursued in three specific aims as follows: 1. Define low doses of the carcinogens 3,2'-dimethyl-4-aminobiphenyl (DMAB) and 2-amino-3-methyl-3H-imidazo[4,5-f]quinoline (IQ) that produce a moderate level of initiation in rat colon and liver to be studied for inhibition by low levels of APAP; 2. Establish the dose responses for inhibition of carcinogen-induced initiation by low levels of APAP against selected doses of carcinogens in order to determine conditions for mechanistic studies and 3. Determine whether low levels of APAP inhibit initiation by reduction of formation of IQ DNA adducts in order to gain insight into potential mechanisms of anticarcinogenicity. These experiments will provide the basis for future studies of prophylaxis against human carcinogens, such as aflatoxin B1. In addition, these experiments will provide support for the epidemiological observations of reduced cancer risk associated with the use of APAP. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: CPG METHYLATION AND MUTATION Principal Investigator & Institution: Pfeifer, Gerd P.; Professor; City of Hope National Medical Center Duarte, Ca 91010 Timing: Fiscal Year 2002; Project Start 01-JUL-2000; Project End 30-JUN-2004 Summary: Mutations in p53 from different human cancers show mutagenic patterns that are presumed to provide insight into mutagenic mechanism. mC->T mutations are prominent in colon cancer, breast cancer and leukemias and are generally thought to be due to spontaneous deamination of m5C. In lung cancer there is a preponderance of G>T mutations in the non-transcribed strand of p53, which is reminiscent of mutagenesis by bulky agents, notably polycyclic aromatic hydrocarbons (PAHs) such as benzo[a]pyrene (BP). In liver cancer, which is associated with aflatoxin B1 (AFB1) exposure, there is an extraordinary hotspot (a G->T mutation at codon 249) in p53. The PI and collaborators have been involved in several significant studies, including one showing that slow DNA repair of UV damage correlated with skin cancer hotspots in
12
Aflatoxin
p53, and hotspots for BP adduction (and slow DNA repair) correlated with lung cancer hotspots in p53. Such correlations are consistent with (but not proof of) a role for these etiological agents in carcinogenesis involving p53 mutations. In this proposal, the PI wishes to investigate these associations at a deeper level by studying the effect of adduction hotspots and differential repair directly on mutagenesis (using a variety of assays) by a number of agents. The focus will be on the mechanism of CpG mutational hotspots associated with the presence of m5C. The PI proposes three specific aims. (1) Sites for DNA adduct formation, repair and mutagenesis with BP and AFB1 will be determined in a single system (fibroblasts from the Big Blue mouse having a lacI mutational target). (2) UV-, BP- and AFB1-induced mutations in a yeast p53-containing vector system will be collected and compared to p53 mutations from human tumors. (3) The PI will investigate whether C->T hotspots at CpGs might be due to one of four endogenous mutagens, which might generate mutations preferentially at m5C residues. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: DIETARY FACTORS IN THE ETIOLOGY OF CANCER IN SHANGHAI Principal Investigator & Institution: Ross, Ronald K.; Professor; Preventive Medicine; University of Southern California 2250 Alcazar Street, Csc-219 Los Angeles, Ca 90033 Timing: Fiscal Year 2002; Project Start 01-APR-1987; Project End 30-JUN-2002 Summary: (Adapted from the Applicant's Abstract): We are requesting continued support for an ongoing cohort study of 18,244 men, ages 45-64, living in a geographically defined area of metropolitan Shanghai, Peoples Republic of China. All cohort members have completed detailed diet and medical histories and have blood and urine samples. Questionnaires have been edited and computerized and blood and urine samples have been processed, aliquoted, and continuously stored at both -20_C and 70_C. The cohort was fully established in 1989. Follow-up of the cohort is proceeding through cancer registration by the population-based Shanghai Cancer Registry, by routine ascertainment of death certificates, and by annual recontact of all cohort members. As of March 1994, 606 have developed cancer and 989 have died. The leading cancers include lung, stomach, liver, and colorectal cancers, while stroke is the number one cause of death. Major accomplishments achieved through this cohort to date include: (1) the first direct evidence linking aflatoxin ingestion to human hepatocellular carcinoma (HCC); (2) strong evidence of synergy between aflatoxin biomarkers and chronic infection with hepatitis B virus in establishing risk of HCC; (3) failure to find an association between H. pylori serology and stomach cancer risk; (4) the absence of an inverse association between antioxidants and fatal stroke; and (5) the first comprehensive and systematic evaluations of smoking-related cancer incidence and mortality in China. We propose to continue to follow this cohort for an additional five years. We will continue to evaluate risk factors for major health outcomes in the cohort, building on previous observations and continuing to exploit the serum and urine banks available for biomarker studies. Although we did not collect buffy coats for genetic studies on cohort members, we have demonstrated that the stored serum samples contain sufficient cells for conducting selected PCR-based genetic studies. Among the scientific goals for the next five years are: (1) to continue to evaluate the aflatoxin/HCC association and to assess the impact of sequence variations in genes involved in aflatoxin metabolism (GSTM1 and EPHX) in modifying risk; (2) to continue to assess the role of H. pylori in gastric cancer etiology in Shanghai, and to assess the possible protective effect of tea polyphenols on risk; and (3) to better understand the complex interrelationships among carotenoids, smoking, and lung cancer and to assess the
Studies
13
possible risk modifying impact of genes involved in metabolism of smoking-related carcinogens. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: EPIDEMIOLOGY OF HEPATOCELLULAR HEPATITIS B VIRUS IN 3 POPULATIONS
CARCINOMA
&
Principal Investigator & Institution: London, W. Thomas.; Senior Member; Fox Chase Cancer Center Philadelphia, Pa 191112434 Timing: Fiscal Year 2002; Project Start 01-APR-2001; Project End 31-MAR-2003 Summary: (Applicant's Description) Prospective studies of 60,984 men in Haimen City, China and 19,469 men in Senegal, west Africa revealed a 14-fold greater death rate from hepatocellular carcinoma (HCC) among the Haimen (168 per 100,000) than the Senegalese cohort (12 per 100,000). Even though chronic infection with hepatitis B virus (HBV) is the major risk factor for HCC in both populations, the age-adjusted prevalence of chronic infection is about 20% in both cohorts. Exposure to aflatoxin, a postulated major risk factor for HCC, is also similar or greater in the Senegalese population. The prevalence of viremia (HBV DNA in serum) among HBV carriers throughout adult life, however, is much higher among the Chinese than the Senegalese population. Nevertheless, within the Chinese cohort, viremia at study entry is not a risk factor for HCC after four years of follow-up. The aims of this project focus on factors that may account for variation in HCC risk in the Chinese and Senegalese cohorts and a cohort of Asian-American HBV carriers living in the Philadelphia area. Continued tracking of these three cohorts will test the hypothesis that with longer duration of follow-up, H B V v iremia and liver damage at study entry are associated with person-specific risks of HCC and that aflatoxin-B1 (AFB1)-albumin adducts are a s s ociated with development of HCC among viremic individuals and/or genotypically determined poor detoxifiers of AFB1 (in collaboration with Project 2). In close cooperation with the studies of WHV in woodchucks (Project 3), an intensive longitudinal study of 1000 male and female HBV carriers in these three populations will be conducted to: a) examine whether perturbations of the stability of HBV serum markers are associated with acute illnesses, aflatoxin exposure, and/or outgrowth of viral mutants; b) assay hepatocyte turnover and immune responses in liver biopsies; c) correlate these measures with viral load; d) examine the relationship of sex differences in changes in HBV serum markers over time to the lower HCC risk of female HBV carriers. Because present studies show that an episode of acute hepatitis in adulthood approximately doubles HCC risk among both HBV carriers and non-carriers, the causes and outcomes of 200 cases of acute hepatitis in Haimen City will be characterized. This research will lead to a new level of understanding of the factors that lead to HCC and to new strategies for the prevention of this lethal disease. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: GENETIC EPIDEMIOLOGY OF PRIMARY HEPATOCELLULAR CARCINOMA Principal Investigator & Institution: Buetow, Kenneth H.; Chief; Fox Chase Cancer Center Philadelphia, Pa 191112434 Timing: Fiscal Year 2002 Summary: The risk of common cancer is produced through gene-gene, and/or geneenvironment interactions. These interactions are poorly understood for most cancers in part due to the diversity and complexity of the exposures. Primary hepatocellular
14
Aflatoxin
carcinoma (HCC) represents a unique opportunity to investigate a complex cancer phenotype in humans. Epidemiologic studies have firmly established the role of chronic hepatitis B virus infection (HBV) and aflatoxin B1 (AFB1) exposure as environmental risk factors. These exposures are well described and are amenable to exposure assessment. it is therefore conceptually possible to examine their relationship to host genetic constitution in determining HCC susceptibility. Significant progress has been made during the current funding period toward understanding the genetic components of the HCC complex phenotype. Statistical analyses has demonstrated familial aggregation consistent with genetic susceptibility of HCC. Comprehensive genomewide allele loss studies have identified multiple regions which could contain novel tumor suppressor genes. An interaction between host genetic constitution, HBV/AFB1 exposures, and HCC was established in c case-control study and confirmed in a cohortderived study population. It is the goal of the of the current application to continue the integrated genetic epidemiologic analysis of HCC. Familial aggregation of HCC and its relationship to HBV and AFB1 exposure will be examined in a significantly expanded collection of families. Comparative genome hybridization (CGH) will be added to permit the localization of putative tumor suppressor genes and oncogenes. Regions observed to have high frequency changes in tumors will be studied by genetic mapping methods to assess their role in familial transmission. The role of genetic variability in candidate genes that modulate responses to HBV infection and AFB1 exposure will be assessed. This will be accomplished by expressing human xenobiotic metabolizing P450 cDNAs and their polymorphic variants in Saccharomyces cerevisiae and determining which ones in combination with AFB1 cause genetic alterations. Human gene mapping methods using a family-based case-control population will be used to test the role polymorphic variants of candidate AFB1 metabolizing loci in HCC. The influence of lipotrope insufficiency and genetic variability in lipotrope metabolism to HCC related end-points will be assessed. Finally, the interaction of major susceptibility genes, risk modifying loci, and environmental exposures and their role in determining risk and familial aggregation will be examined. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: GLOBAL RESPONSES TO AFLATOXIN B1 & ALKYLATING AGENTS Principal Investigator & Institution: Samson, Leona D.; Professor; Biomedical Engineering; Massachusetts Institute of Technology Room E19-750 Cambridge, Ma 02139 Timing: Fiscal Year 2002; Project Start 30-SEP-2001; Project End 31-JUL-2006 Summary: (provided by applicant) In response to RFA:ES-01-002, this is an application to become a member of the NIEHS-sponsored Toxicogenomics Research Consortium. The have proposed a highly integrated plan to explore the transcriptional responses of a variety of organisms, including humans, to a broad range of toxic agents found in the environment. Transcriptional profiling is expected to reveal a truly global view of how cells, tissues and animals attempt to recover, not always successfully from environmental insults. The investigators hope to learn what features of environmentally induced transcriptional responses are predictive of success or failure, and in addition to learn what features correlate with specific outcomes of toxic exposures, for instance, cell death, apoptosis, mutagenesis and carcinogenesis. The model environmental agents to be studied are Aflatoxin B1 and its metabolites, plus a range of SNI and SN2 alkylating agents. Together these agents are representative of toxic agents found in the external environment, food supply, the endogenous cellular environment, and the cancer chemotherapy clinic. The model organisms and cell systems whose transcriptional
Studies
15
responsiveness will be scrutinized include E. coli, S. cerevisiae, cultured rodent and human cell lines, engineered rat and mouse liver tissues, rats and mice. The investigators have integrated an in vitro tissue engineering Project into this application with the goal of developing an alternative to using animals to test for toxicity and carcinogenicity. It seems to the investigators that appropriate transcriptional responsiveness in this system represents a rigorous test of its similarity to in vivo tissues. Two platforms for mRNA profiling will be employed, namely, Affymetrix GeneChip DNA oligonucleotide microarrays, and cDNA arrays fabricated in the MIT BioMicro Center. The Microarraying and Bioinformatics Core will have its center of gravity in the MIT BioMicro Center, and this Core will serve as the focal point for three Research Projects and the Toxicology Research Core Project (TRCP). The TRCP activities will be closely aligned with the activities of the other 4 or 5 members of the Toxicogenomics Research Consortium. Together the overarching goals will be to establishing good working practices in transcriptional profiling as it relates to the area of toxicogenomics, and to contribute to the development of an extensive relational database as a repository for high quality data emerging from the field of toxicogenomics. The investigators anticipate that this research will uncover a myriad of hitherto unknown ways in which cells respond to environmental agents. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: HEPTOCYTE PROLIFERATION AND AFLATOXIN METABOLISM Principal Investigator & Institution: Sell, Stewart; Professor; Pathology and Lab Medicine; Albany Medical College of Union Univ Albany, Ny 12208 Timing: Fiscal Year 2002; Project Start 01-APR-2000; Project End 31-MAR-2003 Summary: The hypothesis that continued proliferation of hepatocytes is associated with an transgenic immature phenotype in regard to metabolism of aflatoxin (AFB1) and development of hepatocellular carcinoma (HCC) will be analyzed in p53 null and p53ser246 mutant transgenic, and HBV mice. World-wide HCC is arguably the tumor that causes the highest cancer mortality. HCCs occurring in high-risk areas of the world are associated with continued proliferation of liver cells in response to liver injury (HBV and HCV), and with aflatoxin (AFB1) exposure. AFB1/HBV associated HCCs have a high frequency of mutations in the tumor suppressor gene p53 at codon 249 (p53ser249). Recently we reported that hepatocytes of p53 null mice continue to proliferate into adulthood and do not become polyploid with aging. In addition, hepatocytes of p53ser246 transgenic mice (equivalent to p53ser249 of humans) maintain a high number of cells in G1. P53 null and p53ser246 mice also have increased susceptibility to AFB1 hepatocarcinogenesis when the carcinogen is administered during the first week of life, and HBV transgenic mice are susceptible to AFB1 carcinogenesis, even when the carcinogen is administered at one month of age when normal mice of the same strain are resistant. We wish to test the hypothesis that the changes in status of cells in the livers of these mice reflects a less-differentiated phenotype associated with increase production of carcinogenic metabolites and increased risk of HCC development in adult mice. In specific aim 1, the metabolism of AFB1 at different ages of normal and transgenic mice will be examined by AFB1 epoxide and adduct formation, glutathione-s-transferase activity and p450 isoenzyme distribution. In addition, oval cells or small hepatocytes will be isolated from cocaine-treated mice and from neonatal and adult transgenic livers to determine if there is distinctive metabolism of AFB1 in these cells. The effect of proliferation of "mature" hepatocytes will be determined using microsomes from partially hepatectomized livers, and metabolism of AFB1 by cultured liver cells at different stages of differentiation will be examined. In Specific Aim 2, AFB1 will be
16
Aflatoxin
administered after one month (when normal mice are not susceptible to carcinogenesis) to p53+/- hemizygous mice, to p53-/- null mice, to p53ser246 hemizygous and homozygous transgenic mice, and to F1 mice of p53ser246 mice cross-bred to p53 null mice and the development of HCC determined. the effect Of HBV associated injury and AFB I hepatocarcinogensis in these mice. In Specific Aim 3, the effect of HBV associated injury and AFB1 hepatocarcinogenesis in these mice will be examined. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: MECHANISM OF CELL DEATH INDUCED BY AFLATOXIN B1 Principal Investigator & Institution: Kosa, Jessica L.; Division of Toxicology; Massachusetts Institute of Technology Room E19-750 Cambridge, Ma 02139 Timing: Fiscal Year 2002; Project Start 01-AUG-2002; Project End 31-MAY-2003 Summary: (Adapted from the Applicant?s Abstract): The goal of this study is to determine how aflatoxin B1 (AFB1) kills hepatocytes. First, I shall probe the sequence of biochemical events that leads to liver cell death. Seond, since aflatoxin is believed to exert its biological effects by inflicting DNA damage, I shall determine which of the several types of DNA damage induced by aflatoxin induces the pattern of gene expression that precedes death. Third, I shall screen for novel genes whose mRNA levels change during AFB1-induced cell death, employing a DNA microarray approach. Apoptosis is the mechanism by which the liver eliminates pre-neoplastic cells, and is known to be induced by AFB1 in transformed liver cells. Initial experiments will test the hypothesis that apoptosis is responsible for the cytotoxicity of AFB1. Expression of genes know to participate in apoptosis is responsible for the cytotoxicity of AFB1. Expression of genes known to participate in apoptosis will be examined by quantitative RT-PCR in order to identify the specific pathways involved in the induction of apoptosis, thereby establishing which genes are vulnerable to oncogenic mutations. Primary rat hepatocytes will be employed in order to model in vivo AFB1 exposure realistically. In order to pinpoint the molecular pathway from DNA damage to cell death, DNA containing the AFB1-induced lesions AFB1-N7-Gua, AFB1-FAPY, and AP sites will be introduced into hepatocytes. The impact of each lesion on cell death, and apoptosis gene expression, will be measured to determine which specific DNA adduct(s) induce cell death. Finally, a microarray of rat genes will be constructed and used to search for novel genes that are induced or repressed during AFB1-induced cell death. Genes whose expression is altered by AFB1 exposure, and especially those that appear to be co-regulated with known apoptosis genes, are likely to participate in the cellular response to the toxin. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: MITOCHONDRIAL DNA DAMAGE AND REPAIR Principal Investigator & Institution: Bogenhagen, Daniel F.; Professor; State University New York Stony Brook Stony Brook, Ny 11794 Timing: Fiscal Year 2002; Project Start 01-APR-2002; Project End 31-MAR-2003 Summary: Mitochondrial DNA is a frequent target of chemical damage. Base loss, oxidative damage and reaction with carcinogenic compounds such as benzo(a)pyrene and aflatoxin are thought to occur at rates equal to or greater than the corresponding rates of damage to nuclear DNA. Mitochondria are able to repair some types of DNA damage, such as abasic sites and oxidative lesions (e.g., 8-oxo-dG), but probably not others. Very little is known concerning the enzymology of DNA repair in mitochondria. Replication through DNA adducts or attempts at repair may contribute to the incidence
Studies
17
of point mutations and deletions observed in a growing list of human diseases. These diseases range from point mutations associated with rare neuromuscular diseases identified with the acronyms MELAS, MERRF, and NARP to large deletions observed in Kearns Sayre Syndrome. Recent studies have found a correlation between mtDNA damage and type 11 diabetes, Parkinson's disease and aging, although more research is required to establish a role for mtDNA damage in the etiology of these conditions. We propose to investigate the effects of specifically localized lesions in DNA templates prepared by our collaborators in this project on DNA replication by the purified mitochondrial DNA polymerase gamma. These studies will employ templates containing abasic sites, 8-oxo-dG, aminofluorene and benzo(a)pyrene adducts. We will also search for accessory factors that may facilitate translesional synthesis by DNA polymerase gamma. We propose experiments to characterize enzymes involved in mtDNA repair and to attempt to reconstitute repair of abasic sites or 8-oxo-dG lesions in mtDNA. Certain lesions, such as cyclobutane pyrimidine dimers in mtDNA are not thought to be repaired efficiently. We will attempt to increase the efficiency of repair by using molecular genetic techniques to direct repair enzymes such as photolyase or T4 endonuclease (denV) to mitochondria. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: MOLECULAR FUNGITOXICANTS
MODE
OF
ACTION
OF
SELECTED
Principal Investigator & Institution: Thompson, Dorothy P.; Southern Univ A&M Col Baton Rouge College Baton Rouge Baton Rouge, La 70813 Timing: Fiscal Year 2002 Summary: This abstract is not available. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: NEUTROPHILS AND HEPATOTOXICITY Principal Investigator & Institution: Roth, Robert A.; Professor; Pharmacology and Toxicology; Michigan State University 301 Administration Bldg East Lansing, Mi 48824 Timing: Fiscal Year 2002; Project Start 15-JUN-1986; Project End 31-MAR-2004 Summary: (Adapted from the investigator's abstract). The overall goal of the proposed research is to understand how the inflammatory response to gram-negative bacterial endotoxin (lipopolysaccharide, LPS) acts as a determinant of susceptibility to intoxication by xenobiotic agents. In concert with this goal, the major focus of this proposal is to understand the role of the neutrophil in LPS-induced amplification of hepatotoxic responses to xenobiotic agents. Evidence has emerged indicating that exposure to small, nontoxic amounts of LPS is an important determinant of the magnitude of response to several hepatotoxicants. Experiments in the first specific aim will determine in rats whether LPS influences the response to chemicals (e.g., aflatoxin B1, monocrotaline) that initiate hepatotoxicity by different mechanisms and produce different lesions. Neutrophils activated in tissues are likely to play an important role in the mechanism by which LPS amplifies hepatotoxic responses, and Aim 2 will address this hypothesis in vivo and in a co-culture system of neutrophils and hepatocytes (HCs). Previous studies indicate that activated neutrophils damage hepatic parenchymal cells (HCs) through the release of toxic proteases such as cathepsin G and elastase. Studies in Aim 3 will determine if cathepsin G and elastase appear in plasma before the onset of liver injury, if administration of anti-proteases prevents LPS potentiation of liver injury, if administration of the proteases into the portal vein of rats reproduces the effects of
18
Aflatoxin
LPS in vivo, and if exposure of HCs in vitro to small concentrations of selected hepatotoxicants renders these cells more vulnerable to injury from cathepsin G and elastase. Tumor necrosis factor-alpha (TNF alpha) is released during LPS exposure and has pro-inflammatory effects on both neutrophils and hepatocytes. Aim 4 will explore the role of this important cytokine in the augmentation of chemical hepatotoxicity by LPS. In Aim 5, specific protein targets of neutrophil proteases on hepatocellular plasma membranes will be identified and their association with enhanced HC injury determined. Identification of such targets will provide important clues as to cellular mechanisms by which neutrophil proteases injure hepatocytes. These studies will reveal the role of neutrophils in LPS amplification of hepatotoxicity and mechanisms by which they act to increase susceptibility to hepatocellular damage from exposure to xenobiotic agents. The results will provide new knowledge about how LPS and the inflammatory events it generates may act as a determinant of the magnitude of response to toxicants. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: PILOT--EFFECT PEROXISOMES OF TROUT
OF
TEMPERATURE
ACCLIMATION
ON
Principal Investigator & Institution: Carpenter, Hillary; Oregon State University Corvallis, or 973391086 Timing: Fiscal Year 2002 Summary: There is no text on file for this abstract. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: REGULATION OF XENOBIOTIC-METABOLIZING CYP3A Principal Investigator & Institution: Zangar, Richard C.; Senior Research Scientist; Battelle Pacific Northwest Laboratories Box 999, 902 Battelle Blvd Richland, Wa 99352 Timing: Fiscal Year 2002; Project Start 30-SEP-1999; Project End 31-AUG-2004 Summary: (Adapted from the Investigator's Abstract) Cytochrome P450 3A (CYP3A) levels are important determinants of aflatoxin and acetaminophen toxicity and the uptake and elimination of numerous therapeutic agents. CYP3A protein has been reported to be stabilized by some CYP3A substrates. The PI reported that several structurally and functionally distinct agents that are not known CYP3A substrates alter CYP3A protein stability in primary cultured rat hepatocytes. The changes in CYP3A stability are consistent with effects of these agents on phospholipase C or D (PLC or PLD, respectively). Studies in microsomes have indicated that the PLD metabolite, phosphatidic acid (PA), is important in determining CYP3A stability. We propose to test this hypothesis that CYP3A protein stability is dependent upon microsomal PA levels and to further elucidate the molecular mechanism by which phospholipases and other enzymes that regulate PA levels contribute to CYP3A protein stability. The specific aims are: 1) To further establish the role of PLD and PLC in the regulation of CYP3A protein stability. 2) To determine if agents that alter CYP3A stability in primary cultured hepatocytes also function in in vitro incubations. 3.) To determine if PA analogs with different fatty acid moieties have distinct effects on CYP3A protein stability in microsomal samples. 4) To determine whether agents that regulate rat CYP3A stability act in a like manner in human primary cultured hepatocytes and microsomes. These studies will provide information that can be used to predict drug interactions by providing an understanding of the underlying molecular mechanisms involved in the post-translational regulation of CYP3A, and will test a new hypothesis regarding the interactions of phospholipase activities and a key drug-metabolizing enzyme.
Studies
19
Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: REMEDIATION PROCESS FOR AFLATOXIN CONTAMINATED FOODS Principal Investigator & Institution: Denvir, Adrian J.; Lynntech, Inc. College Station, Tx 77840 Timing: Fiscal Year 2002; Project Start 25-SEP-2002; Project End 25-JUN-2004 Summary: (provided by applicant): Mycotoxins are carcinogenic compounds that are produced by Aspergillus, Penicillium and Fusarium molds on agricultural produce and affect up to 25 per cent of the worlds food crops. Aflatoxins are naturally occurring mycotoxins produced by two types of mold: Aspergillus flavus and Aspergillus parasiticus. The Food and Drug Administration (FDA) has established action levels of 20 ppb for aflatoxin present in food and 0.5 ppb for aflatoxin M1 in milk. These limits are established by the Agency to provide an adequate margin of safety to protect human and animal health. As such there is an ongoing need for economic processes for detoxifying aflatoxin contaminated agricultural products intended for human and animal consumption. Remediation methods such as oxidation using ozone or ammoniation leave undesirable taste and odor residues on the product. The research in the Phase I will seek to determine the feasibility and economics of extracting aflatoxins in nuts and nut products using a cheap and environmentally benign solvent, which removes the toxin without producing or leaving toxic residues, retains nutritive value and does not alter significantly the technological properties of the nut. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: SPECIES DIFFERENCE IN THE BIOTRANSFORMATION OF AFLATOXIN Principal Investigator & Institution: Eaton, David L.; Professor and Associate Dean; Environmental and Occupational Health Studies; University of Washington Grant & Contract Services Seattle, Wa 98105 Timing: Fiscal Year 2002; Project Start 01-MAY-1991; Project End 31-JUL-2004 Summary: Numerous studies have demonstrated that biologically active, natural components of the diet may confer resistance to chemical carcinogens via induction and/or inhibition of biotransformation enzymes. In particular, specific chemical components of the diet, such as flavonoids, isocyanates, glucosinolates, indoles, dithiolthiones, and polyphenols have been identified as effective inducers and/or inhibitors of carcinogen activation/detoxification pathways in animal models. There is much supporting data from human epidemiological studies on the important relationship between diet and cancer in humans, although the diversity and complexity of the diet, and uncertainty of specific exposures, in such studies makes identification of specific active components nearly impossible. Although animal models are useful for "hypothesis testing", species differences in carcinogen activation and detoxification pathways, as well as differences in gene regulation and expression in response to inducers, make extrapolation of animal data to the human situation tentative, at best. Thus, there is a need to develop model systems that utilize human cells/tissues to determine the efficacy of specific dietary components and/or putative chemoprotectant drugs to favorably modify the biotransformation of human carcinogens. One such model human carcinogen is aflatoxin B1. Aflatoxins are mycotoxins produced by the common fungal molds, Aspergillus flavus and Aspergillus parasiticus. Worldwide, aflatoxins are considered a major public health problem because of their potent
20
Aflatoxin
carcinogenic effects. Human epidemiological data has documented that humans are susceptible to AFB-induced hepatocarcinogenesis, especially in combination with hepatitis B virus infection. However, there are large species differences in the susceptibility to aflatoxin carcinogenesis. Rats are highly sensitive, whereas mice are very resistant. The mechanism for this difference is associated with the expression of a specific enzyme, glutathione S-transferase A3-3 (mGSTA3-3), which is present in the livers of mice, but not rats. Treatment of rats with the drug, oltipraz, or the food additive, ethoxyquin, protects rats from aflatoxin-induced liver cancer. The mechanism for this protection is due to the ability of these chemicals to "turn on" a gene for a glutathione S-transferase, rGSTA5-5, that is normally not expressed in rat liver, but which efficiently detoxifies aflatoxin. Human liver tissue has very low ability to detoxify aflatoxin -- in fact, worse than the poor ability of rats. There has been considerable interest in devising a dietary or chemointervention strategy for humans that increases resistance to AFB by induction of GSTs. The long range goals of this proposal are to: 1) establish in vitro models that utilize isolated human hepatocytes in culture and human cDNA expressing yeast, to assess the efficacy of specific dietary components as putative chemoprotectors against AFB and other chemical carcinogens, and 2) complete the characterization of species differences in glutathione S-transferases with activity toward AFB-epoxide. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: SYMPOSIUM ON ALDO-KETO REDUCTASES & TOXICANT METABOLISM Principal Investigator & Institution: Penning, Trevor M.; Professor; Pharmacology; University of Pennsylvania 3451 Walnut Street Philadelphia, Pa 19104 Timing: Fiscal Year 2002; Project Start 01-AUG-2002; Project End 31-JUL-2003 Summary: (provided by applicant): This proposal is a request for financial support for a half-day symposium on "The Emerging Role of Aldo-keto reductases (AKRs) in the Metabolism of Toxic Substances" to be presented at the American Chemical Society National Meeting, Boston, MA August 18-22nd, 2002. AKRs are a superfamily of monomeric oxidoreductases that play central roles in the metabolism of aldose-sugars, prostaglandins, steroid hormones, and chemical carcinogens. Often they catalyze the conversion of carbonyl groups to alcohols so that the parent compound can be conjugated and eliminated. AKRs are highly conserved in both prokaryotes and eukaryotes. There are currently 150 proteins classified into 12 families and crystal structures exist for many of the proteins. In humans, these enzymes also catalyze the formation of hyperosmotic sugars, the detoxification of reactive a,B-unsaturated aldehydes that result from the decomposition of lipid hydroperoxides, and the metabolism of chemical carcinogens including aflatoxin dialdehyde, nicotine derived nitrosamino-ketones and polycyclic aromatic trans-dihydrodiols. Their emerging role in the metabolism of endogenous and exogenous toxins suggests that the family may be ultimately as important as the well-studied CYP superfamily in drug and xenobiotic metabolism. The speakers chosen for this symposium will cover each of the areas listed. In addition an overview of the AKR superfamily and its nomenclature (accepted by the Human Genome Project) will be given and approaches to studying functional genomics of AKRs in yeast will be presented. Each of the speakers has an international reputation in their area of expertise. The goal of the symposium will be to bring together experts in the AKR field so that they will be able to educate the scientific community concerning these enzymes with the hope of attracting new investigators to the field. Issues that are unexplored include the role of AKR isoforms in drug metabolism; their role in
Studies
21
chemotherapeutic drug resistance; the regulation of human AKR genes; and AKR pharmacogenomics with emphasis on human polymorphisms that may affect individual response to toxicants and susceptibility to chemical carcinogenesis. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: USE OF BIOMARKERS IN HUMAN INTERVENTIONS Principal Investigator & Institution: Kensler, Thomas W.; Professor; Johns Hopkins University 3400 N Charles St Baltimore, Md 21218 Timing: Fiscal Year 2002; Project Start 07-APR-1993; Project End 31-MAY-2007 Summary: (provided by applicant): The goals of this Project are to incorporate the use of biomarkers into primary and secondary (chemoprevention) interventions in high risk populations exposed to aflatoxins. In all preventive interventions there must be objective metrics with which to quantify success. Subsequently, the cost-benefit balance of the intervention can be analyzed and appropriately targeted toward high risk subgroups or individuals within a population. One of the tenets of the molecular epidemiology paradigm is that a mechanistic understanding of the actions of carcinogens can lead to novel prevention technologies. Therefore, the aims of this Project are 3-fold. First, it is to improve existent liquid chromatography-electrospray ionization tandem mass spectroscopy (LC-ESI-MS/MS) methodology for quantitative analysis of major urinary aflatoxin metabolites (e.g., aflatoxin-N7-guanine, aflatoxin M1, aflatoxin P1, aflatoxin-mercapturic acid). Second, it is to determine the impact of primary prevention strategies in West Africa using targeted contamination reduction strategies in community settings. The investigators will develop interventions aimed at: (1) mothers and young children during the weaning period when mycotoxin-contaminated maize-based foods are first introduced into the child?s diet; and (2) local subsistence farmers attempting to reduce contamination of their dietary staple crops, groundnuts and maize. Aflatoxin and fumonisin biomarkers will be used as outcome measures, while in part (1) the investigators will also examine the effects of intervention on child growth and immune parameters. Third, it is to follow up initial results of the investigators' chlorophyllin intervention where they demonstrated a significantly reduced excretion of aflatoxin-N7-guanine at 3 months by examining the impact of the intervention on biomarker modulation at additional time points. They will also analyze urine samples collected during the course of a one-year long intervention with oltipraz in Qidong for magnitude and persistence of modulatory effects on DNA adduct and other aflatoxin biomarkers. It is the hypothesis that levels of biomarkers for the biologically effective dose of carcinogens will be predictive of the efficacy of primary and chemopreventive interventions. The specific aims of this Project have been designed to translate the biomarkers developed and validated in Projects 1 and 4 into metrics to determine the impact of the interventions in high risk populations. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: VALIDATION AND APPLICATION OF RISK, BIOMARKERS IN HUMAN STUDIES Principal Investigator & Institution: Groopman, John D.; Associate Director of Cancer Prevention; Johns Hopkins University 3400 N Charles St Baltimore, Md 21218 Timing: Fiscal Year 2002; Project Start 07-APR-1993; Project End 31-MAY-2007 Summary: (provided by applicant): The goals of this Project are to develop and validate biomarkers of biologically effective dose and risk induced by environmental carcinogens. It is now axiomatic in human cancer that ambient exposures to multiple
22
Aflatoxin
environmental carcinogens are significant factors in the development and progression of many cancer types. Thus, an understanding of the dose-response relationships between exposure and outcomes in critical targets such as DNA may characterize disease potential. While Dr. Tannenbaum's Project has a major focus on the development of novel, sensitive methods for the detection of DNA and protein adducts, this Project extends these strategies into risk-biomarker analysis. Since there are critical genetic targets in cells, such as tumor suppressor genes, for environmental carcinogens, then it is possible that these targets might prove to be useful biomarkers for risk analysis. Cooccurring environmental exposures and genetic susceptibility may modify the above dose-response effects and consequently these parameters will also be considered. The linkage between carcinogen-induced DNA damage and heritable change in genetic targets is a cornerstone of this Program Project's paradigm. Recently, the discovery that DNA from cells undergoing apoptosis and other turnover processes is found in the blood has resulted in the ability to noninvasively measure mutations in targets such as p53 offering the potential to quantify early biological effects in risk individuals. Therefore, a combined use of biologically effective dose biomarkers, susceptibility biomarkers and genetic biomarkers might reveal the subset of high risk people within a population who will benefit from targeted interventions, which is the outcome of studies proposed in Project 3. It is the hypothesis that levels of biomarkers of biologically effective dose in combination with gene mutations are predictive of disease outcome characterizing risk in individuals. Thus, specific aim 1 is to determine the power of p53 mutations and other genetic alterations in sera using the Short Oligonucleotide Mass Analysis (SOMA) methodology combined with aflatoxin-DNA adducts in urine to predict cancer outcome and disease risk in cohorts in rural China and West Africa. Specific aim 2 is designed to extend the investigators' observations on the high level of aflatoxin biomarkers in West African children in order to assess the impact on growth and immune status, including susceptibility to hepatitis B virus (HBV) infection. West African children, unlike adults, have elevated aflatoxin biomarker levels when infected with HBV. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: EXPRESSION
ZEBRAFISH
CARCINOGENESIS
AND
CYTOCHROME
P450
Principal Investigator & Institution: Buhler, Donald R.; Professor; Environ & Molecular Toxicology; Oregon State University Corvallis, or 973391086 Timing: Fiscal Year 2002; Project Start 01-SEP-2001; Project End 31-AUG-2005 Summary: (provided by applicant): Cytochrome P450s (P450s or CYPs) are a superfamily of heme-containing enzyme that catalyze Phase I oxidative, reductive and peroxidative reactions of both endogenous (steroids, fatty acids, vitamins, prostaglandins, retinoids, etc.) and exogenous substrates (chemical pollutants, drugs and carcinogen). The zebrafish (Danio rerio) has become a widely used animal model for studying embryogenesis and developmental genetics and as an animal model to investigate mechanisms of chemical carcinogenesis. Compared to rainbow trout (Oncorhynchus mykiss), however, zebrafish are relatively resistant to certain carcinogens such as aflatoxin B1 (AFB1) and dibenzo[a,1]pyrene (DBP), thus reducing their utility as carcinogenesis models. Their is considerable interest, therefore, in finding zebrafish strains that are more sensitive to carcinogens. Because of their central roles in bioactivation and metabolism processes, it also has become important to establish the contribution of different CYP forms to carcinogenesis and tumor tissue selectivity in the zebrafish and to utilize bioactivating or detoxifying CYP expression as a tool to help
Studies
23
select sensitive zebrafish strains. Therefore, the objectives of this project are to: 1) clone, sequence, heterologously express, enzymatically and kinetically characterize and map major zebrafish CYPs potentially involved in carcinogen activation and detoxification; 2) use zebrafish CYP isozyme specific oligonucleotide probes to determine their tissue and cell-specific expression patterns in zebrafish mutant lines used to assess the sensitivity of the fish to selected carcinogens; 3) select mutant zebrafish line on the basis of inactivating mutations of tumor suppressor genes and/or high carcinogen bioactivating CYP isoform expression; and 4) determine the sensitivity of wild-type and mutant zebrafish lines to AFB1 and DBP. This proposed work should add significantly to the foundation of CYP and carcinogenesis research in zebrafish. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
E-Journals: PubMed Central3 PubMed Central (PMC) is a digital archive of life sciences journal literature developed and managed by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).4 Access to this growing archive of e-journals is free and unrestricted.5 To search, go to http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Pmc, and type “aflatoxin” (or synonyms) into the search box. This search gives you access to fulltext articles. The following is a sample of items found for aflatoxin in the PubMed Central database: •
A beta-glucuronidase reporter gene construct for monitoring aflatoxin biosynthesis in Aspergillus flavus. by Flaherty JE, Weaver MA, Payne GA, Woloshuk CP.; 1995 Jul; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=167519
•
A viral genome containing an unstable aflatoxin B1-N7-guanine DNA adduct situated at a unique site. by Bailey EA, Iyer RS, Harris TM, Essigmann JM.; 1996 Jul 15; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=146009
•
Accumulation of Only Aflatoxin B2 by a Strain of Aspergillus flavus. by Schroeder HW, Carlton WW.; 1973 Jan; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=380751
•
Action of phosphine on production of aflatoxins by various Aspergillus strains isolated from foodstuffs. by Leitao J, de Saint-Blanquat G, Bailly JR.; 1987 Oct; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=204108
•
Activation of ras oncogene in aflatoxin-induced rat liver carcinogenesis. by Sinha S, Webber C, Marshall CJ, Knowles MA, Proctor A, Barrass NC, Neal GE.; 1988 Jun; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=280280
3 4
Adapted from the National Library of Medicine: http://www.pubmedcentral.nih.gov/about/intro.html.
With PubMed Central, NCBI is taking the lead in preservation and maintenance of open access to electronic literature, just as NLM has done for decades with printed biomedical literature. PubMed Central aims to become a world-class library of the digital age. 5 The value of PubMed Central, in addition to its role as an archive, lies in the availability of data from diverse sources stored in a common format in a single repository. Many journals already have online publishing operations, and there is a growing tendency to publish material online only, to the exclusion of print.
24
Aflatoxin
•
Activation of the c-Ki-ras Oncogene in Aflatoxin B1-Induced Hepatocellular Carcinoma and Adenoma in the Rat: Detection by Denaturing Gradient Gel Electrophoresis. by Soman NR, Wogan GN.; 1993 Mar 1; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=46017
•
Aflatoxin and cyclopiazonic acid production by a sclerotium-producing Aspergillus tamarii strain. by Goto T, Wicklow DT, Ito Y.; 1996 Nov; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=168224
•
Aflatoxin and sterigmatocystin contamination of pistachio nuts in orchards. by Sommer NF, Buchanan JR, Fortlage RJ.; 1976 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=170006
•
Aflatoxin B1 dihydrodiol antibody: production and specificity. by Pestka JJ, Chu FS.; 1984 Mar; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=239704
•
Aflatoxin B1 Induction of Lysogenic Bacteria. by Lillehoj EB, Ciegler A.; 1970 Nov; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=377046
•
Aflatoxin B1 Indues the Transversion of G [right arrow] T in Codon 249 of the p53 Tumor Suppressor Gene in Human Hepatocytes. by Aguilar F, Hussain SP, Cerutti P.; 1993 Sep 15; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=47402
•
Aflatoxin B1 Uptake by Flavobacterium aurantiacum and Resulting Toxic Effects. by Lillehoj EB, Ciegler A, Hall HH.; 1967 Jan; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=315019
•
Aflatoxin biosynthesis: detection of transient, acetate-dependent intermediates in Aspergillus by kinetic pulse-labeling. by Zamir LO, Ginsburg R.; 1979 Jun; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=218091
•
Aflatoxin contamination in soybeans: role of proteinase inhibitors, zinc availability, and seed coat integrity. by Stossel P.; 1986 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=203394
•
Aflatoxin contamination of maize in flooded areas of Bhagalpur, India. by Sinha KK.; 1987 Jun; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=203877
•
Aflatoxin Contamination of Preharvest Corn as Influenced by Timing and Method of Inoculation. by Widstrom NW, Wilson DM, McMillian WW.; 1981 Aug; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=243998
Studies
25
•
Aflatoxin contamination of some common drug plants. by Roy AK, Sinha KK, Chourasia HK.; 1988 Mar; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=202555
•
Aflatoxin in corn: ammonia inactivation and bioassay with rainbow trout. by Brekke OL, Sinnhuber RO, Peplinski AJ, Wales JH, Putnam GB, Lee DJ, Ciegler A.; 1977 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=242584
•
Aflatoxin inhibition of viral interferon induction. by Hahon N, Booth JA, Stewart JD.; 1979 Sep; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=352845
•
Aflatoxin localization by the enzyme-linked immunocytochemical technique. by Lawellin DW, Grant DW, Joyce BK.; 1977 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=242593
•
Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography. by Groopman JD, Donahue PR, Zhu JQ, Chen JS, Wogan GN.; 1985 Oct; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=390743
•
Aflatoxin Production in Meats. I. Stored Meats. by Bullerman LB, Hartman PA, Ayres JC.; 1969 Nov; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=378076
•
Aflatoxin Production in Meats. II. Aged Dry Salamis and Aged Country Cured Hams. by Bullerman LB, Hartman PA, Ayres JC.; 1969 Nov; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=378077
•
Aflatoxin Production in Peanut Varieties by aspergillus flavus Link and Aspergillus parasiticus Speare. by Nagarajan V, Bhat RV.; 1973 Feb; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=380798
•
Aflatoxin Production of Species and Strains of the Aspergillus flavus Group Isolated from Field Crops. by Schroeder HW, Boller RA.; 1973 Jun; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=380934
•
Aflatoxin production via cross-feeding of pathway intermediates during cofermentation of aflatoxin pathway-blocked Aspergillus parasiticus mutants. by Cleveland TE, Bhatnagar D, Brown RL.; 1991 Oct; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=183895
•
Aflatoxin variability in pistachios. by Mahoney NE, Rodriguez SB.; 1996 Apr; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=167886
26
Aflatoxin
•
Aflatoxin-Producing Strains of Aspergillus flavus Detected by Fluorescence of Agar Medium Under Ultraviolet Light. by Hara S, Fennell DI, Hesseltine CW.; 1974 Jun; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=380219
•
Altered DNA Mutation Spectrum in Aflatoxin B1-Treated Transgenic Mice That Express the Hepatitis B Virus X Protein. by Madden CR, Finegold MJ, Slagle BL.; 2002 Nov; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=136763
•
An Ethoxyquin-Inducible Aldehyde Reductase from Rat Liver that Metabolizes Aflatoxin B1 Defines a Subfamily of Aldo-Keto Reductases. by Ellis EM, Judah DJ, Neal GE, Hayes JD.; 1993 Nov 1; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=47772
•
An intercalation inhibitor altering the target selectivity of DNA damaging agents: Synthesis of site-specific aflatoxin B1 adducts in a p53 mutational hotspot. by Kobertz WR, Wang D, Wogan GN, Essigmann JM.; 1997 Sep 2; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=23223
•
Analysis of mechanisms regulating expression of the ver-1 gene, involved in aflatoxin biosynthesis. by Liang SH, Wu TS, Lee R, Chu FS, Linz JE.; 1997 Mar; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=168396
•
Antimicrobial Activity of Aflatoxins. by Arai T, Ito T, Koyama Y.; 1967 Jan; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=314968
•
Appearance of enzyme activities catalyzing conversion of sterigmatocystin to aflatoxin B1 in late-growth-phase Aspergillus parasiticus cultures. by Cleveland TE, Lax AR, Lee LS, Bhatnagar D.; 1987 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=203939
•
Aspergillus flavus Infection and Aflatoxin Production in Corn: Influence of Trace Elements. by Lillehoj EB, Garcia WJ, Lambrow M.; 1974 Nov; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=186821
•
Aspergillus flavus infection and aflatoxin production in fig fruits. by Buchanan JR, Sommer NF, Fortlage RJ.; 1975 Aug; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=187160
•
Aspergillus parasiticus growth and aflatoxin production on black and white pepper and the inhibitory action of their chemical constituents. by Madhyastha MS, Bhat RV.; 1984 Aug; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=241521
•
Averufanin is an aflatoxin B1 precursor between averantin and averufin in the biosynthetic pathway. by McCormick SP, Bhatnagar D, Lee LS.; 1987 Jan; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=203593
Studies
27
•
avnA, a gene encoding a cytochrome P-450 monooxygenase, is involved in the conversion of averantin to averufin in aflatoxin biosynthesis in Aspergillus parasiticus. by Yu J, Chang PK, Cary JW, Bhatnagar D, Cleveland TE.; 1997 Apr; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=168428
•
Base substitution mutations induced by metabolically activated aflatoxin B1. by Foster PL, Eisenstadt E, Miller JH.; 1983 May; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=393894
•
Biochemical Alternations in Bacillus megaterium as Produced by Aflatoxin B1. by Beuchat LR, Lechowich RV.; 1971 Jan; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=377129
•
Biological Activity of Aflatoxin B2a. by Lillehoj EB, Ciegler A.; 1969 Apr; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=377733
•
Biosynthetic relationship among aflatoxins B1, B2, G1, and G2. by Yabe K, Ando Y, Hamasaki T.; 1988 Aug; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=202810
•
Biosynthetic relationship among aflatoxins B1, B2, M1, and M2. by Dutton MF, Ehrlich K, Bennett JW.; 1985 Jun; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=241735
•
Biotransformation of aflatoxin B1 and its conjugated metabolites by rat gastrointestinal microfloras. by Wei C, Macy JM, Hsieh DP.; 1981 Feb; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=243730
•
Bright greenish-yellow fluorescence and aflatoxin in agricultural commodities. by Bothast RJ, Hesseltine CW.; 1975 Aug; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=187179
•
Caffeine inhibition of aflatoxin production: mode of action. by Buchanan RL, Hoover DG, Jones SB.; 1983 Nov; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=239540
•
Caffeine inhibition of aflatoxin synthesis: probable site of action. by Buchanan RL, Lewis DF.; 1984 Jun; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=240199
•
Characterization of aflJ, a Gene Required for Conversion of Pathway Intermediates to Aflatoxin. by Meyers DM, Obrian G, Du WL, Bhatnagar D, Payne GA.; 1998 Oct; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=106528
•
Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors. by McMahon G, Davis EF, Huber LJ, Kim Y, Wogan GN.; 1990 Feb; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=53419
28
Aflatoxin
•
Characterization of the Critical Amino Acids of an Aspergillus parasiticus Cytochrome P-450 Monooxygenase Encoded by ordA That Is Involved in the Biosynthesis of Aflatoxins B1, G1, B2, and G2. by Yu J, Chang PK, Ehrlich KC, Cary JW, Montalbano B, Dyer JM, Bhatnagar D, Cleveland TE.; 1998 Dec; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=90931
•
Characterization of the function of the ver-1A and ver-1B genes, involved in aflatoxin biosynthesis in Aspergillus parasiticus. by Liang SH, Skory CD, Linz JE.; 1996 Dec; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=168283
•
Characterization of the polyketide synthase gene (pksL1) required for aflatoxin biosynthesis in Aspergillus parasiticus. by Feng GH, Leonard TJ.; 1995 Nov; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=177466
•
Chlorophyllin intervention reduces aflatoxin --DNA adducts in individuals at high risk for liver cancer. by Egner PA, Wang JB, Zhu YR, Zhang BC, Wu Y, Zhang QN, Qian GS, Kuang SY, Gange SJ, Jacobson LP, Helzlsouer KJ, Bailey GS, Groopman JD, Kensler TW.; 2001 Dec 4; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=64728
•
Chromosomal Location Plays a Role in Regulation of Aflatoxin Gene Expression in Aspergillus parasiticus. by Chiou CH, Miller M, Wilson DL, Trail F, Linz JE.; 2002 Jan; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=126543
•
Cloning and characterization of a cDNA from Aspergillus parasiticus encoding an Omethyltransferase involved in aflatoxin biosynthesis. by Yu J, Cary JW, Bhatnagar D, Cleveland TE, Keller NP, Chu FS.; 1993 Nov; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=182499
•
Cloning and Characterization of the O-Methyltransferase I Gene (dmtA) from Aspergillus parasiticus Associated with the Conversions of Demethylsterigmatocystin to Sterigmatocystin and Dihydrodemethylsterigmatocystin to Dihydrosterigmatocystin in Aflatoxin Biosynthesis. by Motomura M, Chihaya N, Shinozawa T, Hamasaki T, Yabe K.; 1999 Nov; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=91671
•
Cloning of the afl-2 gene involved in aflatoxin biosynthesis from Aspergillus flavus. by Payne GA, Nystrom GJ, Bhatnagar D, Cleveland TE, Woloshuk CP.; 1993 Jan; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=202071
•
Cloning of the Aspergillus parasiticus apa-2 gene associated with the regulation of aflatoxin biosynthesis. by Chang PK, Cary JW, Bhatnagar D, Cleveland TE, Bennett JW, Linz JE, Woloshuk CP, Payne GA.; 1993 Oct; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=182448
•
Coconut as a Medium for the Experimental Production of Aflatoxin. by Arseculeratne SN, De Silva LM, Wijesundera S, Bandunatha CH.; 1969 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=377895
Studies
29
•
Comparative mapping of aflatoxin pathway gene clusters in Aspergillus parasiticus and Aspergillus flavus. by Yu J, Chang PK, Cary JW, Wright M, Bhatnagar D, Cleveland TE, Payne GA, Linz JE.; 1995 Jun; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=167508
•
Comparative Studies on the Detoxification of Aflatoxins by Sodium Hypochlorite and Commercial Bleaches. by Yang CY.; 1972 Dec; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=380691
•
Comparison of antibody production against aflatoxin B1 in goats and rabbits. by Gaur PK, El-Nakib O, Chu FS.; 1980 Sep; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=291637
•
Conditions for induction of bacteriophage from lysogenic Bacillus megaterium with aflatoxin B1. by Whittaker BL, Chipley JR.; 1979 Mar; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=243254
•
Conversion of a new metabolite to aflatoxin B2 by Aspergillus parasiticus. by Cleveland TE, Bhatnagar D, Foell CJ, McCormick SP.; 1987 Dec; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=204202
•
Correlation of Aflatoxin Contamination With Zinc Content of Chicken Feed. by Jones FT, Hagler WM Jr, Hamilton PB.; 1984 Mar; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=239705
•
Correlation of Zn2+ content with aflatoxin content of corn. by Failla LJ, Lynn D, Niehaus WG Jr.; 1986 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=203395
•
Country Cured Ham as a Possible Source of Aflatoxin. by Strzelecki E, Lillard HS, Ayres JC.; 1969 Nov; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=378119
•
Cryptic speciation and recombination in the aflatoxin-producing fungus Aspergillus flavus. by Geiser DM, Pitt JI, Taylor JW.; 1998 Jan 6; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=18233
•
Culture Conditions Control Expression of the Genes for Aflatoxin and Sterigmatocystin Biosynthesis in Aspergillus parasiticus and A. nidulans. by Feng GH, Leonard TJ.; 1998 Jun; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=106313
•
Detection of Aflatoxin B1 in Silkworm Larvae Attacked by an Aspergillus flavus Isolate from a Sericultural Farm. by Ohtomo T, Murakoshi S, Sugiyama J, Kurata H.; 1975 Dec; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=376585
30
Aflatoxin
•
Detection of aflatoxin D1 in ammoniated corn by mass spectrometry-mass spectrometry. by Grove MD, Plattner RD, Peterson RE.; 1984 Oct; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=241638
•
Development of Aflatoxin B1-Lysine Adduct Monoclonal Antibody for Human Exposure Studies. by Wang JS, Abubaker S, He X, Sun G, Strickland PT, Groopman JD.; 2001 Jun; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=92929
•
Dietary aflatoxin exposure and impaired growth in young children from Benin and Togo: cross sectional study. by Gong YY, Cardwell K, Hounsa A, Egal S, Turner PC, Hall AJ, Wild CP.; 2002 Jul 6; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=116667
•
Differentiation of aflatoxins from territrems. by Ling KH, Yang CK, Huang HC.; 1979 Mar; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=243220
•
Direct visual detection of aflatoxin synthesis by minicolonies of Aspergillus species. by Lemke PA, Davis ND, Creech GW.; 1989 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=202954
•
Dothistroma pini, a Forest Pathogen, Contains Homologs of Aflatoxin Biosynthetic Pathway Genes. by Bradshaw RE, Bhatnagar D, Ganley RJ, Gillman CJ, Monahan BJ, Seconi JM.; 2002 Jun; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=123981
•
Effect of Aflatoxin B1 on Cell Cultures. by Gabliks J, Schaeffer W, Friedman L, Wogan G.; 1965 Sep; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=315716
•
Effect of aflatoxin B1 on chromatin-bound ribonucleic acid polymerase and nucleic acid and protein synthesis in germinating maize seeds. by Tripathi RK, Misra RS.; 1981 Sep; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=244025
•
Effect of aflatoxin on phagocytosis of Aspergillus fumigatus spores by rabbit alveolar macrophages. by Richard JL, Thurston JR.; 1975 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=187111
•
Effect of aflatoxins on rat peritoneal macrophages. by Cusumano V, Costa GB, Seminara S.; 1990 Nov; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=184993
•
Effect of C6 to C9 alkenals on aflatoxin production in corn, cottonseed, and peanuts. by Zeringue HJ Jr.; 1991 Aug; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=183592
Studies
31
•
Effect of dietary aflatoxin on fertility, hatchability, and progeny performance of broiler breeder hens. by Howarth B Jr, Wyatt RD.; 1976 May; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=291175
•
Effect of initial pH on aflatoxin production. by Buchanan RL Jr, Ayres JC.; 1975 Dec; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=376591
•
Effect of ochratoxin and aflatoxin on serum proteins, complement activity, and antibody production to Brucella abortus in guinea pigs. by Richard JL, Thurston JR, Deyoe BL, Booth GD.; 1975 Jan; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=186904
•
Effect of phenolic antioxidants on the mutagenicity of aflatoxin B1. by Shelef LA, Chin B.; 1980 Dec; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=291718
•
Effect of pyridazinone herbicides on growth and aflatoxin release by Aspergillus flavus and Aspergillus parasiticus. by Bean GA, Southall A.; 1983 Aug; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=239431
•
Effect of specific amino acids on growth and aflatoxin production by Aspergillus parasiticus and Aspergillus flavus in defined media. by Payne GA, Hagler WM Jr.; 1983 Oct; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=239471
•
Effect of temperature cycling on the production of aflatoxin by Asperfillus parasiticus. by Stutz HK, Krumperman PH.; 1976 Sep; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=170065
•
Effect of temperature on aflatoxin production in Mucuna pruriens seeds. by Roy AK, Chourasia HK.; 1989 Feb; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=184149
•
Effect of zinc on adenine nucleotide pools in relation to aflatoxin biosynthesis in Aspergillus parasiticus. by Gupta SK, Maggon KK, Venkitasubramanian TA.; 1976 Dec; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=170456
•
Effects of Aflatoxin on Germination and Growth of Lettuce. by Crisan EV.; 1973 Mar; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=380808
•
Effects of Aflatoxin on Seeding Growth and Ultrastructure in Plants. by Crisan EV.; 1973 Dec; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=379944
32
Aflatoxin
•
Effects of Light, Temperature, and pH Value on Aflatoxin Production In Vitro. by Joffe AZ, Lisker N.; 1969 Sep; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=378018
•
Effects of Moisture Content and Temperature on Aflatoxin Production in Corn. by Trenk HL, Hartman PA.; 1970 May; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=376788
•
Effects of soil moisture and temperature on preharvest invasion of peanuts by the Aspergillus flavus group and subsequent aflatoxin development. by Hill RA, Blankenship PD, Cole RJ, Sanders TH.; 1983 Feb; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=242335
•
Effects of trace metals on the production of aflatoxins by Aspergillus parasiticus. by Marsh PB, Simpson ME, Trucksess MW.; 1975 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=187113
•
Enzymatic Conversion of Averufin to Hydroxyversicolorone and Elucidation of a Novel Metabolic Grid Involved in Aflatoxin Biosynthesis. by Yabe K, Chihaya N, Hamamatsu S, Sakuno E, Hamasaki T, Nakajima H, Bennett JW.; 2003 Jan; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=152417
•
Enzymatic conversion of norsolorinic acid to averufin in aflatoxin biosynthesis. by Yabe K, Nakamura Y, Nakajima H, Ando Y, Hamasaki T.; 1991 May; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=182952
•
Enzymatic conversion of sterigmatocystin into aflatoxin B1 by cell-free extracts of Aspergillus parasiticus. by Singh R, Hsieh DP.; 1976 May; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=291187
•
Enzymatic Formation of G-Group Aflatoxins and Biosynthetic Relationship between G- and B-Group Aflatoxins. by Yabe K, Nakamura M, Hamasaki T.; 1999 Sep; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=99713
•
Enzymatic formation of the bisfuran structure in aflatoxin biosynthesis. by Wan NC, Hsieh DP.; 1980 Jan; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=291292
•
Enzymatic Function of the Nor-1 Protein in Aflatoxin Biosynthesis in Aspergillus parasiticus. by Zhou R, Linz JE.; 1999 Dec; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=91775
•
Enzyme-linked immunosorbent analysis for aflatoxin B1. by Lawellin DW, Grant DW, Joyce BK.; 1977 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=242594
•
Enzymes and aflatoxin biosynthesis. by Dutton MF.; 1988 Jun; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=373139
Studies
33
•
Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. by Shimada T, Guengerich FP.; 1989 Jan; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=286490
•
Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver. by Forrester LM, Neal GE, Judah DJ, Glancey MJ, Wolf CR.; 1990 Nov; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=54944
•
Field accumulation of aflatoxin in cottonseed as influenced by irrigation termination dates and pink bollworm infestation. by Russell TE, Watson TF, Ryan GF.; 1976 May; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=291181
•
Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1. by Aoyama T, Yamano S, Guzelian PS, Gelboin HV, Gonzalez FJ.; 1990 Jun; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=54203
•
Further Characterization of Tissue Distribution and Metabolism of [14C]Aflatoxin B1 in Chickens. by Chipley JR, Mabee MS, Applegate KL, Dreyfuss MS.; 1974 Dec; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=186876
•
Genetic transformation system for the aflatoxin-producing fungus Aspergillus flavus. by Woloshuk CP, Seip ER, Payne GA, Adkins CR.; 1989 Jan; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=184058
•
High Aflatoxin Production on a Chemically Defined Medium. by Reddy TV, Viswanathan L, Venkitasubramanian TA.; 1971 Sep; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=376320
•
High-affinity monoclonal antibodies for aflatoxins and their application to solidphase immunoassays. by Groopman JD, Trudel LJ, Donahue PR, Marshak-Rothstein A, Wogan GN.; 1984 Dec; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=392225
•
Homologs of Aflatoxin Biosynthesis Genes and Sequence of aflR in Aspergillus oryzae and Aspergillus sojae. by Watson AJ, Fuller LJ, Jeenes DJ, Archer DB.; 1999 Jan; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=91020
•
Identification and Aflatoxin Production of Molds Isolated from Country Cured Hams. by Sutic M, Ayres JC, Koehler PE.; 1972 Mar; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=380403
34
Aflatoxin
•
Identification of aflatoxin biosynthesis genes by genetic complementation in an Aspergillus flavus mutant lacking the aflatoxin gene cluster. by Prieto R, Yousibova GL, Woloshuk CP.; 1996 Oct; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=168161
•
Identification of an activated c-Ki-ras oncogene in rat liver tumors induced by aflatoxin B1. by McMahon G, Hanson L, Lee JJ, Wogan GN.; 1986 Dec; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=387149
•
Identification of averantin as an aflatoxin B1 precursor: placement in the biosynthetic pathway. by Bennett JW, Lee LS, Shoss SM, Boudreaux GH.; 1980 Apr; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=291429
•
Identification of O-methylsterigmatocystin as an aflatoxin B1 and G1 precursor in Aspergillus parasiticus. by Bhatnagar D, McCormick SP, Lee LS, Hill RA.; 1987 May; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=203804
•
Improved method of screening for aflatoxin with a coconut agar medium. by Davis ND, Iyer SK, Diener UL.; 1987 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=203916
•
Improved Yield of Aflatoxin by Incremental Increases of Temperature. by West S, Wyatt RD, Hamilton PB.; 1973 Jun; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=380959
•
In vitro reactions of aflatoxin B1-adducted DNA. by Groopman JD, Croy RG, Wogan GN.; 1981 Sep; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=348762
•
Inactivation of aflatoxin B1 by using the synergistic effect of hydrogen peroxide and gamma radiation. by Patel UD, Govindarajan P, Dave PJ.; 1989 Feb; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=184132
•
Incidence of aflatoxin in California almonds. by Schade JE, McGreevy K, King AD Jr, Mackey B, Fuller G.; 1975 Jan; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=186909
•
Incorporation of (2-14C)acetate into lipids of mink (Mustela vison) liver and intestine during in vitro and in vivo treatment with aflatoxin B1. by Chou CC, Marth EH.; 1975 Dec; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=376573
•
Increased expression of Aspergillus parasiticus aflR, encoding a sequence-specific DNA-binding protein, relieves nitrate inhibition of aflatoxin biosynthesis. by Chang PK, Ehrlich KC, Yu J, Bhatnagar D, Cleveland TE.; 1995 Jun; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=167509
Studies
35
•
Increased production of aflatoxins by Aspergillus parasiticus Speare in the presence of rubratoxin B. by Moss MO, Badii F.; 1982 Apr; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=241938
•
Induction of base substitution mutations by aflatoxin B1 is mucAB dependent in Escherichia coli. by Foster PL, Groopman JD, Eisenstadt E.; 1988 Aug; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=211309
•
Influence of Fungicides and Irrigation Practice on Aflatoxin in Peanuts Before Digging. by Pettit RE, Taber RA, Schroeder HW, Harrison AL.; 1971 Oct; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=376377
•
Influence of inoculum size of Aspergillus parasiticus spores on aflatoxin production. by Sharma A, Behere AG, Padwal-Desai SR, Nadkarni GB.; 1980 Dec; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=291709
•
Influence of modified atmosphere storage on aflatoxin production in high moisture corn. by Wilson DM, Jay E.; 1975 Feb; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=186948
•
Influence of temperature cycling on the production of aflatoxins B1 and G1 by Aspergillus parasiticus. by Lin YC, Ayres JC, Koehler PE.; 1980 Aug; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=291576
•
Influence of tricarboxylic acid cycle intermediates and related metabolites on the biosynthesis of aflatoxin by resting cells of Aspergillus flavus. by Shantha T, Murthy VS.; 1981 Nov; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=244103
•
Influence of white light on production of aflatoxins and anthraquinones in Aspergillus parasiticus. by Bennett JW, Dunn JJ, Goldsman CI.; 1981 Feb; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=243721
•
Influence of yield on in vitro accumulation of aflatoxins in pecan (Carya illinoensis (Wang.) K. Koch) nutmeats. by McMeans JL.; 1983 Feb; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=242351
•
Inhibition of aflatoxin biosynthesis by tolnaftate. by Khan SN, Maggon KK, Venkitasubramanian TA.; 1978 Aug; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=291213
•
Inhibition of aflatoxin formation by 2-mercaptoethanol. by Gupta SK, Maggon KK, Venkitasubramanian TA.; 1976 Sep; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=170064
36
Aflatoxin
•
Inhibition of Aflatoxin Production and Tentative Identification of an Aflatoxin Intermediate "Versiconal Acetate" from Treatment with Dichlorvos. by Schroeder HW, Cole RJ, Grigsby RD, Hein H Jr.; 1974 Feb; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=380041
•
Inhibition of aflatoxin production by selected insecticides. by Draughon FA, Ayres JC.; 1981 Apr; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=243843
•
Inhibition of Aflatoxin Production by Surfactants. by Rodriguez SB, Mahoney NE.; 1994 Jan; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=201276
•
Inhibition of Aspergillus growth and aflatoxin release by derivatives of benzoic acid. by Chipley JR, Uraih N.; 1980 Aug; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=291580
•
Inhibition of deoxyribonucleic acid synthesis in Flavobacterium aurantiacum by aflatoxin B1. by Lillehoj EB, Ciegler A.; 1967 Sep; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=251955
•
Integrated process for ammonia inactivation of aflatoxin-contaminated corn and ethanol fermentation. by Bothast RJ, Nofsinger GW, Lagoda AA, Black LT.; 1982 Apr; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=241949
•
Interaction between Streptococcus lactis and Aspergillus flavus on production of aflatoxin. by Coallier-Ascah J, Idziak ES.; 1985 Jan; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=238363
•
Interconversion of aflatoxin B1 and aflatoxicol by several fungi. by Nakazato M, Morozumi S, Saito K, Fujinuma K, Nishima T, Kasai N.; 1990 May; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=184431
•
Involvement of Two Cytosolic Enzymes and a Novel Intermediate, 5[prime prime or minute]-Oxoaverantin, in the Pathway from 5[prime prime or minute]Hydroxyaverantin to Averufin in Aflatoxin Biosynthesis. by Sakuno E, Yabe K, Nakajima H.; 2003 Nov; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=262255
•
Isolation and characterization of a gene from Aspergillus parasiticus associated with the conversion of versicolorin A to sterigmatocystin in aflatoxin biosynthesis. by Skory CD, Chang PK, Cary J, Linz JE.; 1992 Nov; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=183140
Studies
37
•
Isolation and characterization of Aspergillus parasiticus mutants with impaired aflatoxin production by a novel tip culture method. by Yabe K, Nakamura H, Ando Y, Terakado N, Nakajima H, Hamasaki T.; 1988 Aug; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=202809
•
Mechanism of action of aflatoxin B1 in Bacillus megaterium. by Tiwari RP, Dham CK, Bhalla TC, Saini SS, Vadehra DV.; 1985 Apr; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=238467
•
Metabolic effects of low aflatoxin B1 levels on broiler chicks. by Maurice DV, Bodine AB, Rehrer NJ.; 1983 Mar; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=242400
•
Metabolism of aflatoxin B1 by rat hepatic microsomes induced by polyhalogenated biphenyl congeners. by Halvorson MR, Phillips TD, Safe SH, Robertson LW.; 1985 Apr; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=238464
•
Metabolism of aflatoxin, ochratoxin, zearalenone, and three trichothecenes by intact rumen fluid, rumen protozoa, and rumen bacteria. by Kiessling KH, Pettersson H, Sandholm K, Olsen M.; 1984 May; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=240059
•
Mold flora and aflatoxin contamination of stored and cooked samples of pearl millet in the Paharia tribal belt of Santhal paragana, Bihar, India. by Mishra NK, Daradhiyar SK.; 1991 Apr; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=182872
•
Molecular characterization of aflR, a regulatory locus for aflatoxin biosynthesis. by Woloshuk CP, Foutz KR, Brewer JF, Bhatnagar D, Cleveland TE, Payne GA.; 1994 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=201664
•
Molecular characterization of an Aspergillus parasiticus dehydrogenase gene, norA, located on the aflatoxin biosynthesis gene cluster. by Cary JW, Wright M, Bhatnagar D, Lee R, Chu FS.; 1996 Feb; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=167807
•
Molecular cloning of genes related to aflatoxin biosynthesis by differential screening. by Feng GH, Chu FS, Leonard TJ.; 1992 Feb; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=195269
•
Monitoring the Production of Aflatoxin B1 in Wheat by Measuring the Concentration of nor-1 mRNA. by Mayer Z, Farber P, Geisen R.; 2003 Feb; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=143586
38
Aflatoxin
•
Monoclonal antibody to aflatoxin B1-modified DNA detected by enzyme immunoassay. by Haugen A, Groopman JD, Hsu IC, Goodrich GR, Wogan GN, Harris CC.; 1981 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=319740
•
Morphological Alterations in Bacillus megaterium as Produced by Aflatoxin B1. by Beuchat LR, Lechowich RV.; 1971 Jan; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=377130
•
Mutant of Aspergillus flavus producing more aflatoxin B2 than B1. by Papa KE.; 1977 Jan; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=170625
•
Mutational Properties of the Primary Aflatoxin B1-DNA Adduct. by Bailey EA, Iyer RS, Stone MP, Harris TM, Essigmann JM.; 1996 Feb 20; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=39975
•
New Additive for Culture Media for Rapid Identification of Aflatoxin-Producing Aspergillus Strains. by Fente CA, Ordaz JJ, Vazquez BI, Franco CM, Cepeda A.; 2001 Oct; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=93241
•
Occurrence of Aflatoxins and Aflatoxin-Producing Strains of Aspergillus spp. in Soybeans. by Bean GA, Schillinger JA, Klarman WL.; 1972 Sep; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=376537
•
Occurrence of aflatoxins in oilseeds providing cocoa-butter substitutes. by Kershaw SJ.; 1982 May; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=244209
•
ord1, an oxidoreductase gene responsible for conversion of O-methylsterigmatocystin to aflatoxin in Aspergillus flavus. by Prieto R, Woloshuk CP.; 1997 May; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=168459
•
Persistence of Aflatoxin During the Fermentation of Soy Sauce. by Maing IY, Ayres JC, Koehler PE.; 1973 Jun; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=380958
•
Physical and transcriptional map of an aflatoxin gene cluster in Aspergillus parasiticus and functional disruption of a gene involved early in the aflatoxin pathway. by Trail F, Mahanti N, Rarick M, Mehigh R, Liang SH, Zhou R, Linz JE.; 1995 Jul; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=167540
Studies
39
•
Possible implications of reciprocity between ethylene and aflatoxin biogenesis in Aspergillus flavus and Aspergillus parasiticus. by Sharma A, Padwal-Desai SR, Nadkarni GB.; 1985 Jan; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=238348
•
Precursor recognition by kinetic pulse-labeling in a toxigenic aflatoxin B1-producing strain of Aspergillus. by Zamir LO, Hufford KD.; 1981 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=243979
•
Preharvest aflatoxin contamination: effect of moisture and substrate variation in developing cottonseed and corn kernels. by Lillehoj EB, Wall JH, Bowers EJ.; 1987 Mar; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=203710
•
Preparation of Labeled Aflatoxins with High Specific Activities. by Hsieh DP, Mateles RI.; 1971 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=377379
•
Presence of aflatoxin M1 in commercial ultra-high-temperature-treated milk. by Blanco JL, Dominguez L, Gomez-Lucia E, Garayzabal JF, Garcia JA, Suarez G.; 1988 Jun; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=202709
•
Production and characterization of aflatoxin B2a antiserum. by Gaur PK, Lau HP, Pestka JJ, Chu FS.; 1981 Feb; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=243719
•
Production and characterization of antibody against aflatoxin Q1. by Fan TS, Zhang GS, Chu FS.; 1984 Mar; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=239714
•
Production and characterization of monoclonal antibodies against aflatoxin M1. by Woychik NA, Hinsdill RD, Chu FS.; 1984 Dec; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=241692
•
Production of aflatoxin by an Aspergillus flavus isolate cultured under a limited oxygen supply. by Clevstrom G, Ljunggren H, Tegelstrom S, Tideman K.; 1983 Aug; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=239402
•
Production of Aflatoxin M in a Liquid Medium. by Pai MR, Bai NJ, Venkitasubramanian TA.; 1975 Jun; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=187091
•
Production of aflatoxin on soybeans. by Gupta SK, Venkitasubramanian TA.; 1975 Jun; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=187088
40
Aflatoxin
•
Production of aflatoxins B1 and G1 by Aspergillus flavus and Aspergillus parasiticus isolated from market pecans. by Koehler PE, Hanlin RT, Beraha L.; 1975 Oct; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=187233
•
Production of Aflatoxins by Aspergillus flavus Cultured on Flue-Cured Tobacco. by Pattee HE.; 1969 Nov; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=378129
•
Production of antibody against aflatoxin B1. by Chu FS, Ueno I.; 1977 May; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=170837
•
Purification and Characterization of O-Methyltransferase I Involved in Conversion of Demethylsterigmatocystin to Sterigmatocystin and of Dihydrodemethylsterigmatocystin to Dihydrosterigmatocystin during Aflatoxin Biosynthesis. by Yabe K, Matsushima KI, Koyama T, Hamasaki T.; 1998 Jan; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=124688
•
Purification and Characterization of Two Versiconal Hemiacetal Acetate Reductases Involved in Aflatoxin Biosynthesis. by Matsushima KI, Ando Y, Hamasaki T, Yabe K.; 1994 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=201684
•
Purification of a 40-kilodalton methyltransferase active in the aflatoxin biosynthetic pathway. by Keller NP, Dischinger HC Jr, Bhatnagar D, Cleveland TE, Ullah AH.; 1993 Feb; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=202130
•
Quantitation of aflatoxin B1 adduction within the ribosomal RNA gene sequences of rat liver DNA. by Irvin TR, Wogan GN.; 1984 Feb; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=344895
•
Quantitation of aflatoxin B1 and aflatoxin B1 antibody by an enzyme-linked immunosorbent microassay. by Pestka JJ, Gaur PK, Chu FS.; 1980 Dec; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=291716
•
Reaction of aflatoxin B1 exo-8,9-epoxide with DNA: Kinetic analysis of covalent binding and DNA-induced hydrolysis. by Johnson WW, Guengerich FP.; 1997 Jun 10; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=21012
•
Reactivity of aflatoxin B2a antibody with aflatoxin B1-modified DNA and related metabolites. by Pestka JJ, Li YK, Chu FS.; 1982 Nov; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=242163
•
Regional Differences in Production of Aflatoxin B1 and Cyclopiazonic Acid by Soil Isolates of Aspergillus flavus along a Transect within the United States. by Horn BW, Dorner JW.; 1999 Apr; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=91204
Studies
41
•
Regulated expression of the nor-1 and ver-1 genes associated with aflatoxin biosynthesis. by Skory CD, Chang PK, Linz JE.; 1993 May; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=182131
•
Regulation of aflatoxin biosynthesis: assessment of the role of cellular energy status as a regulator of the induction of aflatoxin production. by Buchanan RL, Jones SB, Gerasimowicz WV, Zaika LL, Stahl HG, Ocker LA.; 1987 Jun; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=203845
•
Regulation of aflatoxin biosynthesis: effect of glucose on activities of various glycolytic enzymes. by Buchanan RL, Lewis DF.; 1984 Aug; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=241508
•
Regulation of aflR and Its Product, AflR, Associated with Aflatoxin Biosynthesis. by Liu BH, Chu FS.; 1998 Oct; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=106529
•
Restricted repair of aflatoxin B1 induced damage in alpha DNA of monkey cells. by Leadon SA, Zolan ME, Hanawalt PC.; 1983 Aug 25; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=326306
•
Role of blastospores in protecting Aspergillus parasiticus NRRL 3240 from high levels of aflatoxins. by Bhatnagar RK, Ahmad S, Mukerji KG, Venkitasubramanian TA.; 1982 Sep; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=242061
•
Role of versicolorin A and its derivatives in aflatoxin biosynthesis. by Dutton MF, Anderson MS.; 1982 Mar; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=241872
•
Sensitivity of aflatoxin b1 to ionizing radiation. by Van Dyck PJ, Tobback P, Feyes M, van de Voorde H.; 1982 Jun; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=244234
•
Sequence context effects in DNA replication blocks induced by aflatoxin B1. by Refolo LM, Conley MP, Sambamurti K, Jacobsen JS, Humayun MZ.; 1985 May; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=397721
•
Sequence specificity in aflatoxin B1--DNA interactions. by Muench KF, Misra RP, Humayun MZ.; 1983 Jan; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=393298
•
Sequence variability in homologs of the aflatoxin pathway gene aflR distinguishes species in Aspergillus section Flavi. by Chang PK, Bhatnagar D, Cleveland TE, Bennett JW.; 1995 Jan; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=167259
42
Aflatoxin
•
Silica gel medium to detect molds that produce aflatoxin. by Torrey GS, Marth EH.; 1976 Sep; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=170073
•
Simple fluorescence method for rapid estimation of aflatoxin levels in a solid culture medium. by Cotty PJ.; 1988 Jan; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=202434
•
Simple method for screening aflatoxin-producing molds by UV photography. by Yabe K, Ando Y, Ito M, Terakado N.; 1987 Feb; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=203642
•
Simultaneous occurrence of deoxynivalenol, zearalenone, and aflatoxin in 1982 scabby wheat from the midwestern United States. by Hagler WM Jr, Tyczkowska K, Hamilton PB.; 1984 Jan; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=239627
•
Site-specific targeting of aflatoxin adduction directed by triple helix formation in the major groove of oligodeoxyribonucleotides. by Jones WR, Stone MP.; 1998 Feb 15; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=147363
•
Sodium bicarbonate reduces viability and alters aflatoxin distribution of Aspergillus parasiticus in Czapek's agar. by Montville TJ, Goldstein PK.; 1987 Oct; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=204104
•
Some Cultural Conditions That Control Biosynthesis of Lipid and Aflatoxin by Aspergillus parasiticus. by Shih CN, Marth EH.; 1974 Mar; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=380064
•
Stability of aflatoxin B-1 and ochratoxin A in brewing. by Chu FS, Chang CC, Ashoor SH, Prentice N.; 1975 Mar; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=186972
•
Stable expression of rat cytochrome P-450IIB1 cDNA in Chinese hamster cells (V79) and metabolic activation of aflatoxin B1. by Doehmer J, Dogra S, Friedberg T, Monier S, Adesnik M, Glatt H, Oesch F.; 1988 Aug; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=281846
•
Step of Dichlorvos Inhibition in the Pathway of Aflatoxin Biosynthesis. by Yao RC, Hsieh DP.; 1974 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=186587
•
Stereochemistry during aflatoxin biosynthesis: conversion of norsolorinic acid to averufin. by Yabe K, Matsuyama Y, Ando Y, Nakajima H, Hamasaki T.; 1993 Aug; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=182310
Studies
43
•
Stereochemistry during aflatoxin biosynthesis: cyclase reaction in the conversion of versiconal to versicolorin B and racemization of versiconal hemiacetal acetate. by Yabe K, Hamasaki T.; 1993 Aug; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=182311
•
Stimulation by Hyphopichia burtonii and Bacillus amyloliquefaciens of aflatoxin production by Aspergillus flavus in irradiated maize and rice grains. by Cuero RG, Smith JE, Lacey J.; 1987 May; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=203822
•
Stimulation of aflatoxin B1 and T-2 toxin production by sorbic acid. by Gareis M, Bauer J, von Montgelas A, Gedek B.; 1984 Feb; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=239684
•
Structural and functional analysis of the nor-1 gene involved in the biosynthesis of aflatoxins by Aspergillus parasiticus. by Trail F, Chang PK, Cary J, Linz JE.; 1994 Nov; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=201939
•
Structure and function of fas-1A, a gene encoding a putative fatty acid synthetase directly involved in aflatoxin biosynthesis in Aspergillus parasiticus. by Mahanti N, Bhatnagar D, Cary JW, Joubran J, Linz JE.; 1996 Jan; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=167785
•
Surface Binding of Aflatoxin B1 by Lactic Acid Bacteria. by Haskard CA, El-Nezami HS, Kankaanpaa PE, Salminen S, Ahokas JT.; 2001 Jul; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=92985
•
Susceptibility to Hepatocellular Carcinoma is Associated with Genetic Variation in the Enzymatic Detoxification of Aflatoxin B1. by McGlynn KA, Rosvold EA, Lustbader ED, Hu Y, Clapper ML, Zhou T, Wild CP, Xia X, Baffoe-Bonnie A, Ofori-Adjei D, Chen G, London WT, Shen F, Buetow KH.; 1995 Mar 14; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=42488
•
The aflatoxin B1 formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma. by Smela ME, Hamm ML, Henderson PT, Harris CM, Harris TM, Essigmann JM.; 2002 May 14; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=124458
•
The alcohol dehydrogenase gene adh1 is induced in Aspergillus flavus grown on medium conducive to aflatoxin biosynthesis. by Woloshuk CP, Payne GA.; 1994 Feb; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=201364
•
The Carboxy-Terminal Portion of the Aflatoxin Pathway Regulatory Protein AFLR of Aspergillus parasiticus Activates GAL1::lacZ Gene Expression in Saccharomyces cerevisiae. by Chang PK, Yu J, Bhatnagar D, Cleveland TE.; 1999 Jun; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=91370
44
Aflatoxin
•
Tissue Distribution and Metabolism of Aflatoxin B1-14C in Broiler Chickens. by Mabee MS, Chipley JR.; 1973 May; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=380908
•
Toxicity of aflatoxin B1 to penaeid shrimp. by Wiseman MO, Price RL, Lightner DV, Williams RR.; 1982 Dec; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=242216
•
Two distinct O-methyltransferases in aflatoxin biosynthesis. by Yabe K, Ando Y, Hashimoto J, Hamasaki T.; 1989 Sep; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=203052
•
Use of aflatoxin-producing ability medium to distinguish aflatoxin-producing strains of Aspergillus flavus. by Wicklow DT, Shotwell OL, Adams GL.; 1981 Mar; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=243762
•
Variability among atoxigenic Aspergillus flavus strains in ability to prevent aflatoxin contamination and production of aflatoxin biosynthetic pathway enzymes. by Cotty PJ, Bhatnagar D.; 1994 Jul; http://www.pubmedcentral.gov/picrender.fcgi?tool=pmcentrez&action=stream&blobt ype=pdf&artid=201639
The National Library of Medicine: PubMed One of the quickest and most comprehensive ways to find academic studies in both English and other languages is to use PubMed, maintained by the National Library of Medicine.6 The advantage of PubMed over previously mentioned sources is that it covers a greater number of domestic and foreign references. It is also free to use. If the publisher has a Web site that offers full text of its journals, PubMed will provide links to that site, as well as to sites offering other related data. User registration, a subscription fee, or some other type of fee may be required to access the full text of articles in some journals. To generate your own bibliography of studies dealing with aflatoxin, simply go to the PubMed Web site at http://www.ncbi.nlm.nih.gov/pubmed. Type “aflatoxin” (or synonyms) into the search box, and click “Go.” The following is the type of output you can expect from PubMed for aflatoxin (hyperlinks lead to article summaries):
6 PubMed was developed by the National Center for Biotechnology Information (NCBI) at the National Library of Medicine (NLM) at the National Institutes of Health (NIH). The PubMed database was developed in conjunction with publishers of biomedical literature as a search tool for accessing literature citations and linking to full-text journal articles at Web sites of participating publishers. Publishers that participate in PubMed supply NLM with their citations electronically prior to or at the time of publication.
Studies
45
•
A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Author(s): Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, Wogan GN, Groopman JD. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1994 January-February; 3(1): 3-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8118382
•
A review on biological control and metabolism of aflatoxin. Author(s): Mishra HN, Das C. Source: Critical Reviews in Food Science and Nutrition. 2003; 43(3): 245-64. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12822672
•
A survey of ethnic foods for microbial quality and aflatoxin content. Author(s): Candlish AAG, Pearson SM, Aidoo KE, Smith JE, Kelly B, Irvine H. Source: Food Additives and Contaminants. 2001 February; 18(2): 129-36. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11288910
•
Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma. Author(s): Lee YI, Lee S, Das GC, Park US, Park SM, Lee YI. Source: Oncogene. 2000 August 3; 19(33): 3717-26. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10949925
•
Activation of toxic chemicals by cytochrome P450 enzymes: regio- and stereoselective oxidation of aflatoxin B1. Author(s): Guengerich FP, Ueng YF, Kim BR, Langouet S, Coles B, Iyer RS, Thier R, Harris TM, Shimada T, Yamazaki H, Ketterer B, Guillouzo A. Source: Advances in Experimental Medicine and Biology. 1996; 387: 7-15. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8794188
•
Aflatoxin and kwashiorkor. Author(s): Mahoud B. Source: Acta Paediatrica (Oslo, Norway : 1992). 2001 January; 90(1): 103. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11227326
•
Aflatoxin and liver cancer. Author(s): Jackson PE, Groopman JD. Source: Bailliere's Best Practice & Research. Clinical Gastroenterology. 1999 December; 13(4): 545-55. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10654919
46
Aflatoxin
•
Aflatoxin and outcome from acute lower respiratory infection in children in The Philippines. Author(s): Denning DW, Quiepo SC, Altman DG, Makarananda K, Neal GE, Camallere EL, Morgan MR, Tupasi TE. Source: Annals of Tropical Paediatrics. 1995 September; 15(3): 209-16. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8534039
•
Aflatoxin as a human carcinogen. Author(s): Wogan GN. Source: Hepatology (Baltimore, Md.). 1999 August; 30(2): 573-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10421671
•
Aflatoxin B1 8,9-epoxide hydrolysis in the presence of rat and human epoxide hydrolase. Author(s): Johnson WW, Yamazaki H, Shimada T, Ueng YF, Guengerich FP. Source: Chemical Research in Toxicology. 1997 June; 10(6): 672-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9208174
•
Aflatoxin B1 aldehyde reductase (AFAR) genes cluster at 1p35-1p36.1 in a region frequently altered in human tumour cells. Author(s): Praml C, Savelyeva L, Schwab M. Source: Oncogene. 2003 July 24; 22(30): 4765-73. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12879023
•
Aflatoxin B1-adduct formation in rat and human small bowel enterocytes. Author(s): Kolars JC, Benedict P, Schmiedlin-Ren P, Watkins PB. Source: Gastroenterology. 1994 February; 106(2): 433-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8299909
•
Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450expressing human liver cell lines. Author(s): Mace K, Aguilar F, Wang JS, Vautravers P, Gomez-Lechon M, Gonzalez FJ, Groopman J, Harris CC, Pfeifer AM. Source: Carcinogenesis. 1997 July; 18(7): 1291-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9230270
•
Aflatoxin B1-induced immortalization of cultured skin fibroblasts from a patient with Li-Fraumeni syndrome. Author(s): Tsutsui T, Fujino T, Kodama S, Tainsky MA, Boyd J, Barrett JC. Source: Carcinogenesis. 1995 January; 16(1): 25-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7834802
Studies
47
•
Aflatoxin contamination of Nigerian foods and feedingstuffs. Author(s): Atawodi SE, Atiku AA, Lamorde AG. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 1994 January; 32(1): 61-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8132166
•
Aflatoxin exposure and cytogenetic alterations in individuals from the Gambia, West Africa. Author(s): Miele M, Donato F, Hall AJ, Whittle H, Chapot B, Bonatti S, De Ferrari M, Artuso M, Gallerani E, Abbondandolo A, Montesano R, Wild CP. Source: Mutation Research. 1996 February 1; 349(2): 209-17. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8600352
•
Aflatoxin exposure and DNA damage in the comet assay in individuals from the Gambia, West Africa. Author(s): Anderson D, Yu TW, Hambly RJ, Mendy M, Wild CP. Source: Teratogenesis, Carcinogenesis, and Mutagenesis. 1999; 19(2): 147-55. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10332811
•
Aflatoxin exposure in Singapore: blood aflatoxin levels in normal subjects, hepatitis B virus carriers and primary hepatocellular carcinoma patients. Author(s): Chao TC, Lo DS, Bloodworth BC, Gunasegaram R, Koh TH, Ng HS. Source: Med Sci Law. 1994 October; 34(4): 289-98. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7830511
•
Aflatoxin M1 contamination in commercial samples of milk and dairy products in Kuwait. Author(s): Srivastava VP, Bu-Abbas A, Alaa-Basuny, Al-Johar W, Al-Mufti S, Siddiqui MK. Source: Food Additives and Contaminants. 2001 November; 18(11): 993-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11665741
•
Aflatoxin M1 in breast-milk of UAE women. Author(s): Abdulrazzaq YM, Osman N, Yousif ZM, Al-Falahi S. Source: Annals of Tropical Paediatrics. 2003 September; 23(3): 173-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14567832
•
Aflatoxin M1 in human breast milk samples from Victoria, Australia and Thailand. Author(s): el-Nezami HS, Nicoletti G, Neal GE, Donohue DC, Ahokas JT. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 1995 March; 33(3): 173-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7896226
48
Aflatoxin
•
Aflatoxin M1 in pasteurized and ultrapasteurized milk with different fat content in Mexico. Author(s): Carvajal M, Bolanos A, Rojo F, Mendez I. Source: J Food Prot. 2003 October; 66(10): 1885-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14572228
•
Aflatoxin M1 occurrence in samples of Grana Padano cheese. Author(s): Peitri A, Bertuzzi T, Bertuzzi P, Piva G. Source: Food Additives and Contaminants. 1997 May-June; 14(4): 341-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9205562
•
Aflatoxin related occupational exposure to maize processing workers. Author(s): Desai MR, Ghosh SK. Source: Cell Mol Biol (Noisy-Le-Grand). 2003 June; 49(4): 529-35. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12899445
•
Aflatoxin, kwashiorkor, and morbidity. Author(s): Adhikari M, Gita-Ramjee, Berjak P. Source: Natural Toxins. 1994; 2(1): 1-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8032688
•
Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans. Author(s): Wild CP, Hasegawa R, Barraud L, Chutimataewin S, Chapot B, Ito N, Montesano R. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1996 March; 5(3): 179-89. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8833618
•
An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico. Author(s): Soini Y, Chia SC, Bennett WP, Groopman JD, Wang JS, DeBenedetti VM, Cawley H, Welsh JA, Hansen C, Bergasa NV, Jones EA, DiBisceglie AM, Trivers GE, Sandoval CA, Calderon IE, Munoz Espinosa LE, Harris CC. Source: Carcinogenesis. 1996 May; 17(5): 1007-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8640905
Studies
49
•
Association of aflatoxin B(1)-albumin adduct levels with hepatitis B surface antigen status among adolescents in Taiwan. Author(s): Chen SY, Chen CJ, Chou SR, Hsieh LL, Wang LY, Tsai WY, Ahsan H, Santella RM. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2001 November; 10(11): 1223-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11700273
•
Associations of plasma aflatoxin B1-albumin adduct level with plasma selenium level and genetic polymorphisms of glutathione S-transferase M1 and T1. Author(s): Chen SY, Chen CJ, Tsai WY, Ahsan H, Liu TY, Lin JT, Santella RM. Source: Nutrition and Cancer. 2000; 38(2): 179-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11525595
•
ATP-dependent transport of aflatoxin B1 and its glutathione conjugates by the product of the multidrug resistance protein (MRP) gene. Author(s): Loe DW, Stewart RK, Massey TE, Deeley RG, Cole SP. Source: Molecular Pharmacology. 1997 June; 51(6): 1034-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9187270
•
Bacterial, fungal and aflatoxin contamination of cereals and cereal products in Bangkok. Author(s): Imwidthaya S, Anukarahanonta T, Komolpis P. Source: J Med Assoc Thai. 1987 July; 70(7): 390-6. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3668419
•
Binding of aflatoxin B1 alters the adhesion properties of Lactobacillus rhamnosus strain GG in a Caco-2 model. Author(s): Kankaanpaa P, Tuomola E, El-Nezami H, Ahokas J, Salminen SJ. Source: J Food Prot. 2000 March; 63(3): 412-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10716575
•
Binding of aflatoxin by plasma albumin in vitro. Author(s): Rao VN, Valmikinathan K, Verghese N. Source: Biochimica Et Biophysica Acta. 1968 September 3; 165(2): 288-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=5683528
•
Bioactivation and inactivation of aflatoxin B1 by human, mouse and rat liver preparations: effect on SCE in human mononuclear leucocytes. Author(s): Wilson AS, Williams DP, Davis CD, Tingle MD, Park BK. Source: Mutation Research. 1997 February 3; 373(2): 257-64. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9042408
50
Aflatoxin
•
Bioactivation of aflatoxin B1 by human liver microsomes: role of cytochrome P450 IIIA enzymes. Author(s): Ramsdell HS, Parkinson A, Eddy AC, Eaton DL. Source: Toxicology and Applied Pharmacology. 1991 May; 108(3): 436-47. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1902334
•
Biochemical and molecular aspects of mammalian susceptibility to aflatoxin B1 carcinogenicity. Author(s): Neal GE. Source: Human & Experimental Toxicology. 1995 July; 14(7): 619-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7576827
•
Biochemical and molecular aspects of mammalian susceptibility to aflatoxin B1 carcinogenicity. Author(s): Massey TE, Stewart RK, Daniels JM, Liu L. Source: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.). 1995 March; 208(3): 213-27. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7878060
•
Biochemical basis for the extreme sensitivity of turkeys to aflatoxin B(1). Author(s): Klein PJ, Buckner R, Kelly J, Coulombe RA Jr. Source: Toxicology and Applied Pharmacology. 2000 May 15; 165(1): 45-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10814552
•
Biological characteristics of the aflatoxin-induced hepatic tumor. Author(s): Woodhead AD. Source: Basic Life Sci. 1982; 21: 127-48. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6756374
•
Biotransformation of aflatoxin B1 in human lung. Author(s): Donnelly PJ, Stewart RK, Ali SL, Conlan AA, Reid KR, Petsikas D, Massey TE. Source: Carcinogenesis. 1996 November; 17(11): 2487-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8968067
•
Blood aflatoxin levels in patients with hepatocellular carcinoma in Singapore. Author(s): Tan CK, Lo DS, Law NM, Ng HS, Chao TC. Source: Singapore Med J. 1995 December; 36(6): 612-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8781632
Studies
51
•
Cancer risks posed by aflatoxin M1. Author(s): Hsieh DP, Cullen JM, Hsieh LS, Shao Y, Ruebner BH. Source: Princess Takamatsu Symp. 1985; 16: 57-65. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3939566
•
Case-control study of cigarette smoking and primary hepatoma in an aflatoxinendemic region of China: a protective effect. Author(s): Lin L, Yang F, Ye Z, Xu E, Yang C, Zhang C, Wu D, Nebert DW. Source: Pharmacogenetics. 1991 November; 1(2): 79-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1668964
•
cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3. Author(s): Knight LP, Primiano T, Groopman JD, Kensler TW, Sutter TR. Source: Carcinogenesis. 1999 July; 20(7): 1215-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10383892
•
Cellular interactions and metabolism of aflatoxin: an update. Author(s): McLean M, Dutton MF. Source: Pharmacology & Therapeutics. 1995 February; 65(2): 163-92. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7540767
•
Characterization of a murine p53ser246 mutant equivalent to the human p53ser249 associated with hepatocellular carcinoma and aflatoxin exposure. Author(s): Ghebranious N, Knoll BJ, Wu H, Lozano G, Sell S. Source: Molecular Carcinogenesis. 1995 June; 13(2): 104-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7605578
•
Chemical and physical properties of the major serum albumin adduct of aflatoxin B1 and their implications for the quantification in biological samples. Author(s): Sabbioni G. Source: Chemico-Biological Interactions. 1990; 75(1): 1-15. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2114222
•
Chromatographic and spectroscopic properties of hemiacetals of aflatoxin and sterigmatocystin metabolites. Author(s): Orti DL, Grainger J, Ashley DL, Hill RH Jr. Source: Journal of Chromatography. 1989 January 13; 462: 269-79. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2738124
52
Aflatoxin
•
Chromosome damage by dothistromin in human peripheral blood lymphocyte cultures: a comparison with aflatoxin B1. Author(s): Ferguson LR, Parslow MI, McLarin JA. Source: Mutation Research. 1986 April-May; 170(1-2): 47-53. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3083246
•
Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Author(s): Chen CJ, Yu MW, Liaw YF, Wang LW, Chiamprasert S, Matin F, Hirvonen A, Bell DA, Santella RM. Source: American Journal of Human Genetics. 1996 July; 59(1): 128-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8659516
•
Circumstances associated with the contamination of food by aflatoxin in a high primary liver cancer area. Author(s): Van Rensburg SJ, Kirsipuu A, Coutinho LP, Van Der Watt JJ. Source: South African Medical Journal. Suid-Afrikaanse Tydskrif Vir Geneeskunde. 1975 May 24; 49(22): 877-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1145389
•
Cirrhosis in children after consumption of aflatoxin-contaminated peanut meal. Author(s): Amla I, Parpia HA, Jayaraj AP. Source: The Journal of Pathology. 1971 February; 103(2): Pxix. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=5567948
•
Cirrhosis in children from peanut meal contaminated by aflatoxin. Author(s): Amla I, Kamala CS, Gopalakrishna GS, Jayaraj AP, Sreenivasamurthy V, Parpia HA. Source: The American Journal of Clinical Nutrition. 1971 June; 24(6): 609-14. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=5581000
•
Cloning and expression of succinic semialdehyde reductase from human brain. Identity with aflatoxin B1 aldehyde reductase. Author(s): Schaller M, Schaffhauser M, Sans N, Wermuth B. Source: European Journal of Biochemistry / Febs. 1999 November; 265(3): 1056-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10518801
Studies
53
•
Cloning of cDNAs from fetal rat liver encoding glutathione S-transferase Yc polypeptides. The Yc2 subunit is expressed in adult rat liver resistant to the hepatocarcinogen aflatoxin B1. Author(s): Hayes JD, Nguyen T, Judah DJ, Petersson DG, Neal GE. Source: The Journal of Biological Chemistry. 1994 August 12; 269(32): 20707-17. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8051171
•
Codon 249 of the human TP53 tumor suppressor gene is no hot spot for aflatoxin B1 in a heterologous background. Author(s): Sengstag C, Morbe JL, Weibel B. Source: Mutation Research. 1999 November 29; 430(1): 131-44. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10592324
•
Comparative cytotoxicity of aflatoxin B1 and saxitoxin in cell cultures. Author(s): Gabliks J, Barter S. Source: Mol Toxicol. 1987 April-September; 1(2-3): 209-16. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3130568
•
Comparative ultrastructural effects of aflatoxin B1 on mouse, rat, and human hepatocytes in primary culture. Author(s): Cole KE, Hsu IC, Trump BF. Source: Cancer Research. 1986 March; 46(3): 1290-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3080241
•
Comparison of rates of enzymatic oxidation of aflatoxin B1, aflatoxin G1, and sterigmatocystin and activities of the epoxides in forming guanyl-N7 adducts and inducing different genetic responses. Author(s): Baertschi SW, Raney KD, Shimada T, Harris TM, Guengerich FP. Source: Chemical Research in Toxicology. 1989 March-April; 2(2): 114-2. Erratum In: Chem Res Toxicol 1989 July-August; 2(4): 272. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2519710
•
Comparison of S9 mix and hepatocytes as external metabolizing systems in mammalian cell cultures: cytogenetic effects of 7,12-dimethylbenzanthracene and aflatoxin B1. Author(s): Madle E, Tiedemann G, Madle S, Ott A, Kaufmann G. Source: Environ Mutagen. 1986; 8(3): 423-37. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3086074
54
Aflatoxin
•
Co-mutagenicity of coumarin (1,2-benzopyrone) with aflatoxin B1 and human liver S9 in mammalian cells. Author(s): Goeger DE, Hsie AW, Anderson KE. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 1999 June; 37(6): 581-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10478826
•
Contribution of the glutathione S-transferases to the mechanisms of resistance to aflatoxin B1. Author(s): Hayes JD, Judah DJ, McLellan LI, Neal GE. Source: Pharmacology & Therapeutics. 1991; 50(3): 443-72. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1754606
•
Correlation of dietary aflatoxin B1 levels with excretion of aflatoxin M1 in human urine. Author(s): Zhu JQ, Zhang LS, Hu X, Xiao Y, Chen JS, Xu YC, Fremy J, Chu FS. Source: Cancer Research. 1987 April 1; 47(7): 1848-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3102051
•
Correspondence re: G-S. Qian, et al., A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol., Biomarkers & Prev., 3:3-10, 1994, and C.C. Harris, Solving the viral-chemical puzzle of human liver carcinogenesis. Cancer Epidemiol., Biomarkers & Prev., 3:1-2, 1994. Author(s): Campbell TC. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1994 September; 3(6): 519-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8000305
•
Correspondence re: T. Colin Campbell et al., Nonassociation of aflatoxin with primary liver cancer in a cross-sectional ecological survey in the People's Republic of China. Cancer Res., 50:6882-6893, 1990. Author(s): Wild CP, Montesano R. Source: Cancer Research. 1991 July 15; 51(14): 3825-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2065337
•
Cost-effectiveness of lowering the aflatoxin tolerance level. Author(s): Dichter CR, Weinstein MC. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 1984 June; 22(6): 439-45. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6429018
Studies
55
•
CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1. Author(s): Devereux TR, Stern MC, Flake GP, Yu MC, Zhang ZQ, London SJ, Taylor JA. Source: Molecular Carcinogenesis. 2001 June; 31(2): 68-73. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11429783
•
Cytochrome P3-450 cDNA encodes aflatoxin B1-4-hydroxylase. Author(s): Faletto MB, Koser PL, Battula N, Townsend GK, Maccubbin AE, Gelboin HV, Gurtoo HL. Source: The Journal of Biological Chemistry. 1988 September 5; 263(25): 12187-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3137222
•
Cytotoxic effects of aflatoxin B1 and its association with cellular components in chicken embryo primary cultured cells. Author(s): Iwaki M, Kitagawa T, Akamatsu Y, Aibara K. Source: Biochimica Et Biophysica Acta. 1990 August 17; 1035(2): 146-53. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1697481
•
Cytotoxicity and mutagenicity of aflatoxin dichloride in normal and repair deficient diploid human fibroblasts. Author(s): Mahoney EM, Ball JC, Swenson DH, Richmond D, Maher VM, McCormick JJ. Source: Chemico-Biological Interactions. 1984 June; 50(1): 59-76. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6428759
•
Cytotoxicity of aflatoxin B1 and its chemically synthesised epoxide derivative on the A549 human epithelioid lung cell line. Author(s): Palanee T, Dutton MF, Chuturgoon AA. Source: Mycopathologia. 2001; 151(3): 155-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11678590
•
Defective repair of tryptophan pyrolysate (Trp P-1 and Trp P-2) and aflatoxin B1 damage in xeroderma pigmentosum cells. Author(s): Okui T, Fujiwara Y. Source: Journal of Radiation Research. 1983 December; 24(4): 356-63. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6427452
•
Defenses against aflatoxin carcinogenesis in humans. Author(s): Masri MS. Source: Advances in Experimental Medicine and Biology. 1984; 177: 115-46. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6496216
56
Aflatoxin
•
Detection and detoxification of aflatoxins: prevention of aflatoxicosis and aflatoxin residues with hydrated sodium calcium aluminosilicate. Author(s): Phillips TD, Clement BA, Kubena LF, Harvey RB. Source: Vet Hum Toxicol. 1990; 32 Suppl: 15-9. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1965459
•
Detection of aflatoxin B1 in serum samples of male Japanese subjects by radioimmunoassay and high-performance liquid chromatography. Author(s): Tsuboi S, Nakagawa T, Tomita M, Seo T, Ono H, Kawamura K, Iwamura N. Source: Cancer Research. 1984 March; 44(3): 1231-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6420055
•
Detection of exposure to aflatoxin in an African population. Author(s): Autrup H, Wakhisi J. Source: Iarc Sci Publ. 1988; (89): 63-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3143673
•
Determinants of aflatoxin exposure in young children from Benin and Togo, West Africa: the critical role of weaning. Author(s): Gong YY, Egal S, Hounsa A, Turner PC, Hall AJ, Cardwell KF, Wild CP. Source: International Journal of Epidemiology. 2003 August; 32(4): 556-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12913029
•
Determinants of specificity for aflatoxin B1-8,9-epoxide in alpha-class glutathione Stransferases. Author(s): McDonagh PD, Judah DJ, Hayes JD, Lian LY, Neal GE, Wolf CR, Roberts GC. Source: The Biochemical Journal. 1999 April 1; 339 ( Pt 1): 95-101. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10085232
•
Determination of aflatoxin B1 biotransformation and binding to hepatic macromolecules in human precision liver slices. Author(s): Heinonen JT, Fisher R, Brendel K, Eaton DL. Source: Toxicology and Applied Pharmacology. 1996 January; 136(1): 1-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8560461
•
Determination of aflatoxin B1 in baby food (infant formula) by immunoaffinity column cleanup liquid chromatography with postcolumn bromination: collaborative study. Author(s): Stroka J, Anklam E, Joerissen U, Gilbert J. Source: J Aoac Int. 2001 July-August; 84(4): 1116-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11501912
Studies
57
•
Determination of aflatoxin M1 levels in cheese and milk consumed in Bursa, Turkey. Author(s): Oruc HH, Sonal S. Source: Vet Hum Toxicol. 2001 October; 43(5): 292-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11577937
•
Determination of aflatoxin Q1 in urine by automated immunoaffinity column cleanup and liquid chromatography. Author(s): Kussak A, Andersson B, Andersson K. Source: Journal of Chromatography. B, Biomedical Applications. 1994 June 17; 656(2): 329-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7987484
•
Determination of exposure to aflatoxins among Danish workers in animal-feed production through the analysis of aflatoxin B1 adducts to serum albumin. Author(s): Autrup JL, Schmidt J, Seremet T, Autrup H. Source: Scand J Work Environ Health. 1991 December; 17(6): 436-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1788537
•
Detoxification of aflatoxin-polluted peanut cakes with monomethylamine/Ca(OH)2: pilot industrial application, nutrition experiments, toxicity evaluation. Author(s): Giddey C, Bunter G, Larroux R, Jemmali M, Rossi J. Source: Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer. 1992 JanuaryFebruary; 11(1): 60-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1740770
•
Development of aflatoxin B(1)-lysine adduct monoclonal antibody for human exposure studies. Author(s): Wang JS, Abubaker S, He X, Sun G, Strickland PT, Groopman JD. Source: Applied and Environmental Microbiology. 2001 June; 67(6): 2712-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11375185
•
Dietary clay in the chemoprevention of aflatoxin-induced disease. Author(s): Phillips TD. Source: Toxicological Sciences : an Official Journal of the Society of Toxicology. 1999 December; 52(2 Suppl): 118-26. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10630600
•
Dietary exposure to aflatoxin in Benin City, Nigeria: a possible public health concern. Author(s): Ibeh IN, Uraih N, Ogonor JI. Source: International Journal of Food Microbiology. 1991 November; 14(2): 171-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1777386
58
Aflatoxin
•
Dietary exposure to aflatoxin in human male infertility in Benin City, Nigeria. Author(s): Ibeh IN, Uraih N, Ogonar JI. Source: Int J Fertil Menopausal Stud. 1994 July-August; 39(4): 208-14. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7951403
•
Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. Author(s): Wild CP, Hudson GJ, Sabbioni G, Chapot B, Hall AJ, Wogan GN, Whittle H, Montesano R, Groopman JD. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1992 March-April; 1(3): 229-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1339083
•
Differential response of primary cultures of human and rat hepatocytes to aflatoxin B1-induced cytotoxicity and protection by the hepatoprotective agent (+)-cyanidanol3. Author(s): Begue JM, Baffet G, Campion JP, Guillouzo A. Source: Biology of the Cell / under the Auspices of the European Cell Biology Organization. 1988; 63(3): 327-33. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3147113
•
Distribution and stability of aflatoxin M1 during processing, ripening and storage of Telemes cheese. Author(s): Govaris A, Roussi V, Koidis PA, Botsoglou NA. Source: Food Additives and Contaminants. 2001 May; 18(5): 437-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11358185
•
DNA binding and adduct formation of aflatoxin B1 in cultured human and animal tracheobronchial and bladder tissues. Author(s): Stoner GD, Daniel FB, Schenck KM, Schut HA, Sandwisch DW, Gohara AF. Source: Carcinogenesis. 1982; 3(11): 1345-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6817939
•
Do aflatoxin and polycyclic hydrocarbon carcinogens delete genes in the regions of chromosomes acted on by steroid hormones? Author(s): Money-Kyrle AF. Source: Medical Hypotheses. 1977 July-August; 3(4): 146-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=895590
Studies
59
•
Do aflatoxin-DNA adduct measurements in humans provide accurate data for cancer risk assessment? Author(s): Groopman JD. Source: Iarc Sci Publ. 1988; (89): 55-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3143672
•
Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States? Author(s): Hoque A, Patt YZ, Yoffe B, Groopman JD, Greenblatt MS, Zhang YJ, Santella RM. Source: Nutrition and Cancer. 1999; 35(1): 27-33. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10624703
•
Dose dependency of aflatoxin B1 binding on human high molecular weight DNA in the activation of proto-oncogene. Author(s): Yang SS, Taub JV, Modali R, Vieira W, Yasei P, Yang GC. Source: Environmental Health Perspectives. 1985 October; 62: 231-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3002775
•
Effect of aflatoxin B1 on human platelet protein kinase C. Author(s): Van den Heever LH, Dirr HW. Source: Int J Biochem. 1991; 23(9): 839-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1773888
•
Effect of an extract of the root of Scutellaria baicalensis and its flavonoids on aflatoxin B1 oxidizing cytochrome P450 enzymes. Author(s): Kim BR, Kim DH, Park R, Kwon KB, Ryu DG, Kim YC, Kim NY, Jeong S, Kang BK, Kim KS. Source: Planta Medica. 2001 July; 67(5): 396-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11488450
•
Effects of aflatoxin B1 on murine lymphocytic functions. Author(s): Reddy RV, Sharma RP. Source: Toxicology. 1989 January; 54(1): 31-44. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2492685
•
Effects of aflatoxin on the immune system of the chick. Author(s): Virdi JS, Tiwari RP, Saxena M, Khanna V, Singh G, Saini SS, Vadehra DV. Source: Journal of Applied Toxicology : Jat. 1989 August; 9(4): 271-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2778263
60
Aflatoxin
•
Effects of dietary oltipraz and ethoxyquin on aflatoxin B1 biotransformation in nonhuman primates. Author(s): Bammler TK, Slone DH, Eaton DL. Source: Toxicological Sciences : an Official Journal of the Society of Toxicology. 2000 March; 54(1): 30-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10746929
•
Effects of hydrogen ion and fatty acid concentrations on the binding of aflatoxin B1 to human albumin. Author(s): Dirr HW. Source: Biochem Int. 1987 April; 14(4): 727-33. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3134025
•
Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Author(s): Chen CJ, Wang LY, Lu SN, Wu MH, You SL, Zhang YJ, Wang LW, Santella RM. Source: Hepatology (Baltimore, Md.). 1996 July; 24(1): 38-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8707279
•
Elevated HPRT mutation frequencies in aflatoxin-exposed residents of daxin, Qidong county, People's Republic of China. Author(s): Wang SS, O'Neill JP, Qian GS, Zhu YR, Wang JB, Armenian H, Zarba A, Wang JS, Kensler TW, Cariello NF, Groopman JD, Swenberg JA. Source: Carcinogenesis. 1999 November; 20(11): 2181-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10545423
•
Environmental and genetic determinants of aflatoxin-albumin adducts in the Gambia. Author(s): Wild CP, Yin F, Turner PC, Chemin I, Chapot B, Mendy M, Whittle H, Kirk GD, Hall AJ. Source: International Journal of Cancer. Journal International Du Cancer. 2000 April 1; 86(1): 1-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10728587
•
Epidemiology of human aflatoxin exposures and their relationship to liver cancer. Author(s): Groopman JD, Scholl P, Wang JS. Source: Prog Clin Biol Res. 1996; 395: 211-22. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8895991
Studies
61
•
Estimation of the daily exposure of Koreans to aflatoxin B1 through food consumption. Author(s): Park JW, Kim EK, Kim YB. Source: Food Additives and Contaminants. 2004 January; 21(1): 70-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14744682
•
Evaluation of a commercial immunoassay system for sulfamethazine and aflatoxin detection in biological fluids and feeds. Author(s): Stahr HM, Pfeiffer RL, Mace B. Source: Vet Hum Toxicol. 1991 October; 33(5): 509-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1746151
•
Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment. Author(s): Wild CP, Jiang YZ, Sabbioni G, Chapot B, Montesano R. Source: Cancer Research. 1990 January 15; 50(2): 245-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2104776
•
Evidence for human antibodies that recognize an aflatoxin epitope in groups with high and low exposure to aflatoxins. Author(s): Autrup H, Seremet T, Wakhisi J. Source: Archives of Environmental Health. 1990 January-February; 45(1): 31-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1690532
•
Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver. Author(s): Forrester LM, Neal GE, Judah DJ, Glancey MJ, Wolf CR. Source: Proceedings of the National Academy of Sciences of the United States of America. 1990 November; 87(21): 8306-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2122459
•
Evidence for membrane-mediated chromosomal damage by aflatoxin B1 in human lymphocytes. Author(s): Amstad P, Levy A, Emerit I, Cerutti P. Source: Carcinogenesis. 1984 June; 5(6): 719-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6426812
•
Evidence that mutational activation of the ras genes may not be involved in aflatoxin B(1)-induced human hepatocarcinogenesis, based on sequence analysis of the ras and p53 genes. Author(s): Chao HK, Tsai TF, Lin CS, Su TS. Source: Molecular Carcinogenesis. 1999 October; 26(2): 69-73. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10506750
62
Aflatoxin
•
Excision repair of aflatoxin B1-DNA adducts in human fibroblasts. Author(s): Leadon SA, Tyrrell RM, Cerutti PA. Source: Cancer Research. 1981 December; 41(12 Pt 1): 5125-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6796265
•
Exposure of infants to aflatoxin M1 from mothers' breast milk in Abu Dhabi, UAE. Author(s): Saad AM, Abdelgadir AM, Moss MO. Source: Food Additives and Contaminants. 1995 March-April; 12(2): 255-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7781822
•
Expression of stably transfected murine glutathione S-transferase A3-3 protects against nucleic acid alkylation and cytotoxicity by aflatoxin B1 in hamster V79 cells expressing rat cytochrome P450-2B1. Author(s): Fields WR, Morrow CS, Doehmer J, Townsend AJ. Source: Carcinogenesis. 1999 June; 20(6): 1121-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10357798
•
Failure of dietary dimethylsulfoxide to protect against aflatoxin in young broiler chickens. Author(s): Yen CC, Hamilton PB. Source: Poultry Science. 1982 February; 61(2): 255-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7088790
•
Field studies of aflatoxin exposure, metabolism and induction of genetic alterations in relation to HBV infection and hepatocellular carcinoma in The Gambia and Thailand. Author(s): Wild CP, Shrestha SM, Anwar WA, Montesano R. Source: Toxicology Letters. 1992 December; 64-65 Spec No: 455-61. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1471197
•
Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1. Author(s): Aoyama T, Yamano S, Guzelian PS, Gelboin HV, Gonzalez FJ. Source: Proceedings of the National Academy of Sciences of the United States of America. 1990 June; 87(12): 4790-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2162057
•
Food additives and plant components control growth and aflatoxin production by toxigenic aspergilli: a review. Author(s): Rusul G, Marth EH. Source: Mycopathologia. 1988 January; 101(1): 13-23. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3281019
Studies
63
•
Food surveillance in the Basque Country (Spain). II. Estimation of the dietary intake of organochlorine pesticides, heavy metals, arsenic, aflatoxin M1, iron and zinc through the Total Diet Study, 1990/91. Author(s): Urieta I, Jalon M, Eguilero I. Source: Food Additives and Contaminants. 1996 January; 13(1): 29-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8647305
•
Formation and removal of aflatoxin B1-induced DNA lesions in epithelioid human lung cells. Author(s): Wang TC, Cerutti PA. Source: Cancer Research. 1979 December; 39(12): 5165-70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=498143
•
Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan. Author(s): Sun CA, Wang LY, Chen CJ, Lu SN, You SL, Wang LW, Wang Q, Wu DM, Santella RM. Source: Carcinogenesis. 2001 August; 22(8): 1289-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11470760
•
Genotoxicity of aflatoxin B1: evidence for a recombination-mediated mechanism in Saccharomyces cerevisiae. Author(s): Sengstag C, Weibel B, Fasullo M. Source: Cancer Research. 1996 December 1; 56(23): 5457-65. Erratum In: Cancer Res 1997 February 15; 57(4): 793. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8968101
•
Glutathione conjugation of aflatoxin B1 exo- and endo-epoxides by rat and human glutathione S-transferases. Author(s): Raney KD, Meyer DJ, Ketterer B, Harris TM, Guengerich FP. Source: Chemical Research in Toxicology. 1992 July-August; 5(4): 470-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1391613
•
Glutathione S-transferase-catalyzed conjugation of bioactivated aflatoxin B(1) in human lung: differential cellular distribution and lack of significance of the GSTM1 genetic polymorphism. Author(s): Stewart RK, Smith GB, Donnelly PJ, Reid KR, Petsikas D, Conlan AA, Massey TE. Source: Carcinogenesis. 1999 October; 20(10): 1971-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10506113
64
Aflatoxin
•
Health risk and regulatory aspects of aflatoxin. Author(s): Robens JF. Source: Vet Hum Toxicol. 1980 August; 22(4): 264-6. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7404988
•
Hepatitis B infection and aflatoxin biomarker levels in Gambian children. Author(s): Turner PC, Mendy M, Whittle H, Fortuin M, Hall AJ, Wild CP. Source: Tropical Medicine & International Health : Tm & Ih. 2000 December; 5(12): 83741. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11169271
•
Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies. Author(s): Stern MC, Umbach DM, Yu MC, London SJ, Zhang ZQ, Taylor JA. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2001 June; 10(6): 617-25. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11401911
•
Hepatocarcinogenic material in urine specimens from humans consuming aflatoxin. Author(s): Campbell TC, Sinnhuber RO, Lee DJ, Wales JH, Salamat L. Source: Journal of the National Cancer Institute. 1974 May; 52(5): 1647-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4364740
•
Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China. Author(s): Wang JS, Huang T, Su J, Liang F, Wei Z, Liang Y, Luo H, Kuang SY, Qian GS, Sun G, He X, Kensler TW, Groopman JD. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2001 February; 10(2): 143-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11219772
•
Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Author(s): Van Rensburg SJ, Cook-Mozaffari P, Van Schalkwyk DJ, Van der Watt JJ, Vincent TJ, Purchase IF. Source: British Journal of Cancer. 1985 May; 51(5): 713-26. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2986667
Studies
65
•
Hepatocellular carcinoma p53 G > T transversions at codon 249: the fingerprint of aflatoxin exposure? Author(s): Lasky T, Magder L. Source: Environmental Health Perspectives. 1997 April; 105(4): 392-7. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9189703
•
Heterologous expression of CYP2K1 and identification of the expressed protein (BVCYP2K1) as lauric acid (omega-1)-hydroxylase and aflatoxin B1 exo-epoxidase. Author(s): Yang YH, Miranda CL, Henderson MC, Wang-Buhler JL, Buhler DR. Source: Drug Metabolism and Disposition: the Biological Fate of Chemicals. 2000 November; 28(11): 1279-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11038153
•
High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Author(s): Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM. Source: Molecular Carcinogenesis. 2002 October; 35(2): 85-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12325038
•
High serum concentrations of aflatoxin in Nepal as measured by enzyme-linked immunosorbent serum assay. Author(s): Denning DW, Sykes JA, Wilkinson AP, Morgan MR. Source: Human & Experimental Toxicology. 1990 May; 9(3): 143-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2165416
•
HLA related genetic control of natural killer activity and aflatoxin B1 suppression of lymphocytic blastogenesis. Author(s): Wang CY, Yu XS, Hong JX, Lin TZ, Yang YQ. Source: Chinese Medical Journal. 1987 January; 100(1): 29-33. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3109821
•
Human aflatoxin B1 metabolism: an investigation of the importance of aflatoxin Q1 as a metabolite of hepatic post-mitochondrial fraction. Author(s): Yourtee DM, Bean TA, Kirk-Yourtee CL. Source: Toxicology Letters. 1987 October; 38(3): 213-24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3116726
66
Aflatoxin
•
Human glutathione S-transferase-expressing Salmonella typhimurium tester strains to study the activation/detoxification of mutagenic compounds: studies with halogenated compounds, aromatic amines and aflatoxin B1. Author(s): Simula TP, Glancey MJ, Wolf CR. Source: Carcinogenesis. 1993 July; 14(7): 1371-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8330352
•
Human hepatitis B virus and hepatocellular carcinoma. II. Experimental induction of hepatocellular carcinoma in tree shrews exposed to hepatitis B virus and aflatoxin B1. Author(s): Yan RQ, Su JJ, Huang DR, Gan YC, Yang C, Huang GH. Source: Journal of Cancer Research and Clinical Oncology. 1996; 122(5): 289-95. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8609152
•
Human variability in hepatic glutathione S-transferase-mediated conjugation of aflatoxin B1-epoxide and other substrates. Author(s): Slone DH, Gallagher EP, Ramsdell HS, Rettie AE, Stapleton PL, Berlad LG, Eaton DL. Source: Pharmacogenetics. 1995 August; 5(4): 224-33. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8528269
•
Identification of an aflatoxin G1-serum albumin adduct and its relevance to the measurement of human exposure to aflatoxins. Author(s): Sabbioni G, Wild CP. Source: Carcinogenesis. 1991 January; 12(1): 97-103. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1899057
•
Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma. Author(s): Yakicier MC, Legoix P, Vaury C, Gressin L, Tubacher E, Capron F, Bayer J, Degott C, Balabaud C, Zucman-Rossi J. Source: Oncogene. 2001 August 23; 20(37): 5232-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11526514
•
Immunobiological activities of mould products: functional impairment of human monocytes exposed to aflatoxin B1. Author(s): Cusumano V, Rossano F, Merendino RA, Arena A, Costa GB, Mancuso G, Baroni A, Losi E. Source: Research in Microbiology. 1996 June; 147(5): 385-91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8763624
Studies
67
•
Immunological and HPLC detection of aflatoxin adducts in human tissues after an acute poisoning incident in S.E. Asia. Author(s): Harrison JC, Garner RC. Source: Carcinogenesis. 1991 April; 12(4): 741-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1901526
•
Immunoperoxidase detection of 8-hydroxydeoxyguanosine in aflatoxin B1-treated rat liver and human oral mucosal cells. Author(s): Yarborough A, Zhang YJ, Hsu TM, Santella RM. Source: Cancer Research. 1996 February 15; 56(4): 683-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8630995
•
In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Author(s): Guengerich FP, Kim DH. Source: Carcinogenesis. 1990 December; 11(12): 2275-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2265479
•
In vitro mutational spectrum of aflatoxin B1 in the human hypoxanthine guanine phosphoribosyltransferase gene. Author(s): Cariello NF, Cui L, Skopek TR. Source: Cancer Research. 1994 August 15; 54(16): 4436-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8044792
•
Inability of aflatoxin B1 to stimulate arachidonic acid metabolism in human polymorphonuclear and mononuclear leukocytes. Author(s): Geissler FT, Henderson WR. Source: Carcinogenesis. 1988 July; 9(7): 1135-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2838195
•
Incidence of aflatoxin contamination in non-perishable food commodities. Author(s): Munir MA, Saleem M, Malik ZR, Ahmed M, Ali A. Source: J Pak Med Assoc. 1989 June; 39(6): 154-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2504956
•
Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. Author(s): Sun Z, Lu P, Gail MH, Pee D, Zhang Q, Ming L, Wang J, Wu Y, Liu G, Wu Y, Zhu Y. Source: Hepatology (Baltimore, Md.). 1999 August; 30(2): 379-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10421643
68
Aflatoxin
•
Influence of four Nigerian food additives on the mutagenicity of aflatoxin B1. Author(s): Osowole OA, Ogidi HJ, Uwaifo AO. Source: Afr J Med Med Sci. 1992 December; 21(2): 83-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1308087
•
Inhibition of aflatoxin B1 genotoxicity in human liver-derived HepG2 cells by kolaviron biflavonoids and molecular mechanisms of action. Author(s): Nwankwo JO, Tahnteng JG, Emerole GO. Source: European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 2000 October; 9(5): 351-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11075889
•
Inhibition of aflatoxin B1 mutagenicity by cyclopiazonic acid in the presence of human liver preparations. Author(s): Sabater Vilar M, Kuilman-Wahls ME, Fink-Gremmels J. Source: Toxicology Letters. 2003 August 28; 143(3): 291-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12849689
•
Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture. Author(s): Langouet S, Coles B, Morel F, Becquemont L, Beaune P, Guengerich FP, Ketterer B, Guillouzo A. Source: Cancer Research. 1995 December 1; 55(23): 5574-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7585637
•
In-house direct cELISA for determining aflatoxin B1 in Thai corn and peanuts. Author(s): Lipigorngoson S, Limtrakul P, Suttajit M, Yoshizawa T. Source: Food Additives and Contaminants. 2003 September; 20(9): 838-45. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=13129779
•
Intracellular localization of aflatoxin B1 in rat and human livers. Author(s): Stora C. Source: Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer. 1990 May-June; 10(3): 129-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2174970
•
In-utero exposure to aflatoxin in west Africa. Author(s): Wild CP, Rasheed FN, Jawla MF, Hall AJ, Jansen LA, Montesano R. Source: Lancet. 1991 June 29; 337(8757): 1602. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1675725
Studies
69
•
Investigation of various extractants for the analysis of aflatoxin B1 in different food and feed matrices. Author(s): Stroka J, Petz M, Joerissen U, Anklam E. Source: Food Additives and Contaminants. 1999 August; 16(8): 331-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10645347
•
Involvement of cytochrome P450, glutathione S-transferase, and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancer. Author(s): Guengerich FP, Johnson WW, Ueng YF, Yamazaki H, Shimada T. Source: Environmental Health Perspectives. 1996 May; 104 Suppl 3: 557-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8781383
•
Involvement of NO, H2O2 and TNF-alpha in the reduced antitumor activity of murine peritoneal macrophages by aflatoxin B1. Author(s): Moon EY, Rhee DK, Pyo S. Source: Cancer Letters. 1999 March 1; 136(2): 167-76. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10355746
•
Killing and mutation of human lymphoblast cells by aflatoxin B1: evidence for an inducible repair response. Author(s): Kaden DA, Call KM, Leong PM, Komives EA, Thilly WG. Source: Cancer Research. 1987 April 15; 47(8): 1993-2001. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3103909
•
Kinds of mutations induced by aflatoxin B1 in a shuttle vector replicating in human cells transiently expressing cytochrome P4501A2 cDNA. Author(s): Trottier Y, Waithe WI, Anderson A. Source: Molecular Carcinogenesis. 1992; 6(2): 140-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1326989
•
Kinetics of hydrolysis and reaction of aflatoxin B1 exo-8,9-epoxide and relevance to toxicity and detoxication. Author(s): Guengerich FP, Johnson WW. Source: Drug Metabolism Reviews. 1999 February; 31(1): 141-58. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10065369
•
Letter: Aflatoxin--human colon carcinogenesis? Author(s): Deger GE. Source: Annals of Internal Medicine. 1976 August; 85(2): 204-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=942142
70
Aflatoxin
•
Liquid chromatographic method for aflatoxin M1 in milk. Author(s): van Egmond HP, Dragacci S. Source: Methods in Molecular Biology (Clifton, N.J.). 2001; 157: 59-69. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11050994
•
Liver carcinogen aflatoxin B1 as an inducer of mitotic recombination in a human cell line. Author(s): Stettler PM, Sengstag C. Source: Molecular Carcinogenesis. 2001 July; 31(3): 125-38. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11479921
•
Liver injury induced by aflatoxin. Author(s): Butler WH. Source: Prog Liver Dis. 1970; 3: 408-18. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4908708
•
Liver microsomal metabolism of aflatoxin B 1 to a reactive derivative toxic to Salmonella typhimurium TA 1530. Author(s): Garner RC, Miller EC, Miller JA. Source: Cancer Research. 1972 October; 32(10): 2058-66. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4404160
•
Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. Author(s): O'connor T, Ireland LS, Harrison DJ, Hayes JD. Source: The Biochemical Journal. 1999 October 15; 343 Pt 2: 487-504. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10510318
•
Manual sorting to eliminate aflatoxin from peanuts. Author(s): Galvez FC, Francisco ML, Villarino BJ, Lustre AO, Resurreccion AV. Source: J Food Prot. 2003 October; 66(10): 1879-84. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14572227
•
Measurement of aflatoxin in Nigerian sera by enzyme-linked immunosorbent assay. Author(s): Denning DW, Onwubalili JK, Wilkinson AP, Morgan MR. Source: Transactions of the Royal Society of Tropical Medicine and Hygiene. 1988; 82(1): 169-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3140442
Studies
71
•
Mechanisms of aflatoxin B1 lung tumorigenesis. Author(s): Massey TE, Smith GB, Tam AS. Source: Experimental Lung Research. 2000 December; 26(8): 673-83. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11195464
•
Mechanisms of aflatoxin carcinogenesis. Author(s): Eaton DL, Gallagher EP. Source: Annual Review of Pharmacology and Toxicology. 1994; 34: 135-72. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8042848
•
Metabolic behaviour of aflatoxin producing strain and non-toxigenic strain of Aspergillus flavus to different sources of nitrogen and glucose concentration. Author(s): Thapar GS. Source: Mycopathologia. 1988 April; 102(1): 9-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3138542
•
Metabolism of aflatoxin B1 by human hepatocytes in primary culture. Author(s): Langouet S, Coles B, Morel F, Maheo K, Ketterer B, Guillouzo A. Source: Advances in Experimental Medicine and Biology. 1996; 387: 439-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8794238
•
Metabolism of aflatoxin B1 by normal human bronchial epithelial cells. Author(s): Van Vleet TR, Klein PJ, Coulombe RA Jr. Source: Journal of Toxicology and Environmental Health. Part A. 2001 August 10; 63(7): 525-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11497333
•
Micronuclei, chromosomal aberrations and aflatoxin-albumin adducts in experimental animals after exposure to aflatoxin B1. Author(s): Anwar WA, Khalil MM, Wild CP. Source: Mutation Research. 1994 July; 322(1): 61-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7517505
•
Molecular biology of aflatoxin biosynthesis. Author(s): Trail F, Mahanti N, Linz J. Source: Microbiology (Reading, England). 1995 April; 141 ( Pt 4): 755-65. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7773383
72
Aflatoxin
•
Molecular dosimetry of aflatoxin DNA adducts in humans and experimental rat models. Author(s): Groopman JD, Roebuck BD, Kensler TW. Source: Prog Clin Biol Res. 1992; 374: 139-55. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1320272
•
Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa. Author(s): Groopman JD, Hall AJ, Whittle H, Hudson GJ, Wogan GN, Montesano R, Wild CP. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1992 March-April; 1(3): 221-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1339082
•
Molecular dosimetry of hepatic aflatoxin B1-DNA adducts: linear correlation with hepatic cancer risk. Author(s): Bechtel DH. Source: Regulatory Toxicology and Pharmacology : Rtp. 1989 August; 10(1): 74-81. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2505337
•
Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China. Author(s): Groopman JD, Zhu JQ, Donahue PR, Pikul A, Zhang LS, Chen JS, Wogan GN. Source: Cancer Research. 1992 January 1; 52(1): 45-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1727385
•
Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans. Author(s): Groopman JD, Wild CP, Hasler J, Junshi C, Wogan GN, Kensler TW. Source: Environmental Health Perspectives. 1993 March; 99: 107-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8319607
•
Mutagenic activation of aflatoxin B1 by P-450 HFLa in human fetal livers. Author(s): Kitada M, Taneda M, Ohi H, Komori M, Itahashi K, Nagao M, Kamataki T. Source: Mutation Research. 1989 September; 227(1): 53-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2549412
Studies
73
•
Mutagenic effect of aflatoxin G1 in comparison with B1. Author(s): el-Zawahri MM, Morad MM, Khishin AF. Source: Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer. 1990 JanuaryApril; 10(1-2): 45-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2121957
•
Mutational properties of the primary aflatoxin B1-DNA adduct. Author(s): Bailey EA, Iyer RS, Stone MP, Harris TM, Essigmann JM. Source: Proceedings of the National Academy of Sciences of the United States of America. 1996 February 20; 93(4): 1535-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8643667
•
Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet. Author(s): Hsia CC, Kleiner DE Jr, Axiotis CA, Di Bisceglie A, Nomura AM, Stemmermann GN, Tabor E. Source: Journal of the National Cancer Institute. 1992 November 4; 84(21): 1638-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1279184
•
Mycological survey for potential aflatoxin and ochratoxin producers and their toxicological properties in harvested Brazilian black pepper. Author(s): Gatti MJ, Fraga ME, Magnoli C, Dalcero AM, da Rocha Rosa CA. Source: Food Additives and Contaminants. 2003 December; 20(12): 1120-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14726275
•
Natural co-occurrence of aflatoxin and cyclopiazonic acid in peanuts grown in Argentina. Author(s): Fernandez Pinto V, Patriarca A, Locani O, Vaamonde G. Source: Food Additives and Contaminants. 2001 November; 18(11): 1017-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11665730
•
Nitrogen fertilizer influence on aflatoxin contamination of corn in Louisiana. Author(s): Tubajika KM, Mascagni HJ Jr, Damann KE, Russin JS. Source: Journal of Agricultural and Food Chemistry. 1999 December; 47(12): 5257-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10606605
•
Nonassociation of aflatoxin with primary liver cancer in a cross-sectional ecological survey in the People's Republic of China. Author(s): Campbell TC, Chen JS, Liu CB, Li JY, Parpia B. Source: Cancer Research. 1990 November 1; 50(21): 6882-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2208157
74
Aflatoxin
•
Occupational exposure to airborne fungi among rice mill workers with special reference to aflatoxin producing A. flavus strains. Author(s): Desai MR, Ghosh S. Source: Annals of Agricultural and Environmental Medicine : Aaem. 2003; 10(2): 159-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14677906
•
Occurrence of aflatoxin in commodities imported into Qatar, 1997-2000. Author(s): Abdulkadar AH, Al-Ali A, Al-Jedah JH. Source: Food Additives and Contaminants. 2002 July; 19(7): 666-70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12113661
•
Occurrence of aflatoxin M(1) in raw and market milk commercialized in Greece. Author(s): Roussi V, Govaris A, Varagouli A, Botsoglou NA. Source: Food Additives and Contaminants. 2002 September; 19(9): 863-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12396397
•
Occurrence of Aspergillus section flavi and aflatoxin B1 in corn genotypes and corn meal in Argentina. Author(s): Etcheverry M, Nesci A, Barros G, Torres A, Chulze S. Source: Mycopathologia. 1999; 147(1): 37-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10872514
•
Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers. Author(s): Kensler TW, He X, Otieno M, Egner PA, Jacobson LP, Chen B, Wang JS, Zhu YR, Zhang BC, Wang JB, Wu Y, Zhang QN, Qian GS, Kuang SY, Fang X, Li YF, Yu LY, Prochaska HJ, Davidson NE, Gordon GB, Gorman MB, Zarba A, Enger C, Munoz A, Helzlsouer KJ, et al. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1998 February; 7(2): 127-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9488587
•
Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention. Author(s): Buetler TM, Bammler TK, Hayes JD, Eaton DL. Source: Cancer Research. 1996 May 15; 56(10): 2306-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8625305
Studies
75
•
On influence of aflatoxin B1 on the physical properties of the avian myeloblastosis virus BAI strain A (AMV) and on the biosynthesis of viral nucleic acids. Author(s): Kremen J, Lexova J+LEXOVA J, Sula J. Source: Neoplasma. 1974; 21(3): 275-83. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4371293
•
Outbreak of acute hepatitis caused by aflatoxin poisoning in Kenya. Author(s): Ngindu A, Johnson BK, Kenya PR, Ngira JA, Ocheng DM, Nandwa H, Omondi TN, Jansen AJ, Ngare W, Kaviti JN, Gatei D, Siongok TA. Source: Lancet. 1982 June 12; 1(8285): 1346-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6123648
•
Overexpression of cytochrome P-450 isoforms involved in aflatoxin B1 bioactivation in human liver with cirrhosis and hepatitis. Author(s): Kirby GM, Batist G, Alpert L, Lamoureux E, Cameron RG, Alaoui-Jamali MA. Source: Toxicologic Pathology. 1996 July-August; 24(4): 458-67. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8864187
•
Oxidation of aflatoxin B1 by bacterial recombinant human cytochrome P450 enzymes. Author(s): Ueng YF, Shimada T, Yamazaki H, Guengerich FP. Source: Chemical Research in Toxicology. 1995 March; 8(2): 218-25. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7766804
•
Oxidation of aflatoxins and sterigmatocystin by human liver microsomes: significance of aflatoxin Q1 as a detoxication product of aflatoxin B1. Author(s): Raney KD, Shimada T, Kim DH, Groopman JD, Harris TM, Guengerich FP. Source: Chemical Research in Toxicology. 1992 March-April; 5(2): 202-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1643250
•
Oxidative metabolism of aflatoxin B1 by lipoxygenase purified from human term placenta and intrauterine conceptal tissues. Author(s): Datta K, Kulkarni AP. Source: Teratology. 1994 October; 50(4): 311-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7716738
•
p53 codon 249ser mutations in hepatocellular carcinoma patients with low aflatoxin exposure. Author(s): Patel P, Stephenson J, Scheuer PJ, Francis GE. Source: Lancet. 1992 April 4; 339(8797): 881. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1347900
76
Aflatoxin
•
P53 gene of chang-liver cells (Atcc-Ccl13) exposed to aflatoxin B1 (Afb): the effect of lysine on mutation at codon 249 of exon 7. Author(s): Uwaifo O. Source: Afr J Med Med Sci. 1999 March-June; 28(1-2): 71-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12953991
•
p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Author(s): Ozturk M. Source: Lancet. 1991 November 30; 338(8779): 1356-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1682737
•
p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand. Author(s): Hollstein MC, Wild CP, Bleicher F, Chutimataewin S, Harris CC, Srivatanakul P, Montesano R. Source: International Journal of Cancer. Journal International Du Cancer. 1993 January 2; 53(1): 51-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8380058
•
p53 proteins and aflatoxin b1: the good, the bad, and the ugly. Author(s): Liang TJ. Source: Hepatology (Baltimore, Md.). 1995 October; 22(4 Pt 1): 1330-2. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7557889
•
Plasma antioxidant vitamins, chronic hepatitis B virus infection and urinary aflatoxin B1-DNA adducts in healthy males. Author(s): Yu MW, Chiang YC, Lien JP, Chen CJ. Source: Carcinogenesis. 1997 June; 18(6): 1189-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9214602
•
Policy forum: public health. Reducing liver cancer--global control of aflatoxin. Author(s): Henry SH, Bosch FX, Troxell TC, Bolger PM. Source: Science. 1999 December 24; 286(5449): 2453-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10636808
•
Possible effects of aflatoxin consumption by man. Author(s): Copper P. Source: Food Cosmet Toxicol. 1976 April; 14(2): 151-2. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=178583
Studies
77
•
Precipitins to an aflatoxin-producing strain of Aspergillus flavus in patients with malignancy. Author(s): Wray BB, Harmon CA, Rushing EJ, Cole RJ. Source: Journal of Cancer Research and Clinical Oncology. 1982; 103(2): 181-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6807994
•
Preliminary study on serum enzyme changes in Long Evans rats given parenteral ochratoxin A, aflatoxin B1 and their combination. Author(s): Brownie CF, Brownie C. Source: Vet Hum Toxicol. 1988 June; 30(3): 211-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3133871
•
Presence of aflatoxin B1 in human liver in the United States. Author(s): Phillips DL, Yourtee DM, Searles S. Source: Toxicology and Applied Pharmacology. 1976 May; 36(2): 403-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1273856
•
Presence of aflatoxin B1 in human liver referred to as Reye's syndrome in Venezuela. Author(s): Burguera JA. Source: Acta Cient Venez. 1986; 37(3): 325-6. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3113145
•
Prevalence of exposure to aflatoxin and hepatitis B and C viruses in Guinea, West Africa. Author(s): Diallo MS, Sylla A, Sidibe K, Sylla BS, Trepo CR, Wild CP. Source: Natural Toxins. 1995; 3(1): 6-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7749585
•
Primary liver cancer and aflatoxin intake in Transkei. Author(s): van Rensburg SJ, van Schalkwyk GC, van Schalkwyk DJ. Source: Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer. 1990 JanuaryApril; 10(1-2): 11-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2231312
•
Primary liver cancer is of multifactorial origin: importance of hepatitis B virus infection and dietary aflatoxin. Author(s): Saracco G. Source: Journal of Gastroenterology and Hepatology. 1995 September-October; 10(5): 604-8. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8963039
78
Aflatoxin
•
Production of aflatoxicol from aflatoxin B1 by postmitochondrial liver fractions. Author(s): Salhab AS, Edwards GS. Source: Journal of Toxicology and Environmental Health. 1977 January; 2(3): 583-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=846007
•
Proficiency testing for the evaluation of the ability of European Union-National Reference laboratories to determine aflatoxin M1 in milk at levels corresponding to the new European Union legislation. Author(s): Dragacci S, Grosso F, Pfauwathel-Marchond N, Fremy JM, Venant A, Lombard B. Source: Food Additives and Contaminants. 2001 May; 18(5): 405-15. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11358182
•
Protective activity of different hepatic cytosolic glutathione S-transferases against DNA-binding metabolites of aflatoxin B1. Author(s): Quinn BA, Crane TL, Kocal TE, Best SJ, Cameron RG, Rushmore TH, Farber E, Hayes MA. Source: Toxicology and Applied Pharmacology. 1990 September 15; 105(3): 351-63. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2173169
•
Protective effects of coffee diterpenes against aflatoxin B1-induced genotoxicity: mechanisms in rat and human cells. Author(s): Cavin C, Mace K, Offord EA, Schilter B. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 2001 June; 39(6): 549-56. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11346484
•
Pulmonary interstitial fibrosis with evidence of aflatoxin B1 in lung tissue. Author(s): Dvorackova I, Pichova V. Source: Journal of Toxicology and Environmental Health. 1986; 18(1): 153-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3084802
•
Quantification and validation of enzyme immunoassay for urinary aflatoxin B1-N7guanine adduct for biological monitoring of aflatoxins. Author(s): Nayak S, Sashidhar RB, Bhat RV. Source: The Analyst. 2001 February; 126(2): 179-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11235100
•
Quantitation and mapping of aflatoxin B1-induced DNA damage in genomic DNA using aflatoxin B1-8,9-epoxide and microsomal activation systems. Author(s): Denissenko MF, Cahill J, Koudriakova TB, Gerber N, Pfeifer GP. Source: Mutation Research. 1999 April 6; 425(2): 205-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10216213
Studies
79
•
Quantitation of aflatoxin B1-N7-guanine adduct in urine by enzyme-linked immunosorbent assay coupled with immunoaffinity chromatography. Author(s): Vidyasagar T, Vyjayanthi V, Sujatha N, Rao BS, Bhat RV. Source: J Aoac Int. 1997 September-October; 80(5): 1013-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9325579
•
Quantitative analysis of aflatoxin-albumin adducts. Author(s): Sheabar FZ, Groopman JD, Qian GS, Wogan GN. Source: Carcinogenesis. 1993 June; 14(6): 1203-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8508508
•
Rapid immunochemical screening method for aflatoxin B1 in human and animal urine. Author(s): Stubblefield RD, Greer JI, Shotwell OL, Aikens AM. Source: J Assoc Off Anal Chem. 1991 May-June; 74(3): 530-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1908454
•
Recent aflatoxin exposure and mutation at codon 249 of the human p53 gene: lack of association. Author(s): Hsieh DP, Atkinson DN. Source: Food Additives and Contaminants. 1995 May-June; 12(3): 421-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7664937
•
Reduction of aflatoxin B(1) adduct biomarkers by oltipraz in the tree shrew (Tupaia belangeri chinensis). Author(s): Li Y, Su J, Qin L, Egner PA, Wang J, Groopman JD, Kensler TW, Roebuck BD. Source: Cancer Letters. 2000 June 1; 154(1): 79-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10799742
•
Reduction of aflatoxin B1 dialdehyde by rat and human aldo-keto reductases. Author(s): Guengerich FP, Cai H, McMahon M, Hayes JD, Sutter TR, Groopman JD, Deng Z, Harris TM. Source: Chemical Research in Toxicology. 2001 June; 14(6): 727-37. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11409944
•
Regulation of glutathione S-transferases and aldehyde reductase by chemoprotectors: studies of mechanisms responsible for inducible resistance to aflatoxin B1. Author(s): Hayes JD, McLeod R, Ellis EM, Pulford DJ, Ireland LS, McLellan LI, Judah DJ, Manson MM, Neal GE. Source: Iarc Sci Publ. 1996; (139): 175-87. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8923030
80
Aflatoxin
•
Regulatory surveillance for aflatoxin and other mycotoxins in feeds, meat, and milk. Author(s): Wessel JR, Stoloff L. Source: J Am Vet Med Assoc. 1973 December 1; 163(11): 1284-7. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4800880
•
Relation between geographical distribution of liver cancer and climate-aflatoxin B1 in China. Author(s): Wang YB, Lan LZ, Ye BF, Xu YC, Liu YY, Li WG. Source: Sci Sin [b]. 1983 November; 26(11): 1166-75. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6422550
•
Relationship between fungal growth and aflatoxin production in varities of maize and groundnut. Author(s): Priyadarshini E, Tulpule PG. Source: Journal of Agricultural and Food Chemistry. 1978 January-February; 26(1): 24952. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=621329
•
Repair of DNA in human cells after treatment with activated aflatoxin B1. Author(s): Sarasin AR, Smith CA, Hanawalt PC. Source: Cancer Research. 1977 June; 37(6): 1786-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=192462
•
Response of culture human skin fibroblasts to aflatoxin B1. Author(s): McCoy BJ, Llewellyn GC. Source: Bulletin of Environmental Contamination and Toxicology. 1980 July; 25(1): 7-14. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7459485
•
Response: relative versus absolute risk modeling of aflatoxin. Author(s): Bowers JC. Source: Risk Analysis : an Official Publication of the Society for Risk Analysis. 1993 February; 13(1): 9-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8451464
•
Response: risk assessment for aflatoxin. Author(s): Bruce RD. Source: Risk Analysis : an Official Publication of the Society for Risk Analysis. 1994 December; 14(6): 897. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7846323
Studies
81
•
Risk assessment for aflatoxin B1: a modeling approach. Author(s): Wu-Williams AH, Zeise L, Thomas D. Source: Risk Analysis : an Official Publication of the Society for Risk Analysis. 1992 December; 12(4): 559-67. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1336206
•
Risk assessment for aflatoxin: an evaluation based on the multistage model. Author(s): Bowers J, Brown B, Springer J, Tollefson L, Lorentzen R, Henry S. Source: Risk Analysis : an Official Publication of the Society for Risk Analysis. 1993 December; 13(6): 637-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8310162
•
Risk assessment for aflatoxin: I. Metabolism of aflatoxin B1 by different species. Author(s): Gorelick NJ. Source: Risk Analysis : an Official Publication of the Society for Risk Analysis. 1990 December; 10(4): 539-59. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2287782
•
Risk assessment for aflatoxin: II. Implications of human epidemiology data. Author(s): Bruce RD. Source: Risk Analysis : an Official Publication of the Society for Risk Analysis. 1990 December; 10(4): 561-9. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2287783
•
Risk assessment for aflatoxin: III. Modeling the relative risk of hepatocellular carcinoma. Author(s): Hoseyni MS. Source: Risk Analysis : an Official Publication of the Society for Risk Analysis. 1992 March; 12(1): 123-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1315449
•
Risk estimates of liver cancer due to aflatoxin exposure from peanuts and peanut products. Author(s): Dichter CR. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 1984 June; 22(6): 431-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6539733
82
Aflatoxin
•
Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma. Author(s): Tiemersma EW, Omer RE, Bunschoten A, van't Veer P, Kok FJ, Idris MO, Kadaru AM, Fedail SS, Kampman E. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2001 July; 10(7): 785-91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11440964
•
Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1. Author(s): Gallagher EP, Wienkers LC, Stapleton PL, Kunze KL, Eaton DL. Source: Cancer Research. 1994 January 1; 54(1): 101-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8261428
•
Screening method for the detection of aflatoxin and metabolites in human urine: aflatoxins B1, G1, M1, B2a, G2a, aflatoxicols I and II. Author(s): Lovelace CE, Njapau H, Salter LF, Bayley AC. Source: Journal of Chromatography. 1982 January 8; 227(1): 256-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6799532
•
Selection and characterisation of recombinant single-chain antibodies to the hapten Aflatoxin-B1 from naive recombinant antibody libraries. Author(s): Moghaddam A, Lobersli I, Gebhardt K, Braunagel M, Marvik OJ. Source: Journal of Immunological Methods. 2001 August 1; 254(1-2): 169-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11406162
•
Sequence specificity of aflatoxin B1-induced mutations in a plasmid replicated in xeroderma pigmentosum and DNA repair proficient human cells. Author(s): Levy DD, Groopman JD, Lim SE, Seidman MM, Kraemer KH. Source: Cancer Research. 1992 October 15; 52(20): 5668-73. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1394191
•
Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1. Author(s): Gan LS, Skipper PL, Peng XC, Groopman JD, Chen JS, Wogan GN, Tannenbaum SR. Source: Carcinogenesis. 1988 July; 9(7): 1323-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3133131
Studies
83
•
Shuttle-vector mutagenesis by aflatoxin B1 in human cells: effects of sequence context on the supF mutational spectrum. Author(s): Courtemanche C, Anderson A. Source: Mutation Research. 1994 April 15; 306(2): 143-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7512213
•
Site-specific synthesis of aflatoxin B(1) adducts within an oligodeoxyribonucleotide containing the human p53 codon 249 sequence. Author(s): Jones WR, Johnston DS, Stone MP. Source: Chemical Research in Toxicology. 1999 August; 12(8): 707-14. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10458704
•
Species comparison of in vitro metabolism of aflatoxin B1. Author(s): Roebuck BD, Wogan GN. Source: Cancer Research. 1977 June; 37(6): 1649-56. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=404034
•
Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformation. Author(s): Ramsdell HS, Eaton DL. Source: Cancer Research. 1990 February 1; 50(3): 615-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2105159
•
Specificity of aflatoxin B1 binding on human proto-oncogene nucleotide sequence. Author(s): Modali R, Yang SS. Source: Prog Clin Biol Res. 1986; 207: 147-58. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3083425
•
Stable expression of human cytochrome P450IA2 cDNA in a human lymphoblastoid cell line: role of the enzyme in the metabolic activation of aflatoxin B1. Author(s): Crespi CL, Steimel DT, Aoyama T, Gelboin HV, Gonzalez FJ. Source: Molecular Carcinogenesis. 1990; 3(1): 5-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2108694
•
Study on the binding of aflatoxin B1 to cellular components. I. Binding of aflatoxin B1 to albumin in vitro. Author(s): Lu FJ, Ling KH. Source: Taiwan Yi Xue Hui Za Zhi. 1973 August; 72(8): 434-9. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4520340
84
Aflatoxin
•
Substances with affinity to a monoclonal aflatoxin B1 antibody in Danish urine samples. Author(s): Dragsted LO, Bull I, Autrup H. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 1988 March; 26(3): 233-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2452776
•
Suppression of the interleukin-2 gene expression by aflatoxin B1 is mediated through the down-regulation of the NF-AT and AP-1 transcription factors. Author(s): Han SH, Jeon YJ, Yea SS, Yang KH. Source: Toxicology Letters. 1999 July 30; 108(1): 1-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10472804
•
Survey of the occurrence of aflatoxin M1 in dairy products marketed in Italy: second year of observation. Author(s): Galvano F, Galofaro V, Ritieni A, Bognanno M, De Angelis A, Galvano G. Source: Food Additives and Contaminants. 2001 July; 18(7): 644-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11469321
•
Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans. Author(s): McGlynn KA, Hunter K, LeVoyer T, Roush J, Wise P, Michielli RA, Shen FM, Evans AA, London WT, Buetow KH. Source: Cancer Research. 2003 August 1; 63(15): 4594-601. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12907637
•
Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Author(s): McGlynn KA, Rosvold EA, Lustbader ED, Hu Y, Clapper ML, Zhou T, Wild CP, Xia XL, Baffoe-Bonnie A, Ofori-Adjei D, et al. Source: Proceedings of the National Academy of Sciences of the United States of America. 1995 March 14; 92(6): 2384-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7892276
•
Synergism between hepatitis B virus and aflatoxin in hepatocellular carcinoma. Author(s): Ayoola EA. Source: Iarc Sci Publ. 1984; (63): 167-79. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6100268
Studies
85
•
Synergistic hepatocarcinogenic effect of hepadnaviral infection and dietary aflatoxin B1 in woodchucks. Author(s): Bannasch P, Khoshkhou NI, Hacker HJ, Radaeva S, Mrozek M, Zillmann U, Kopp-Schneider A, Haberkorn U, Elgas M, Tolle T, et al. Source: Cancer Research. 1995 August 1; 55(15): 3318-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7614467
•
Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. Author(s): Kew MC. Source: Liver International : Official Journal of the International Association for the Study of the Liver. 2003 December; 23(6): 405-9. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14986813
•
Systemic aspergillosis caused by an aflatoxin-producing strain of Aspergillus flavus. Author(s): Mori T, Matsumura M, Yamada K, Irie S, Oshimi K, Suda K, Oguri T, Ichinoe M. Source: Medical Mycology : Official Publication of the International Society for Human and Animal Mycology. 1998 April; 36(2): 107-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9776821
•
Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigenpositive and antigen-negative residents of Daxin, Qidong County, People's Republic of China. Author(s): Wang JS, Qian GS, Zarba A, He X, Zhu YR, Zhang BC, Jacobson L, Gange SJ, Munoz A, Kensler TW, et al. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1996 April; 5(4): 253-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8722216
•
The 1995 Pharmacological Society of Canada Merck Frosst Award. Cellular and molecular targets in pulmonary chemical carcinogenesis: studies with aflatoxin B1. Author(s): Massey TE. Source: Canadian Journal of Physiology and Pharmacology. 1996 June; 74(6): 621-8. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8909771
•
The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma. Author(s): Smela ME, Hamm ML, Henderson PT, Harris CM, Harris TM, Essigmann JM. Source: Proceedings of the National Academy of Sciences of the United States of America. 2002 May 14; 99(10): 6655-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12011430
86
Aflatoxin
•
The aflatoxin-lysine adduct quantified by high-performance liquid chromatography from human serum albumin samples. Author(s): Sabbioni G, Ambs S, Wogan GN, Groopman JD. Source: Carcinogenesis. 1990 November; 11(11): 2063-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2121383
•
The anticalmodulin effect of aflatoxin B1 on purified erythrocyte Ca(2+)-ATPase. Author(s): Adebayo AO, Okunade GW, Olorunsogo OO. Source: Bioscience Reports. 1995 August; 15(4): 209-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8562872
•
The binding of aflatoxin B1 with serum albumin. Author(s): Bassir O, Bababunmi EA. Source: Biochemical Pharmacology. 1973 January 1; 22(1): 132-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4763240
•
The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis. Author(s): Smela ME, Currier SS, Bailey EA, Essigmann JM. Source: Carcinogenesis. 2001 April; 22(4): 535-45. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11285186
•
The cytogenetic effects of aflatoxin and gamma-rays on human leukocytes in vitro. Author(s): Promchainant C, Baimai V, Nondasuta A. Source: Mutation Research. 1972 December; 16(4): 373-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=5084979
•
The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3. Author(s): Crespi CL, Penman BW, Steimel DT, Gelboin HV, Gonzalez FJ. Source: Carcinogenesis. 1991 February; 12(2): 355-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1899812
•
The endo-8,9-epoxide of aflatoxin B1: a new metabolite. Author(s): Raney KD, Coles B, Guengerich FP, Harris TM. Source: Chemical Research in Toxicology. 1992 May-June; 5(3): 333-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1504254
Studies
87
•
The Escherichia coli DNA repair protein UvrA can re-associate with the UvrB: aflatoxin B1-DNA complex in vitro. Author(s): Allan JM, Routledge MN, Garner RC. Source: Mutation Research. 1996 April 2; 362(3): 261-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8637504
•
The metabolism of aflatoxin B1 by human liver. Author(s): Moss EJ, Neal GE. Source: Biochemical Pharmacology. 1985 September 1; 34(17): 3193-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3929787
•
The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations. Author(s): Yourtee DM, Kirk-Yourtee CL. Source: Res Commun Chem Pathol Pharmacol. 1986 October; 54(1): 101-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3099349
•
The role of aflatoxin metabolism in its toxic lesion. Author(s): Campbell TC, Hayes JR. Source: Toxicology and Applied Pharmacology. 1976 February; 35(2): 199-222. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4903
•
The role of dietary aflatoxin in the genesis of hepatocellular cancer in developing countries. Author(s): Enwonwu CO. Source: Lancet. 1984 October 27; 2(8409): 956-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6149345
•
The role of infection by Opisthorchis viverrini, hepatitis B virus, and aflatoxin exposure in the etiology of liver cancer in Thailand. A correlation study. Author(s): Srivatanakul P, Parkin DM, Jiang YZ, Khlat M, Kao-Ian UT, Sontipong S, Wild C. Source: Cancer. 1991 December 1; 68(11): 2411-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1657355
•
The use of monoclonal antibody affinity columns for assessing DNA damage and repair following exposure to aflatoxin B1. Author(s): Groopman JD, Kensler TW. Source: Pharmacology & Therapeutics. 1987; 34(2): 321-34. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3120202
88
Aflatoxin
•
Toward less misleading comparisons of uncertain risks: the example of aflatoxin and alar. Author(s): Finkel AM. Source: Environmental Health Perspectives. 1995 April; 103(4): 376-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7607139
•
Toxicity testing in vitro. I. The effects of delta 9-tetrahydrocannabinol and aflatoxin B1 on the growth of cultured human fibroblasts. Author(s): Cooper JT, Goldstein S. Source: Canadian Journal of Physiology and Pharmacology. 1976 August; 54(4): 541-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=974881
•
Transplacental transfer of aflatoxin in humans. Author(s): Denning DW, Allen R, Wilkinson AP, Morgan MR. Source: Carcinogenesis. 1990 June; 11(6): 1033-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2112058
•
U.S. Food and Drug Administration approach to risk assessment of aflatoxin in human foods. Author(s): Henry SH, Scheuplein RJ, Bowers J, Tollefson L. Source: Quality Assurance (San Diego, Calif.). 1993 March-June; 2(1-2): 71-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8156225
•
Uncertainties in the risk assessment of three mycotoxins: aflatoxin, ochratoxin, and zearalenone. Author(s): Kuiper-Goodman T. Source: Canadian Journal of Physiology and Pharmacology. 1990 July; 68(7): 1017-24. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2143430
•
Urinary aflatoxin B and effects of preservatives on its detecton. Author(s): Parpia HA, Sreenivasamurthy V, Shantha T, Shankaramurti A, Amla I, Srikantia S. Source: The American Journal of Clinical Nutrition. 1972 January; 25(1): 13-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4621421
•
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Author(s): Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, Groopman JD, Gao YT, Henderson BE. Source: Lancet. 1992 April 18; 339(8799): 943-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1348796
Studies
89
•
Urinary aflatoxin levels, hepatitis-B virus infection and hepatocellular carcinoma in Taiwan. Author(s): Hatch MC, Chen CJ, Levin B, Ji BT, Yang GY, Hsu SW, Wang LW, Hsieh LL, Santella RM. Source: International Journal of Cancer. Journal International Du Cancer. 1993 July 30; 54(6): 931-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8392983
•
Urinary excretion of aflatoxin and liver cancer in Karachi. Author(s): Nizami F, Nizami HM, Ahmad M. Source: J Pak Med Assoc. 1986 May; 36(5): 112-4. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3093719
•
Use of aflatoxin adducts as intermediate endpoints to assess the efficacy of chemopreventive interventions in animals and man. Author(s): Kensler TW, Groopman JD, Roebuck BD. Source: Mutation Research. 1998 June 18; 402(1-2): 165-72. Review. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9675269
•
Use of an improved method for analysis of urinary aflatoxin M1 in a survey of mainland China and Taiwan. Author(s): Cheng Z, Root M, Pan W, Chen J, Campbell TC. Source: Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 1997 July; 6(7): 523-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9232340
•
Variability in aflatoxin B(1)-macromolecular binding and relationship to biotransformation enzyme expression in human prenatal and adult liver. Author(s): Doi AM, Patterson PE, Gallagher EP. Source: Toxicology and Applied Pharmacology. 2002 May 15; 181(1): 48-59. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12030842
•
Variability in aflatoxin-albumin adduct levels and effects of hepatitis B and C virus infection and glutathione S-transferase M1 and T1 genotype. Author(s): Ahsan H, Wang LY, Chen CJ, Tsai WY, Santella RM. Source: Environmental Health Perspectives. 2001 August; 109(8): 833-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11564620
90
Aflatoxin
•
Variability of aflatoxin and cyclopiazonic acid production by Aspergillus section flavi from different substrates in Argentina. Author(s): Vaamonde G, Patriarca A, Fernandez Pinto V, Comerio R, Degrossi C. Source: International Journal of Food Microbiology. 2003 November 15; 88(1): 79-84. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14527788
•
Vitamin A ameliorates the genotoxicity in mice of aflatoxin B1-containing Aspergillus flavus infested food. Author(s): Sinha SP, Dharmshila K. Source: Cytobios. 1994; 79(317): 85-95. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7835072
91
CHAPTER 2. NUTRITION AND AFLATOXIN Overview In this chapter, we will show you how to find studies dedicated specifically to nutrition and aflatoxin.
Finding Nutrition Studies on Aflatoxin The National Institutes of Health’s Office of Dietary Supplements (ODS) offers a searchable bibliographic database called the IBIDS (International Bibliographic Information on Dietary Supplements; National Institutes of Health, Building 31, Room 1B29, 31 Center Drive, MSC 2086, Bethesda, Maryland 20892-2086, Tel: 301-435-2920, Fax: 301-480-1845, E-mail:
[email protected]). The IBIDS contains over 460,000 scientific citations and summaries about dietary supplements and nutrition as well as references to published international, scientific literature on dietary supplements such as vitamins, minerals, and botanicals.7 The IBIDS includes references and citations to both human and animal research studies. As a service of the ODS, access to the IBIDS database is available free of charge at the following Web address: http://ods.od.nih.gov/databases/ibids.html. After entering the search area, you have three choices: (1) IBIDS Consumer Database, (2) Full IBIDS Database, or (3) Peer Reviewed Citations Only. Now that you have selected a database, click on the “Advanced” tab. An advanced search allows you to retrieve up to 100 fully explained references in a comprehensive format. Type “aflatoxin” (or synonyms) into the search box, and click “Go.” To narrow the search, you can also select the “Title” field.
7 Adapted from http://ods.od.nih.gov. IBIDS is produced by the Office of Dietary Supplements (ODS) at the National Institutes of Health to assist the public, healthcare providers, educators, and researchers in locating credible, scientific information on dietary supplements. IBIDS was developed and will be maintained through an interagency partnership with the Food and Nutrition Information Center of the National Agricultural Library, U.S. Department of Agriculture.
92
Aflatoxin
The following information is typical of that found when using the “Full IBIDS Database” to search for “aflatoxin” (or a synonym): •
A pilot clinical study examining the ability of a mixture of Lactobacillus and Propionibacterium to remove aflatoxin from the gastrointestinal tract of healthy Egyptian volunteers. Author(s): RMIT University, Melbourne (Australie). Key Centre for Toxicology Source: Ahokas, J.T. El Nezami, H.S. Kankaanpaeae, P. Mykkaenen, H. Salminen, S. Revue-de-Medecine-Veterinaire (France). (June 1998). volume 146(6) page 568.
•
Study on the ability of esterified glucomannans (EGM) to prevent the gastrointestinal absorption of mycotoxins in laying hens. Author(s): Bologna Univ. (Italy). Dipartimento di Sanita Pubblica Veterinaria e Patologia Animale Bologna Univ. (Italy). Dipartimento di Morfofisiologia Veterinaria e Produzioni Animali Source: Zaghini, A. Altafini, A. Rizzi, L. Simioli, M. Proceedings-of-the-ASPA-CongressRecent-Progress-in-Animal-Production-Science (Italy). (2001). volume 2 page 442-444.
•
Trials for restoring the toxicity of aflatoxin. Author(s): Tanta Univ., Kafr El-Sheikh (Egypt). Faculty of Veterinary Medicine Source: Abdel Aziz, M.I. kamel, F.M. Hegazi, S. Alexandria-Journal-of-VeterinaryScience (Egypt). (April 1995). volume 11 (1) page 19-26. Received 1999.
Additional physician-oriented references include: •
A rationale for the control of aflatoxin in human foods. Source: Stoloff, L. Bioactive-Mol. Amsterdam : Elsevier Science Publishers, B.V. 1986. volume 1 page 457-471.
•
Aflatoxin and aflatoxicosis. IV. The effect of dietary aflatoxins on adult fertile male and female rabbits at various reproductive conditons. Source: Hafez, A.H. Gomma, A. Mousa, S.A. Megalla, S.E. Mycopathologia. The Hague : W. Junk. November 25, 1983. volume 83 (3) page 183-186. 0301-486X
•
Aflatoxin B1 induces apoptosis in rat liver: protective effect of melatonin. Author(s): Biochemistry Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
[email protected]. Source: Meki, A R Abdel Ghaffar, S K El Gibaly, I Neuroendocrinol-Lett. 2001 December; 22(6): 417-26 0172-780X
•
Aflatoxin B1 production in orange (Citrus reticulata) juice by isolates of Aspergillus flavus Link. Source: Varma, S K Verma, R A Mycopathologia. 1987 February; 97(2): 101-4 0301-486X
•
Aflatoxin excretion in children with kwashiorkor or marasmic kwashiorkor--a clinical investigation. Author(s): St Mary's Hospital Mumias, Kakamega district, Kenya. Source: de Vries, H R Maxwell, S M Hendrickse, R G Mycopathologia. 1990 April; 110(1): 1-9 0301-486X
•
Aflatoxin in the Philippines. Source: Garcia, R.P. Ilag, L.L. Aflatoxin in maize : proceedings of the workshop, El Batan, Mexico, April 7-11, 1986 / sponspored by CIMMYT, UNDP and USAID. Mexico, D.F. : CIMMYT, [1986]. page 365-372. ISBN: 9686127127
Nutrition
93
•
Aflatoxin production in supplemental feeders provided for northern bobwhite in Texas and Oklahoma. Author(s): Department of Range, Wildlife, and Fisheries Management, Texas Tech University, Lubbock, Texas 79409-2125, USA. Source: Oberheu, D G Dabbert, C B J-Wildl-Dis. 2001 July; 37(3): 475-80 0090-3558
•
Aflatoxins in sunflower seeds: effect of zinc in aflatoxin production by two strains of Aspergillus parasiticus. Author(s): Department of Microbiology and Immunology, National University of Rio Cuarto, Argentina. Source: Chulze, S Fusero, S Dalcero, A Etcheverry, M Varsavsky, E Mycopathologia. 1987 August; 99(2): 91-4 0301-486X
•
Alteration of aflatoxin B1 metabolic profiles and reduction of aflatoxin B1 mutagenicity by hepatic microsomes of rats fed butylated hydroxyanisole. Author(s): Department of Pharmacology and Toxicology, Inha Medical College, Inchon, Japan. Source: Choi, C Y Park, S H Park, E H Cha, Y N J-Toxicol-Sci. 1991 February; 16 Suppl 1119-32 0388-1350
•
Altered DNA mutation spectrum in aflatoxin b1-treated transgenic mice that express the hepatitis B virus x protein. Author(s): Department of Molecular Virology and Microbiology. Department of Pathology, Baylor College of Medicine, Houston, Texas 77030, USA. Source: Madden, C R Finegold, M J Slagle, B L J-Virol. 2002 November; 76(22): 11770-4 0022-538X
•
Application of monoclonal antibodies and dietary antioxidant-based animal models to define human exposure to aflatoxin B1. Source: Groopman, J D Roebuck, B D Kensler, T W Prog-Exp-Tumor-Res. 1987; 3152-62 0079-6263
•
Combined effect of aflatoxin and vitamin A on clastogeny in mice chromosomes. Source: Kumari, D. Sinha, S.P. Cytologia-Int-J-Cytol. Tokyo : Cytologia. Sept 1990. volume 55 (3) page 387-390. 0011-4545
•
Comparative uptake, vascular transport, and cellular internalization of aflatoxin-B1 and benzo(a)pyrene. Author(s): Department of Anatomy, College of Veterinary Medicine, Texas A&M University, College Station 77843. Source: Busbee, D L Norman, J O Ziprin, R L Arch-Toxicol. 1990; 64(4): 285-90 0340-5761
•
Conservation of structure and function of the aflatoxin regulatory gene aflR from Aspergillus nidulans and A. flavus. Source: Yu, J.H. Butchko, R.A.E. Fernandes, M. Keller, N.P. Leonard, T.J. Adams, T.H. Curr-genet. Berlin; New York : Springer-Verlag, 1979-. 1996. volume 29 (6) page 549-555. 0172-8083
•
Contaminated diet of Oreochromis niloticus genotoxic and pathological effects of aflatoxin. Author(s): Alexandria Univ. (Egypt). Faculty of Veterinary Medicine Source: El Fiky, S.A. Zaki, V.H. Alexandria-Journal-of-Veterinary-Science (Egypt). (1997). volume 13(3) page 159-170. Received 1998. oreochromis niloticus mycotoxins pathology aflatoxins 1110-3047
94
Aflatoxin
•
Decontamination of groundnut meal containing aflatoxin by treatment with calcium hydroxide and paraformaldehyde. Source: Piva, G. Pietri, A. Carini, E. Amerio, M. Gatti, S. New strategies for improving animal production for human welfare : proceedings / the Fifth World Conference on Animal Production, August 14-19, 1983. Tokyo, Japan : Japanese Society of Zootechnical Science, 1983. volume 2 page 563-564.
•
Detection of aflatoxin B1 guanine adducts in human urine samples from Kenya. Source: Dragsted, L.O. Wakhisi, J. Autrup, H. Environmental epidemiology / [edited by] Frederick C. Kopfler, Gunther F. Craun. Chelsea, Mich. : Lewis Publishers, c1986. page 1-15. ISBN: 0873710738
•
Determinants of formation of aflatoxin-albumin adducts: a seven-township study in Taiwan. Author(s): School of Public Health, National Defense Medical Center, School of Public Health, No. 161, Section 6, Min-Chuan East Road, Taipei 114, Taiwan, Republic of China.
[email protected] Source: Sun, C A Wu, D M Wang, L Y Chen, C J You, S L Santella, R M Br-J-Cancer. 2002 October 21; 87(9): 966-70 0007-0920
•
Effect of (+)-catechin, dimethyl sulfoxide and ethanol on the microsome-mediated metabolism of two hepatocarcinogens, N-nitrosodimethylamine and aflatoxin B1. Author(s): Fels Research Institute, Philadelphia, PA. Source: Prasanna, H R Lotlikar, P D Hacobian, N Ho, L L Magee, P N IARC-Sci-Publ. 1987; (84): 175-7 0300-5038
•
Effect of aflatoxin B1 on the delayed type hypersensitivity and phagocytic activity of reticuloendothelial system in chickens. Author(s): Department of Veterinary Microbiology, Haryana Agricultural University, Hisar, India. Source: Kadian, S K Monga, D P Goel, M C Mycopathologia. 1988 October; 104(1): 33-6 0301-486X
•
Effect of alpha-tocopherol supplementation on the impact of aflatoxin B1 on the testes of rats. Author(s): Embryotoxicology section industrial toxicology research centre (ITRC), Lucknow, India. Source: Ibeh, I N Saxena, D K Exp-Toxicol-Pathol. 1998 June; 50(3): 221-4 0940-2993
•
Effect of ascorbic acid on some biochemical parameters of rabbits affected by aflatoxin B1. Source: Yousef, M.I. El Demerdash, F.M. El Agamy, E.I. Environ-nutr-interact. Philadelphia, PA : Taylor & Francis. July/Sept 1999. volume 3 (3) page 141-143. 10865683
•
Effect of dietary aflatoxin B1 on the growth response and haematologic changes of young Japanese quail. Author(s): Department of Veterinary Pathology, Haryana Agricultural University, Hisar, India. Source: Sadana, J R Asrani, R K Pandita, A Mycopathologia. 1992 June; 118(3): 133-7 0301-486X
Nutrition
95
•
Effect of dietary beta-1,3 glucan on immune responses and disease resistance of healthy and aflatoxin B1-induced immunocompromised rohu (Labeo rohita Hamilton). Author(s): Central Institute of Freshwater Aquaculture, Kausalyaganga, Bhubaneswar, India.
[email protected] Source: Sahoo, P K Mukherjee, S C Fish-Shellfish-Immunol. 2001 November; 11(8): 68395 1050-4648
•
Effect of long term feeding and withdrawal of aflatoxin B1 and ochratoxin A on kidney cell transformation in albino rats. Author(s): Department of Microbiology & Sanitation, Central Food Technological Research Institute, Mysore, India. Source: Rati, E R Shantha, T Ramesh, H P Indian-J-Exp-Biol. 1991 September; 29(9): 813-7 0019-5189
•
Effect of long-term feeding of nivalenol on aflatoxin B1-initiated hepatocarcinogenesis in mice. Author(s): Department of Toxicology and Microbial Chemistry, Faculty of Pharmaceutical Sciences, Science University of Tokyo, Japan. Source: Ueno, Y Kobayashi, T Yamamura, H Kato, T Tashiro, F Nakamura, K Ohtsubo, K IARC-Sci-Publ. 1991; (105): 420-3 0300-5038
•
Effect of low level of dietary aflatoxins on baladi rabbits. Author(s): Dept. of Animal and Poultry Production, Fac. of Agriculture, Mansoura University, Egypt. Source: Abdelhamid, A M el Shawaf, I el Ayoty, S A Ali, M M Gamil, T Arch-Tierernahr. 1990 May-June; 40(5-6): 517-37 0003-942X
•
Effect of low protein diet on chronic aflatoxin B1-induced liver injury in rhesus monkeys. Author(s): Department of Pathology, All India Institute of Medical Sciences, New Delhi. Source: Mathur, M Rizvi, T A Nayak, N C Mycopathologia. 1991 March; 113(3): 175-9 0301-486X
•
Effect of melatonin on the production of microsomal hydrogen peroxide and cytochrome P-450 content in rat treated with aflatoxin B(1). Author(s): Department of Environmental Studies, Institute of Graduate Studies and Research, Alexandria University, 163 Horreya Avenue, Chatby, 21131, Alexandria, Egypt.
[email protected] Source: Awney, Hala A Attih, Ahmed M Habib, Sami L Mostafa, Mostafa H Toxicology. 2002 March 20; 172(2): 143-8 0300-483X
•
Effect of parboiling and bran removal on aflatoxin levels in Sri Lankan rice. Author(s): Department of Agricultural Biology, University of Peradeniya, Sri Lanka. Source: Bandara, J M Vithanege, A K Bean, G A Mycopathologia. 1991 July; 115(1): 31-5 0301-486X
•
Effect of peanut tannin extracts on growth of Aspergillus parasiticus and aflatoxin production. Author(s): Texas A & M University, Department of Plant Pathology, College Station 77843. Source: Azaizeh, H A Pettit, R E Sarr, B A Phillips, T D Mycopathologia. 1990 June; 110(3): 125-32 0301-486X
96
Aflatoxin
•
Effects of cyclopiazonic acid and aflatoxin singly and in combination on selected clinical, pathological and immunological responses of guinea pigs. Author(s): Department of Veterinary Sciences, University of Wyoming, Laramie 82071. Source: Pier, A C Belden, E L Ellis, J A Nelson, E W Maki, L R Mycopathologia. 1989 March; 105(3): 135-42 0301-486X
•
Effects of dietary fat and aflatoxin B1 on microsomal monooxygenase activity. Source: Nyandieka, H S Arch-Toxicol. 1987; 60(1-3): 59-60 0340-5761
•
Effects of prolonged oral administration of fumonisin B1 and aflatoxin B1 in rats. Source: Pozzi, C.R. Correa, B. Xavier, J.G. Direito, G.M. Orsi, R.B. Matarazzo, S.V. Mycopathologia. Dordrecht : Kluwer Academic Publishers. 2001. volume 151 (1) page 21-27. 0301-486X
•
Effects of various inducers on the activities of cytochrome P-450-mixed function oxidases and aflatoxin B1 activation in microsomes of hamster livers. Author(s): Division of Pharmacology, National Institute of Hygienic Sciences, Tokyo, Japan. Source: Sunouchi, M Fukuhara, M Ohno, Y Takanaka, A J-Toxicol-Sci. 1988 November; 13(4): 193-204 0388-1350
•
Fungal contamination, natural occurrence of mycotoxins and resistance for aflatoxin accumulation of some broad bean (Vicia faba L.) cultivars. Author(s): Botany Department, Faculty of Science, Assiut University, Sohag, Egypt. Source: Saber, S M J-Basic-Microbiol. 1992; 32(4): 249-58 0233-111X
•
Genetic selection for aflatoxin B1 resistance influences chicken T-cell and thymocyte proliferation. Author(s): Department of Poultry Science, Clemson University, SC 29634. Source: Scott, T R Rowland, S M Rodgers, R S Bodine, A B Dev-Comp-Immunol. 1991 Fall; 15(4): 383-91 0145-305X
•
In vivo effect of selenium on the mutagenic activity of aflatoxin B1. Author(s): Institute of Hygiene and Epidemiology, Prague, Czechoslovakia. Source: Petr, T Barta, I Turek, B J-Hyg-Epidemiol-Microbiol-Immunol. 1990; 34(2): 123-8 0022-1732
•
Influence of dietary aflatoxin on certain serum enzyme levels in broiler chickens. Author(s): Department of Pathology, Madras Veterinary College, India. Source: Balachandran, C Ramarkrishnan, R Mycopathologia. 1988 February; 101(2): 65-7 0301-486X
•
Influence of gamma-irradiation and maize lipids on the production of aflatoxin B1 by Aspergillus flavus. Author(s): National Center for Radiation Research and Technology, Microbiology Department, P.O. Box 29, Nasr City, Cairo, Egypt. Source: Aziz, N H el Zeany, S A Moussa, L A Nahrung. 2002 October; 46(5): 327-31 0027769X
•
Inhibition by the bioflavonoid ternatin of aflatoxin B1-induced lipid peroxidation in rat liver. Author(s): Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil. Source: Souza, M F Tome, A R Rao, V S J-Pharm-Pharmacol. 1999 February; 51(2): 125-9 0022-3573
Nutrition
97
•
Inhibition of aflatoxin production & growth of Aspergillus flavus by eugenol & onion & garlic extracts. Author(s): University Department of Botany, Bhagalpur University. Source: Bilgrami, K S Sinha, K K Sinha, A K Indian-J-Med-Res. 1992 June; 96171-5 09715916
•
Initial characterization of a type I fatty acid synthase and polyketide synthase multienzyme complex NorS in the biosynthesis of aflatoxin B(1). Author(s): Department of Chemistry, The Johns Hopkins University, 3400 N. Charles Street, Baltimore, MD 21218, USA. Source: Watanabe, C M Townsend, C A Chem-Biol. 2002 September; 9(9): 981-8 10745521
•
Interaction of fumonisin B(1) and aflatoxin B(1) in a short-term carcinogenesis model in rat liver. Author(s): PROMEC Unit, Medical Research Council, P.O. Box 19070, 7505, Tygerberg, South Africa.
[email protected] Source: Gelderblom, W C A Marasas, W F O Lebepe Mazur, S Swanevelder, S Vessey, C J Hall, P de la M Toxicology. 2002 February 28; 171(2-3): 161-73 0300-483X
•
Interrelationship of kernel water activity, soil temperature, maturity, and phytoalexin production in preharvest aflatoxin contamination of drought-stressed peanuts. Author(s): USDA, ARS, National Peanut Research Laboratory, Dawson, Georgia, 31742. Source: Dorner, J W Cole, R J Sanders, T H Blankenship, P D Mycopathologia. 1989 February; 105(2): 117-28 0301-486X
•
Liver fibrosis in guinea pigs experimentally induced by combined copper and aflatoxin application. Author(s): Federal Environmental Agency, Institute for Water-, Soil- and Air-Hygiene, Berlin, Germany. Source: Schiller, F Lippold, U Heinze, R Hoffmann, A Seffner, W Exp-Toxicol-Pathol. 1998 September; 50(4-6): 519-27 0940-2993
•
Long-term immune dysfunction in rainbow trout (Oncorhynchus mykiss) exposed as embryos to aflatoxin B1. Author(s): Department of Environmental Sciences, School of Marine Science, Virginia Institute of Marine Science, College of William and Mary, Gloucester Point 23062, USA. Source: Ottinger, C A Kaattari, S L Fish-Shellfish-Immunol. 2000 January; 10(1): 101-6 1050-4648
•
Mechanism of biochemical action of substituted 4-methylbenzopyran-2-ones. Part II: Mechanism-based inhibition of rat liver microsome-mediated aflatoxin B1-DNA binding by the candidate antimutagen 7,8-diacetoxy-4-methylcoumarin. Author(s): Department of Biochemistry, V. P. Chest Institute, University of Delhi, India. Source: Raj, H G ParMarch, V S Jain, S C Goel, S Singh, A Gupta, K Rohil, V Tyagi, Y K Jha, H N Olsen, C E Wengel, J Bioorg-Med-Chem. 1998 October; 6(10): 1895-904 09680896
•
Metabolism of aflatoxin B1 by Petroselinum crispum (parsley). Author(s): Department of Biochemistry, University of Natal, South Africa. Source: Howes, A W Dutton, M F Chuturgoon, A A Mycopathologia. 1991 January; 113(1): 25-9 0301-486X
98
Aflatoxin
•
Modulating role of Semecarpus anacardium L. nut milk extract on aflatoxin B(1) biotransformation. Author(s): Department of Medical Biochemistry, Dr. A.L.M. Post-Graduate Institute of Basic Medical Sciences, University of Madras, Taramani Campus, Chennai, 600 113, India. Source: Premalatha, B Sachdanandam, P Pharmacol-Res. 2000 January; 41(1): 19-24 10436618
•
On the effect of aflatoxin on lipid metabolism in three strains of broiler chickens. Author(s): PCSIR Labs., Karachi (Pakistan) Source: Khan, B.A. Husain, S.S. Ahmed, M.A. Sultana, L. Khalid, Q. Pakistan-Journal-ofScientific-and-Industrial-Research (Pakistan). (August 1989). volume 32(8) page 528-530. broiler chickens aflatoxins lipid metabolism weight cholesterol 0030-9885
•
Potential natural exposure of Mississippi sandhill cranes to aflatoxin B1. Author(s): College of Veterinary Medicine, Mississippi State University, Mississippi State 39762. Source: Couvillion, C E Jackson, J R Ingram, R P Bennett, L W McCoy, C P J-Wildl-Dis. 1991 October; 27(4): 650-6 0090-3558
•
Protective effect of Cochlospermum tinctorium A. Rich extract versus aflatoxin B1induced liver damage in rats. Source: Dalvi, R.R. Sere, A. Int-J-Crude-Drug-Res. Lisse : Swets & Zeitlinger. June 1988. volume 26 (2) page 117-120. 0167-7314
•
Quantitative risk analysis of aflatoxin toxicity for the consumers of 'kenkey'-- a fermented maize product. Source: Nickelsen, L. Jakobsen, M. Food-control. Oxford, UK : Elsevier Science Ltd. June 1997. volume 8 (13) page 149-159. 0956-7135
•
Reduction of aflatoxin content of infected cowpea seeds during processing into food. Author(s): Department of Chemistry, University of Ibadan, Nigeria. Source: Ogunsanwo, B M Faboya, O O Idowu, O R Ikotun, T Nahrung. 1989; 33(6): 595-7 0027-769X
•
Reliability of a short-term test for hepatocarcinogenesis induced by aflatoxin B1. Author(s): Department of Pathology, Guangxi Cancer Institute, Nanning, China. Source: Li, Y Yan, R Q Qin, G Z Qin, L L Duan, X X IARC-Sci-Publ. 1991; (105): 431-3 0300-5038
•
Selection pressure and altered hepatocellular islands after a single injection of aflatoxin B1. Author(s): Department of Experimental Pathology, Cancer Institute, Tokyo. Source: Moore, M A Nakagawa, K Ishikawa, T Jpn-J-Cancer-Res. 1988 February; 79(2): 187-94 0910-5050
•
Short-term moderate aflatoxin B1 exposure has only minor effects on the gutassociated lymphoid tissue of Brown Norway rats. Author(s): Institute of Nutritional Physiology, Federal Research Centre for Nutrition, Karlsruhe, Germany.
[email protected] Source: Watzl, B Neudecker, C Hansch, G M Rechkemmer, G Pool Zobel, B L Toxicology. 1999 November 5; 138(2): 93-102 0300-483X
•
Studies of aflatoxins in Chiang Mai, Thailand. Author(s): Department of Clinical Microbiology, Faculty of Associated Medical Sciences, Chiang Mai University, Thailand.
Nutrition
99
Source: Sutabhaha, S Suttajit, M Niyomca, P Kitasato-Arch-Exp-Med. 1992 April; 65(1): 45-52 0023-1924 •
Studies on the toxicity of shrimp (Penaeus vannamei) fed diets dosed with aflatoxin B1 to humans. Source: Divakaran, S. Tacon, A.G.J. J-aquat-food-prod-technol. Binghamton, NY : Food Products Press, 1992-. 2000. volume 9 (3) page 115-120. 1049-8850
•
The determination of ultra-trace amounts of aflatoxin M1 in human urine in the Czech Republic. Author(s): National Institute of Public Health Prague, Brno (Republique Tcheque). Centre for the Hygiene of Food Chains Source: Ostry, V. Ruprich, J. Cerna, M. Revue-de-Medecine-Veterinaire (France). (June 1998). volume 149(6) page 712. mankind urine aflatoxins analytical methods surveys czech republic 0035-1555
•
The effect of diet on carcinogenicity of aflatoxin B1 in animals: a review. Source: Nyathi, C.B. Hasler, J.A. Chetsanga, C.J. Zimbabwe-Vet-J. Causeway : Zimbabwe Veterinary Association. June 1985. volume 16 (1/2) page 18-22.
Federal Resources on Nutrition In addition to the IBIDS, the United States Department of Health and Human Services (HHS) and the United States Department of Agriculture (USDA) provide many sources of information on general nutrition and health. Recommended resources include: •
healthfinder®, HHS’s gateway to health information, including diet and nutrition: http://www.healthfinder.gov/scripts/SearchContext.asp?topic=238&page=0
•
The United States Department of Agriculture’s Web site dedicated to nutrition information: www.nutrition.gov
•
The Food and Drug Administration’s Web site for federal food safety information: www.foodsafety.gov
•
The National Action Plan on Overweight and Obesity sponsored by the United States Surgeon General: http://www.surgeongeneral.gov/topics/obesity/
•
The Center for Food Safety and Applied Nutrition has an Internet site sponsored by the Food and Drug Administration and the Department of Health and Human Services: http://vm.cfsan.fda.gov/
•
Center for Nutrition Policy and Promotion sponsored by the United States Department of Agriculture: http://www.usda.gov/cnpp/
•
Food and Nutrition Information Center, National Agricultural Library sponsored by the United States Department of Agriculture: http://www.nal.usda.gov/fnic/
•
Food and Nutrition Service sponsored by the United States Department of Agriculture: http://www.fns.usda.gov/fns/
100
Aflatoxin
Additional Web Resources A number of additional Web sites offer encyclopedic information covering food and nutrition. The following is a representative sample: •
AOL: http://search.aol.com/cat.adp?id=174&layer=&from=subcats
•
Family Village: http://www.familyvillage.wisc.edu/med_nutrition.html
•
Google: http://directory.google.com/Top/Health/Nutrition/
•
Healthnotes: http://www.healthnotes.com/
•
Open Directory Project: http://dmoz.org/Health/Nutrition/
•
Yahoo.com: http://dir.yahoo.com/Health/Nutrition/
•
WebMDHealth: http://my.webmd.com/nutrition
•
WholeHealthMD.com: http://www.wholehealthmd.com/reflib/0,1529,00.html
The following is a specific Web list relating to aflatoxin; please note that any particular subject below may indicate either a therapeutic use, or a contraindication (potential danger), and does not reflect an official recommendation: •
Food and Diet Peanuts Source: Healthnotes, Inc.; www.healthnotes.com
101
CHAPTER 3. ALTERNATIVE MEDICINE AND AFLATOXIN Overview In this chapter, we will begin by introducing you to official information sources on complementary and alternative medicine (CAM) relating to aflatoxin. At the conclusion of this chapter, we will provide additional sources.
National Center for Complementary and Alternative Medicine The National Center for Complementary and Alternative Medicine (NCCAM) of the National Institutes of Health (http://nccam.nih.gov/) has created a link to the National Library of Medicine’s databases to facilitate research for articles that specifically relate to aflatoxin and complementary medicine. To search the database, go to the following Web site: http://www.nlm.nih.gov/nccam/camonpubmed.html. Select “CAM on PubMed.” Enter “aflatoxin” (or synonyms) into the search box. Click “Go.” The following references provide information on particular aspects of complementary and alternative medicine that are related to aflatoxin: •
A UK retail survey of aflatoxins in herbs and spices and their fate during cooking. Author(s): MacDonald S, Castle L. Source: Food Additives and Contaminants. 1996 January; 13(1): 121-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8647302
•
Aflatoxin - induced alteration in the levels of membrane chemical of subcellular organelles isolated from excised, incubated glycine max, cv. “Essex” roots. I. Nonenriched organelles. Author(s): Danley JM, Staggers S, Walker S, Varner A, Llewellyn GC, Dashek WV. Source: Mycopathologia. 1981 June 5; 74(3): 149-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6166863
•
Aflatoxin B1 degradation by flavobacterium aurantiacum in the presence of reducing conditions and seryl and sulfhydryl group inhibitors. Author(s): D'Souza DH, Brackett RE.
102
Aflatoxin
Source: J Food Prot. 2001 February; 64(2): 268-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11271780 •
Aflatoxin B1 in common Egyptian foods. Author(s): Selim MI, Popendorf W, Ibrahim MS, el Sharkawy S, el Kashory ES. Source: J Aoac Int. 1996 September-October; 79(5): 1124-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8823921
•
Aflatoxin B1-induced micronuclei and cell cycle alterations in lung and bone marrow cells and their modulation by Piper argyrophyllum extract. Author(s): Raj HG, Gupta K, Rohil V, Bose M, Biswas G, Singh SK, Jain SC, Parmar VS, Olsen CE, Wengel J. Source: Teratogenesis, Carcinogenesis, and Mutagenesis. 1998; 18(5): 249-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9876014
•
Aflatoxin contamination in foods and foodstuffs in Tokyo: 1986-1990. Author(s): Tabata S, Kamimura H, Ibe A, Hashimoto H, Iida M, Tamura Y, Nishima T. Source: J Aoac Int. 1993 January-February; 76(1): 32-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8448440
•
Aflatoxin contamination of some common drug plants. Author(s): Roy AK, Sinha KK, Chourasia HK. Source: Applied and Environmental Microbiology. 1988 March; 54(3): 842-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3132102
•
Aflatoxin exposure is higher in vegetarians than nonvegetarians in Thailand. Author(s): Vinitketkumnuen U, Chewonarin T, Kongtawelert P, Lertjanyarak A, Peerakhom S, Wild CP. Source: Natural Toxins. 1997; 5(4): 168-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9407561
•
Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Author(s): Peers F, Bosch X, Kaldor J, Linsell A, Pluijmen M. Source: International Journal of Cancer. Journal International Du Cancer. 1987 May 15; 39(5): 545-53. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3570547
•
Aflatoxin formation and varietal difference of cow pea (Vigna unguiculata (L.) Walp.) and garden pea (Pisum sativum L.) cultivars. Author(s): El-Kady IA, El-Maraghy SS, Zohri AA.
Alternative Medicine 103
Source: Mycopathologia. 1996; 133(3): 185-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8927121 •
Aflatoxin in betel nut and its control by use of food preservatives. Author(s): Raisuddin S, Misra JK. Source: Food Additives and Contaminants. 1991 November-December; 8(6): 707-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1812017
•
Aflatoxin production in supplemental feeders provided for northern bobwhite in Texas and Oklahoma. Author(s): Oberheu DG, Dabbert CB. Source: J Wildl Dis. 2001 July; 37(3): 475-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11504221
•
Aflatoxin-albumin adduct formation after single and multiple doses of aflatoxin B(1) in rats treated with Thai medicinal plants. Author(s): Vinitketkumnuen U, Chewonarin T, Dhumtanom P, Lertprasertsuk N, Wild CP. Source: Mutation Research. 1999 July 16; 428(1-2): 345-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10518006
•
Aflatoxins and fungal flora in lentil (Lens esculenta L.). Author(s): el-Maraghy SS. Source: Mycopathologia. 1988 April; 102(1): 31-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3419482
•
Aflatoxins B1 in different grades of chillies (Capsicum annum L.) in India as determined by indirect competitive-ELISA. Author(s): Reddy SV, Mayi DK, Reddy MU, Thirumala-Devi K, Reddy DV. Source: Food Additives and Contaminants. 2001 June; 18(6): 553-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11407753
•
Aflatoxins in Egyptian foodstuffs. Author(s): Girgis AN, el-Sherif S, Rofael N, Nesheim S. Source: J Assoc Off Anal Chem. 1977 May; 60(3): 746-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=858708
•
Aflatoxins in spices marketed in Portugal. Author(s): Martins ML, Martins HM, Bernardo F. Source: Food Additives and Contaminants. 2001 April; 18(4): 315-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11339266
104
Aflatoxin
•
Aflatoxins: production of the toxins on rice-corn steep medium according to some cultural conditions. Author(s): Mabrouk SS, el-Shayeb NM. Source: Zentralbl Bakteriol Naturwiss. 1981; 136(4): 330-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6795852
•
Anticancer potency of the milk extract of Semecarpus anacardium Linn. nuts against aflatoxin B1 mediated hepatocellular carcinoma bearing Wistar rats with reference to tumour marker enzymes. Author(s): Premalatha B, Muthulakshmi V, Sachdanandam P. Source: Phytotherapy Research : Ptr. 1999 May; 13(3): 183-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10353153
•
Antioxidants and radical scavenging properties of vegetable extracts in rats fed aflatoxin-contaminated diet. Author(s): Abdel-Wahhab MA, Aly SE. Source: Journal of Agricultural and Food Chemistry. 2003 April 9; 51(8): 2409-14. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12670189
•
Application of a minicolumn detection method for screening spices for aflatoxin. Author(s): Seenappa M, Kempton AG. Source: Journal of Environmental Science and Health. Part. B, Pesticides, Food Contaminants, and Agricultural Wastes. 1980; 15(3): 219-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6769994
•
Aspergillus infection and aflatoxin production in some cowpea (Vigna unguiculata (L.) Walp) lines in Tanzania. Author(s): Seenappa M, Keswani CL, Kundya TM. Source: Mycopathologia. 1983 November 21; 83(2): 103-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6422301
•
Atmospheric pressure photo-ionization liquid chromatography/mass spectrometric determination of aflatoxins in food. Author(s): Takino M, Tanaka T, Yamaguchi K, Nakahara T. Source: Food Additives and Contaminants. 2004 January; 21(1): 76-84. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14744683
•
Binding of aflatoxin B1 to DNA inhibited by ajoene and diallyl sulfide. Author(s): Tadi PP, Lau BH, Teel RW, Herrmann CE. Source: Anticancer Res. 1991 November-December; 11(6): 2037-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1776837
Alternative Medicine 105
•
Bioactivation of aflatoxin B1 by human liver microsomes: role of cytochrome P450 IIIA enzymes. Author(s): Ramsdell HS, Parkinson A, Eddy AC, Eaton DL. Source: Toxicology and Applied Pharmacology. 1991 May; 108(3): 436-47. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1902334
•
Chemoprevention of aflatoxin B1-initiated and carbon tetrachloride-promoted hepatocarcinogenesis in the rat by green tea. Author(s): Qin G, Ning Y, Lotlikar PD. Source: Nutrition and Cancer. 2000; 38(2): 215-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11525600
•
Chinese medicinal herbs modulate mutagenesis, DNA binding and metabolism of aflatoxin B1. Author(s): Wong BY, Lau BH, Tadi PP, Teel RW. Source: Mutation Research. 1992 June 1; 279(3): 209-16. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1377337
•
Chromosome aberrations induced by aflatoxin B1 in rat bone marrow cells in vivo and their suppression by green tea. Author(s): Ito Y, Ohnishi S, Fujie K. Source: Mutation Research. 1989 March; 222(3): 253-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2922009
•
Comparative effect of dietary butylated hydroxyanisole and beta-naphthoflavone on aflatoxin B1 metabolism, DNA adduct formation, and carcinogenesis in rainbow trout. Author(s): Goeger DE, Shelton DW, Hendricks JD, Pereira C, Bailey GS. Source: Carcinogenesis. 1988 October; 9(10): 1793-800. Erratum In: Carcinogenesis 1988 November; 9(11): 2146. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3139317
•
Comparison of the effects of dietary selenium, zinc, and selenium and zinc supplementation on growth and immune response between chick groups that were inoculated with Salmonella and aflatoxin or Salmonella. Author(s): Hegazy SM, Adachi Y. Source: Poultry Science. 2000 March; 79(3): 331-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10735198
•
Comparison of the prevention of aflatoxin b(1)-induced genotoxicity by quercetin and quercetin pentaacetate. Author(s): Kohli E, Raj HG, Kumari R, Rohil V, Kaushik NK, Prasad AK, Parmar VS.
106
Aflatoxin
Source: Bioorganic & Medicinal Chemistry Letters. 2002 September 16; 12(18): 2579-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12182864 •
Comparison of the profiles of seedborne fungi and the occurrence of aflatoxins in mould-damaged beans and soybeans. Author(s): Tseng TC, Tu JC, Soo LC. Source: Microbios. 1995; 84(339): 105-16. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8628121
•
Comparison of three methods for determining aflatoxins in sunflower seed meals. Author(s): Trucksess MW, Stoloff L. Source: J Assoc Off Anal Chem. 1980 November; 63(6): 1357-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7451399
•
Dependence of aflatoxin in almonds on the type and amount of insect damage. Author(s): Schatzki TF, Ong MS. Source: Journal of Agricultural and Food Chemistry. 2001 September; 49(9): 4513-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11559163
•
Dietary exposure to aflatoxin in Benin City, Nigeria: a possible public health concern. Author(s): Ibeh IN, Uraih N, Ogonor JI. Source: International Journal of Food Microbiology. 1991 November; 14(2): 171-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1777386
•
Diminution of aflatoxin toxicity to growing lambs by dietary supplementation with hydrated sodium calcium aluminosilicate. Author(s): Harvey RB, Kubena LF, Phillips TD, Corrier DE, Elissalde MH, Huff WE. Source: Am J Vet Res. 1991 January; 52(1): 152-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1850585
•
DNA binding and mutagenicity of aflatoxin B1 catalyzed by isolated rabbit lung cells. Author(s): Daniels JM, Matula TI, Massey TE. Source: Carcinogenesis. 1993 July; 14(7): 1429-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8330361
•
Drug resistance patterns and susceptibility to aflatoxin B1 of strains of Escherichia coli and Staphylococcus aureus. Author(s): Tiwari RP, Singh G, Vadehra DV. Source: Journal of Medical Microbiology. 1986 September; 22(2): 115-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3091837
Alternative Medicine 107
•
Effect of a lignan-enriched extract of Schisandra chinensis on aflatoxin B1 and cadmium chloride-induced hepatotoxicity in rats. Author(s): Ip SP, Mak DH, Li PC, Poon MK, Ko KM. Source: Pharmacology & Toxicology. 1996 June; 78(6): 413-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8829203
•
Effect of aflatoxin G1 on germination, growth and metabolic activities of some crop plants. Author(s): el-Naghy MA, Fadl-Allah EM, Samhan M. Source: Cytobios. 1999; 97(385): 87-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10418120
•
Effect of aflatoxin in growing lambs fed ruminally degradable or escape protein sources. Author(s): Edrington TS, Harvey RB, Kubena LF. Source: Journal of Animal Science. 1994 May; 72(5): 1274-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8056674
•
Effect of allixin, a phytoalexin produced by garlic, on mutagenesis, DNA-binding and metabolism of aflatoxin B1. Author(s): Yamasaki T, Teel RW, Lau BH. Source: Cancer Letters. 1991 August; 59(2): 89-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1909211
•
Effect of alpha-tocopherol supplementation on the impact of aflatoxin B1 on the testes of rats. Author(s): Ibeh IN, Saxena DK. Source: Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie. 1998 June; 50(3): 221-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9681652
•
Effect of an extract of the root of Scutellaria baicalensis and its flavonoids on aflatoxin B1 oxidizing cytochrome P450 enzymes. Author(s): Kim BR, Kim DH, Park R, Kwon KB, Ryu DG, Kim YC, Kim NY, Jeong S, Kang BK, Kim KS. Source: Planta Medica. 2001 July; 67(5): 396-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11488450
•
Effect of C6 to C9 alkenals on aflatoxin production in corn, cottonseed, and peanuts. Author(s): Zeringue HJ Jr. Source: Applied and Environmental Microbiology. 1991 August; 57(8): 2433-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1768117
108
Aflatoxin
•
Effect of cyclopropenoid fatty acids on the hepatic microsomal mixed-functionoxidase system and aflatoxin metabolism in rabbits. Author(s): Eisele TA, Loveland PM, Kruk DL, Meyers TR, Sinnhuber RO, Nixon JE. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 1982 August; 20(4): 407-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6813208
•
Effect of diallyl sulfide and diallyl disulfide, the active principles of garlic, on the aflatoxin B(1)-induced DNA damage in primary rat hepatocytes. Author(s): Sheen LY, Wu CC, Lii CK, Tsai SJ. Source: Toxicology Letters. 2001 May 31; 122(1): 45-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11397556
•
Effect of different inhibitors of sterol biosynthesis on both fungal growth and aflatoxin production. Author(s): Fanelli C, Fabbri AA, Brasini S, De Luca C, Passi S. Source: Natural Toxins. 1995; 3(2): 109-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7613735
•
Effect of herba artemisiae scopariae on cytogenetic damage induced by aflatoxin B1. Author(s): Hong Z, Ye T, Chen S, Liu L, Lin L. Source: J Tradit Chin Med. 1996 March; 16(1): 51-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8758712
•
Effect of Piper betle L. and its extracts on the growth and aflatoxin production by Aspergillus parasiticus. Author(s): Chou CC, Yu RC. Source: Proc Natl Sci Counc Repub China B. 1984 January; 8(1): 30-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6531413
•
Effect of Salvia miltiorrhiza on aflatoxin B1-induced oxidative stress in cultured rat hepatocytes. Author(s): Liu J, Yang CF, Lee BL, Shen HM, Ang SG, Ong CN. Source: Free Radical Research. 1999 December; 31(6): 559-68. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10630680
•
Effects of capsaicin on rat liver S9-mediated metabolism and DNA binding of aflatoxin. Author(s): Teel RW. Source: Nutrition and Cancer. 1991; 15(1): 27-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1901992
Alternative Medicine 109
•
Effects of saturated and unsaturated dietary fat on aflatoxin B1 metabolism. Author(s): Marzuki A, Norred WP. Source: Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association. 1984 May; 22(5): 383-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6427082
•
Ergosterol oxidation may be considered a signal for fungal growth and aflatoxin production in Aspergillus parasiticus. Author(s): De Luca C, Passi S, Fabbri AA, Fanelli C. Source: Food Additives and Contaminants. 1995 May-June; 12(3): 445-50. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7664941
•
Failure of plant tissues to metabolize aflatoxin B1? Author(s): Reiss J. Source: Mycopathologia. 1984 March 15; 85(1-2): 43-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6427615
•
Failure of vitamin supplementation to alter the fatty liver syndrome caused by aflatoxin. Author(s): Hamilton PB, Garlich JD. Source: Poultry Science. 1972 March; 51(2): 688-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4629962
•
Fungal contamination, natural occurrence of mycotoxins and resistance for aflatoxin accumulation of some broad bean (Vicia faba L.) cultivars. Author(s): Saber SM. Source: Journal of Basic Microbiology. 1992; 32(4): 249-58. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1460568
•
Fungi and aflatoxins associated with spices in the Sultanate of Oman. Author(s): Elshafie AE, Al-Rashdi TA, Al-Bahry SN, Bakheit CS. Source: Mycopathologia. 2002; 155(3): 155-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12617502
•
Hepatocurative effect of picroliv and silymarin against aflatoxin B1 induced hepatotoxicity in rats. Author(s): Rastogi R, Srivastava AK, Srivastava M, Rastogi AK. Source: Planta Medica. 2000 December; 66(8): 709-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11199126
•
High pressure liquid chromatographic determination of aflatoxins in spices. Author(s): Awe MJ, Schranz JL.
110
Aflatoxin
Source: J Assoc Off Anal Chem. 1981 November; 64(6): 1377-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7309657 •
Immunoaffinity column cleanup with liquid chromatography using post-column bromination for determination of aflatoxins in peanut butter, pistachio paste, fig paste, and paprika powder: collaborative study. Author(s): Stroka J, Anklam E, Jorissen U, Gilbert J. Source: J Aoac Int. 2000 March-April; 83(2): 320-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10772170
•
In vitro cytochrome P450 monooxygenase and prostaglandin H-synthase mediated aflatoxin B1 biotransformation in guinea pig tissues: effects of beta-naphthoflavone treatment. Author(s): Liu L, Nakatsu K, Massey TE. Source: Archives of Toxicology. 1993; 67(6): 379-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8215906
•
In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Author(s): Guengerich FP, Kim DH. Source: Carcinogenesis. 1990 December; 11(12): 2275-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2265479
•
In vivo effect of dietary factors on the molecular action of aflatoxin B1: role of nonnutrient phenolic compounds on the catalytic activity of liver fractions. Author(s): Aboobaker VS, Balgi AD, Bhattacharya RK. Source: In Vivo. 1994 November-December; 8(6): 1095-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7772744
•
Incidence of aflatoxin B1 in the Egyptian cured meat basterma and control by gammairradiation. Author(s): Refai MK, Niazi ZM, Aziz NH, Khafaga NE. Source: Die Nahrung. 2003 December; 47(6): 377-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=14727763
•
Incidence of aflatoxin-potential contamination in Spanish sausages. Author(s): Guergue J, Ramirez C. Source: Ann Nutr Aliment. 1977; 31(4-6): 485-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=613913
•
Incidence of seed-borne fungi and aflatoxins in Sudanese lentil seeds. Author(s): el-Nagerabi SA, Elshafie AE.
Alternative Medicine 111
Source: Mycopathologia. 2001; 149(3): 151-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11307599 •
Increase in glucuronide conjugation of aflatoxin P1 after pretreatment with microsomal enzyme inducers. Author(s): Ehrich M, Huckle WR, Larsen C. Source: Toxicology. 1984 August; 32(2): 145-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6464026
•
Indole-3-carbinol and beta-naphthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of aflatoxin B1 in the rat. Author(s): Stresser DM, Bailey GS, Williams DE. Source: Drug Metabolism and Disposition: the Biological Fate of Chemicals. 1994 MayJune; 22(3): 383-91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8070314
•
Indole-3-carbinol induces a rat liver glutathione transferase subunit (Yc2) with high activity toward aflatoxin B1 exo-epoxide. Association with reduced levels of hepatic aflatoxin-DNA adducts in vivo. Author(s): Stresser DM, Williams DE, McLellan LI, Harris TM, Bailey GS. Source: Drug Metabolism and Disposition: the Biological Fate of Chemicals. 1994 MayJune; 22(3): 392-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8070315
•
Influence of ascorbic acid supplementation on the haematological and clinical biochemistry parameters of male rabbits exposed to aflatoxin B1. Author(s): Yousef MI, Salem MH, Kamel KI, Hassan GA, El-Nouty FD. Source: Journal of Environmental Science and Health. Part. B, Pesticides, Food Contaminants, and Agricultural Wastes. 2003 March; 38(2): 193-209. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12617557
•
Influence of sundrying on the chemical composition, aflatoxin content and fungal counts of two pepper varieties--Capsicum annum and Capsicum frutescens. Author(s): Adegoke GO, Allamu AE, Akingbala JO, Akanni AO. Source: Plant Foods for Human Nutrition (Dordrecht, Netherlands). 1996 February; 49(2): 113-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8811723
•
Inhibition by the bioflavonoid ternatin of aflatoxin B1-induced lipid peroxidation in rat liver. Author(s): Souza MF, Tome AR, Rao VS.
112
Aflatoxin
Source: The Journal of Pharmacy and Pharmacology. 1999 February; 51(2): 125-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10217309 •
Inhibition of aflatoxin B1 carcinogenesis in rainbow trout by flavone and indole compounds. Author(s): Nixon JE, Hendricks JD, Pawlowski NE, Pereira CB, Sinnhuber RO, Bailey GS. Source: Carcinogenesis. 1984 May; 5(5): 615-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6426808
•
Inhibition of aflatoxin B1 genotoxicity in human liver-derived HepG2 cells by kolaviron biflavonoids and molecular mechanisms of action. Author(s): Nwankwo JO, Tahnteng JG, Emerole GO. Source: European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 2000 October; 9(5): 351-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11075889
•
Inhibition of aflatoxin B1-hepatocarcinogenesis in rats by beta-naphthoflavone. Author(s): Gurtoo HL, Koser PL, Bansal SK, Fox HW, Sharma SD, Mulhern AI, Pavelic ZP. Source: Carcinogenesis. 1985 May; 6(5): 675-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3924427
•
Inhibition of aflatoxin B1-induced initiation of hepatocarcinogenesis in the rat by green tea. Author(s): Qin G, Gopalan-Kriczky P, Su J, Ning Y, Lotlikar PD. Source: Cancer Letters. 1997 January 30; 112(2): 149-54. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9066721
•
Inhibition of aflatoxin formation by some spices. Author(s): Mabrouk SS, El-Shayeb NM. Source: Z Lebensm Unters Forsch. 1980; 171(5): 344-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6778016
•
Inhibition of aflatoxin production & growth of Aspergillus flavus by eugenol & onion & garlic extracts. Author(s): Bilgrami KS, Sinha KK, Sinha AK. Source: The Indian Journal of Medical Research. 1992 June; 96: 171-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1512040
•
Inhibition of Aspergillus growth and aflatoxin release by derivatives of benzoic acid. Author(s): Chipley JR, Uraih N.
Alternative Medicine 113
Source: Applied and Environmental Microbiology. 1980 August; 40(2): 352-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6781406 •
Inhibition of dexamethasone-induced cytochrome P450-mediated mutagenicity and metabolism of aflatoxin B1 by Chinese medicinal herbs. Author(s): Wong BY, Lau BH, Yamasaki T, Teel RW. Source: European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 1993 July; 2(4): 351-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8358288
•
Inhibition of growth and aflatoxin production in Aspergillus parasiticus by essential oils of selected plant materials. Author(s): Tantaoui-Elaraki A, Beraoud L. Source: Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer. 1994; 13(1): 67-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7823297
•
Inhibition of growth and aflatoxin production of Aspergillus parasiticus by citrus oils. Author(s): Alderman GG, Marth EH. Source: Z Lebensm Unters Forsch. 1976 April 28; 160(4): 353-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=973437
•
Interaction of aflatoxin B 1 metabolite with rat liver RNA. Author(s): Gurtoo HL, Dave C. Source: Res Commun Chem Pathol Pharmacol. 1973 May; 5(3): 635-45. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4144818
•
Investigation of various extractants for the analysis of aflatoxin B1 in different food and feed matrices. Author(s): Stroka J, Petz M, Joerissen U, Anklam E. Source: Food Additives and Contaminants. 1999 August; 16(8): 331-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10645347
•
Isolation of aflatoxin from Acacia and the incidence of Aspergillus flavus in the Sudan. Author(s): Abdalla MH. Source: Mycopathologia. 1988 December; 104(3): 143-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3148862
114
Aflatoxin
•
Isolation, purification and characterization of enzyme(s) responsible for conversion of sterigmatocystin to aflatoxin B1. Author(s): Mashaly RI, Habib SL, el-Deeb SA, Salem MH, Safwat MM. Source: Z Lebensm Unters Forsch. 1988 February; 186(2): 118-24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3128018
•
Long term effect of aflatoxin B(1) on lipid peroxidation in rat liver and kidney: effect of picroliv and silymarin. Author(s): Rastogi R, Srivastava AK, Rastogi AK. Source: Phytotherapy Research : Ptr. 2001 June; 15(4): 307-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11406853
•
Malonate as a precursor in the biosynthesis of aflatoxins. Author(s): Gupta SR, Prasanna HR, Viswanathan L, Venkitasurbramanian TA. Source: J Gen Microbiol. 1975 June; 88(2): 317-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=239093
•
Mechanism of action of aflatoxin B1 in Bacillus megaterium. Author(s): Tiwari RP, Dham CK, Bhalla TC, Saini SS, Vadehra DV. Source: Applied and Environmental Microbiology. 1985 April; 49(4): 904-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3923926
•
Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism. Author(s): Manson MM, Ball HW, Barrett MC, Clark HL, Judah DJ, Williamson G, Neal GE. Source: Carcinogenesis. 1997 September; 18(9): 1729-38. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9328168
•
Mechanisms of protection against aflatoxin B(1) genotoxicity in rats treated by organosulfur compounds from garlic. Author(s): Guyonnet D, Belloir C, Suschetet M, Siess MH, Le Bon AM. Source: Carcinogenesis. 2002 August; 23(8): 1335-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12151352
•
Medicinal herb, Thonningia sanguinea protects against aflatoxin B1 acute hepatotoxicity in Fischer 344 rats. Author(s): Gyamfi MA, Aniya Y. Source: Human & Experimental Toxicology. 1998 August; 17(8): 418-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9756133
Alternative Medicine 115
•
Modifying role of dietary factors on the mutagenicity of aflatoxin B1: in vitro effect of plant flavonoids. Author(s): Francis AR, Shetty TK, Bhattacharya RK. Source: Mutation Research. 1989 April; 222(4): 393-401. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2495440
•
Modulating effect of Semecarpus anacardium Linn. nut extract on glucose metabolizing enzymes in aflatoxin B1-induced experimental hepatocellular carcinoma. Author(s): Premalatha B, Sujatha V, Sachdanandam P. Source: Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 1997 September; 36(3): 187-92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9367662
•
Modulating role of Semecarpus anacardium L. nut milk extract on aflatoxin B(1) biotransformation. Author(s): Premalatha B, Sachdanandam P. Source: Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 2000 January; 41(1): 19-24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10600265
•
Modulation of aflatoxin B1 activated protein kinase C by phenolic compounds. Author(s): Mistry KJ, Krishna M, Bhattacharya RK. Source: Cancer Letters. 1997 December 16; 121(1): 99-104. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9459180
•
Modulation of aflatoxin B1 biotransformation by beta-naphthoflavone in isolated rabbit lung cells. Author(s): Im SH, Bolt MW, Stewart RK, Massey TE. Source: Archives of Toxicology. 1996; 71(1-2): 72-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9010588
•
Modulation of aflatoxin B1 biotransformation in rabbit pulmonary and hepatic microsomes. Author(s): Daniels JM, Massey TE. Source: Toxicology. 1992 August; 74(1): 19-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1514185
•
Modulatory effects of essential oils from spices on the formation of DNA adduct by aflatoxin B1 in vitro. Author(s): Hashim S, Aboobaker VS, Madhubala R, Bhattacharya RK, Rao AR.
116
Aflatoxin
Source: Nutrition and Cancer. 1994; 21(2): 169-75. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8058527 •
Mutation of Chinese Hamster V79 cells and transformation and mutation of mouse fibroblast C3H/10T1/2 clone 8 cells by aflatoxin B1 and four other furocoumarins isolated from two Nigerian medicinal plants. Author(s): Uwaifo AO, Billings PC, Heidelberger C. Source: Cancer Research. 1983 March; 43(3): 1054-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=6402296
•
Negative ion chemical ionization mass spectrometric method for confirmation of identity of aflatoxin B1: collaborative study. Author(s): Park DL, Diprossimo V, Abdel-Malek E, Trucksess MW, Nesheim S, Brumley WC, Sphon JA, Barry TL, Petzinger G. Source: J Assoc Off Anal Chem. 1985 July-August; 68(4): 636-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=3928591
•
Organosulfur compounds of garlic modulate mutagenesis, metabolism, and DNA binding of aflatoxin B1. Author(s): Tadi PP, Teel RW, Lau BH. Source: Nutrition and Cancer. 1991; 15(2): 87-95. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1903884
•
Oxidative metabolism of aflatoxin B1 by rat liver microsomes in vitro and its effect on lipid peroxidation. Author(s): Raj HG, Santhanam K, Gupta RP, Venkitasubramanian TA. Source: Res Commun Chem Pathol Pharmacol. 1974 August; 8(4): 703-6. No Abstract Available. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=4153624
•
Piperine inhibits aflatoxin B1-induced cytotoxicity and genotoxicity in V79 Chinese hamster cells genetically engineered to express rat cytochrome P4502B1. Author(s): Reen RK, Wiebel FJ, Singh J. Source: Journal of Ethnopharmacology. 1997 November; 58(3): 165-73. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9421252
•
Potency of Semecarpus anacardium Linn. nut milk extract against aflatoxin B(1)induced hepatocarcinogenesis: reflection on microsomal biotransformation enzymes. Author(s): Premalatha B, Sachdanandam P. Source: Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 2000 August; 42(2): 161-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=10887046
Alternative Medicine 117
•
Potential mold growth, aflatoxin production, and antimycotic activity of selected natural spices and herbs. Author(s): Llewellyn GC, Burkett ML, Eadie T. Source: J Assoc Off Anal Chem. 1981 July; 64(4): 955-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=7275911
•
Preventive action of garlic on aflatoxin B1-induced carcinogenesis in the toad Bufo regularis. Author(s): el-Mofty MM, Sakr SA, Essawy A, Abdel Gawad HS. Source: Nutrition and Cancer. 1994; 21(1): 95-100. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8183725
•
Protection of salvia miltiorrhiza against aflatoxin-B1-induced hepatocarcinogenesis in Fischer 344 rats dual mechanisms involved. Author(s): Liu J, Yang CF, Wasser S, Shen HM, Tan CE, Ong CN. Source: Life Sciences. 2001 June 8; 69(3): 309-26. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11441922
•
Protective effect of food additives on aflatoxin-induced mutagenicity and hepatocarcinogenicity. Author(s): Soni KB, Lahiri M, Chackradeo P, Bhide SV, Kuttan R. Source: Cancer Letters. 1997 May 19; 115(2): 129-33. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=9149115
•
Protective effect of soybean saponins and major antioxidants against aflatoxin B1induced mutagenicity and DNA-adduct formation. Author(s): Jun HS, Kim SE, Sung MK. Source: Journal of Medicinal Food. 2002 Winter; 5(4): 235-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12639399
•
Protective effects of baicalein and wogonin against benzo[a]pyrene- and aflatoxin B(1)-induced genotoxicities. Author(s): Ueng YF, Shyu CC, Liu TY, Oda Y, Lin YL, Liao JF, Chen CF. Source: Biochemical Pharmacology. 2001 December 15; 62(12): 1653-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=11755119
•
Purification and characterization of the esterases involved in aflatoxin biosynthesis in Aspergillus parasiticus. Author(s): Kusumoto K, Hsieh DP. Source: Canadian Journal of Microbiology. 1996 August; 42(8): 804-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=8776851
118
Aflatoxin
•
Quantification of the copy number of nor-1, a gene of the aflatoxin biosynthetic pathway by real-time PCR, and its correlation to the cfu of Aspergillus flavus in foods. Author(s): Mayer Z, Bagnara A, Farber P, Geisen R. Source: International Journal of Food Microbiology. 2003 April 25; 82(2): 143-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=12568754
•
Reduction of aflatoxin content of infected cowpea seeds during processing into food. Author(s): Ogunsanwo BM, Faboya OO, Idowu OR, Ikotun T. Source: Die Nahrung. 1989; 33(6): 595-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=2797118
•
Reliability of a short-term test for hepatocarcinogenesis induced by aflatoxin B1. Author(s): Li Y, Yan RQ, Qin GZ, Qin LL, Duan XX. Source: Iarc Sci Publ. 1991; (105): 431-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1677348
•
Reversal of aflatoxin induced liver damage by turmeric and curcumin. Author(s): Soni KB, Rajan A, Kuttan R. Source: Cancer Letters. 1992 September 30; 66(2): 115-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=A bstract&list_uids=1394115
•
Screening of aflatoxins in Shiro and ground red pepper in Addis Ababa. Author(s): Fufa H, Urga K. Source: Ethiop Med J. 1996 October; 34(4): 24